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CHAPTER I 
INTRODUCTION 
Parts of thia chapter are taken from: 
"Some aspects of HnRNA Processing" by W.J. van VenrooS and 
E.C.M. Mariman. Cell Compartmentatlon and Metabolic 
Chaneling, 1980, Elseviers/North-Holland Biomedical Press. 

1. RNA PROCESSING 
In the nucleus of eukaryotic cells 5-15? of the DNA is 
transcribed into heterogeneous nuclear RNA (hnRNA). HnRNA can 
be distinguished from other types of nuclear RNA Ъу pulse labe­
ling since it is rapidly labeled before other types of nuclear 
RNA (as for instance (pre)ribosoinal RNA) have accumulated signi­
ficant label. Part of the hnRNA is processed to translatable 
mRNA by a series of post-transoriptlonal modifications (reviewed 
in 1-6) and is therefore referred to as "pre-mRNA". Рг -mRNA is 
synthesized by RNA-polymerase II snd as such its synthesis can 
be repressed by ot-amanitin, a specific inhibitor of RNA-poly­
merase II when used in low concentrations (7)· 
The processing of pre-mRNA to mRNA generally includes several 
steps: capping, polyadenylation» methylation and splicing. Each of 
these steps will be described below. 
1.1. CAPPING 
Analysis of the 5' terminus of eukaryotic mRNAs has revealed 
in almost all cases the presence of a blocked structure, 
m GS'pppS'N, referred to as "cap" (8,9). Kinetic labeling ex­
periments (10) and the presence of cap structures in prematurely 
terminated RNA-polymerase II transcripts (11,12) indicate that 
cap formation is an early event occurring on the hnRNA while 
transcription proceeds. In the case of reovirus it was found 
that the mRNA is already capped at the level of the nascent 
dinucleotide (13,H), while in the case of cytoplasmic poly-
hedrosis virus mRNA the cap is formed even before the start of 
transcription (15-17). Generally capping occurs before further 
processing as polyadenylation and splicing (11,12,22), 
At least four mechanism have been suggested for cap-formation. 
Three of these can be distinguished by the origin of the g-
phoshate of the triphosphate bridge of the resulting cap struc­
ture (Fig. 1). 
1. Dephosphorylation of the 5'-triphosphate terminus of the RNA 
(by a nucleotide phosphohydrolase) followed by condensation 
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1 and 3» by GTP in mechanism 4 or obtained 
η reaction in mechanism 2. In mechanism 1, 2 
monophosphate, in mechanism 4. a diphosphate 
chanism 3 only one enzyme (guanylyltransferase) 
of the diphosphate terminating derivatives with GTP (by a 
guanylyl transferase) produces the unmethylated cap struc­
ture. Methylating enzymes will subsequently transfer methyl-
groups from S-adenosyl-methionine to these structures. 
The triphosphate bridge of the resulting cap structures is 
derived from the α-phosphate of GTP and the
 α
- and ß-phos-
phates of the RNA acceptor. This pattern of reactions was 
observed in reovirus (14·) and in cytoplasmic polyhedrosis 
virus (15). and seems to be operative in L-cells (18), 
Hela-cells (19) and rat liver cells (20) as well. 
It seems likely that most eukaryotic cells follow this 
mechanism in cap formation. 
2. Capping in L-cells may not only occur at the 5' terminus of 
the primary transcript but also at internal cleavage sites 
(18). It was proposed that an as yet not detected poly­
nucleotide 5'-monophosphate kinase produces the intermediate 
diphosphate ppXpYpZp... which subsequently can react with 
GTP and methylating enzymes. 
3. Guanylyl transferase purified from vaccinia virus catalyzed 
the reaction between GTP and the 5'-triphosphate terminus of 
RNA (21). Also in this case the triphosphate bridge of the 
cap is constructed from the a- and 3- phosphates of the RNA 
acceptor (compare mechanism 1). 
Д. Cap-formation on RNA of vesicular stomatitis virus seems to 
occur after cleavage of the RNA. The 5'-monophosphate ter­
minating RNA molecules then react with GTP under release of 
the y-phosphate of GTP (8) 
Although some animal and plant RNAs are not capped, generally 
cap-formation seems to be closely linked to the initiation of 
transcription by RNA-polymeraae II (22). Analysis of the 5' ter­
minal nucleotide of mRNAs has revealed that cap addition pre­
ferentially occurs to A > G » U > С, and that a 5' end of a 
specific mRNA may be heterogeneous as if the polymerase looks 
for pyrimidine residues within a narrow region of the DNA to 
start initiation of transcription, accompanied by the addition 
of GMP to the selected ultimate residue (23-25). 
The exact function of the cap remains unclear. Early capping 
may protect the nascent hnRNA chains from S'-exonucleolytic 
degradation (26). The cap may also be involved in the binding 
of the RNA to nuclear or cytoplasmic skeletal structures, in 
transport and/or translation of the processed mRNA (27). 
1.2. POLY(A)-ADDITION 
To the 3' end of pre-mRNA, AMP-residues are added by nuclear 
poly(A)-polymerases. Reported values of completed poly(A)-
segments range between 180 and 200 nucleotides (28,29). 
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Polyadenylation may occur before or after termination of trans­
cription (Fig. 2). In some viral and cellular transcription 
units it has been demonstrated that transcription proceeds be­
yond the termination site (6,30). In other cases the hnRNA 
seems to be terminated first and the excess RNA at the 3' end, 
if present, is removed before addition of the AMP residues 
(31-33)· Anyway, it seems to be a common phenomenon that the 
polyadenylation site does not coincide with the site for 
termination of transcription (6). However, in yeast gene ex­
pression, and probably in the production of adenoviral LI-mRNAs 
as well, termination occurs at or close to the polyadenylation 
site (33,34)· 
Polyadenylation occurs within 1 or 2 min after transcription 
has passed beyond the poly(A)-site (35) and it has been sugges­
ted that it precedes the process of RNA splicing (30). However, 
the length of adenoviral L5-specific processing intermediates 
(36) and studies on in vitro transcription and processing (34) 
have indicated that this might not always be the case (see 
also Chapter II of this thepis), 
The hexanucleotide З'-АЛиЛАА-З' or a variation thereof, 
AUUAAA (38,1^1,152), forms part of the recognition site for 
polyadenylation. The synthesis of poly(A) seems to occur at a 
fixed distance downstream of this signal, somewhere between 11 
and 30 nucleotides beyond the hexanucleotide (33,37), Other 
signals may also be involved in marking the polyadenylation 
site, since yeast mRNAs lack the common hexanucleotide (33)· 
Although it is assumed that the poly(A)-addition occurs within 
a fixed distance beyond the hexanucleotide signal, it was found 
in prolactin messengers that this distance can vary (39). An 
interesting fact is that in a-amylase and chicken vimentin 
RNA-polyadenylation either of two sequential poly(A)-sites may 
be used resulting in messengers which differ in the length of 
their 3' untranslated region (ДО,242). The longer mRNA thus 
contains a non-used poly(A)-addition site. A similar situation 
in which either of three sequential poly(A)-sites can be used 
was observed in chicken ovomucoid mRNA production (141). An 
adenoviral L5 nuclear RNA species was detected which was poly-
sbnylated at a site downstream from the poly(A)-site of L5 mRNAs 
(36). If this species is an intermediate in the formation of 
L5 mRNAs, then further processing must involve cleavage of 
this large polyadenylated precursor at the mRNA poly(A)-addition 
site followed by the synthesis of poly(A) at the newly formed 
3' end. Such a processing pathway may provide one explanation 
for the existence of polyadenylated RNA species which do not 
enter the cytoplasm. 
The poly(A)-polymeraeee catalyze the reaction: 
primer + nATP ->• primer-(AMP) + nPPi 
η 
Characteristics of the poly(A)-polymerases are their absolute 
2+ 2+ 
Mn or Mg dependency and their specificity for ATP as sub­
strate (41-43). The whole process of polyadenylation may need 
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several polyadenylating enzymes. This is also indicated by the 
fact that in extracts of rat liver cells at last three distinct 
poly(A)-polyraerases were found, one of them having a preference 
for primers containing 3' oligo(A)-stretches (4-4)· An intriguing 
finding is that the poly(A)-polymerase can act as a 3'-exonuclease 
at low ATP concentrations (4-5). As a consequence the ATP concen-
tration in the nucleus may play an important role in the turn-
over of nuclear poly(A). It is also conceivable that nuclear 
poly(A) might function as an adenosine stock which is mobilized 
when the nuclear ATP concentration runs too low (45). From hy-
bridization studies it has been concluded that a.o. in Hela 
cells poly(A) is also added to hnRNA molecules that do not 
function as pre-mRNA (4.6,47). It is possible that in particular 
the poly(A)-tails added to this non-precursor class of hnRNA 
are functioning as an alternative adenosine pool and are sub-
ject to rapid turnover. This is in agreement with the observa-
tion that poly(A)-segments added to pre-mRNAs, as in adenovirus 
transcripts (30), are almost completely conserved during pro-
cessing and transport to the cytoplasm. Finally, the absence 
of poly(A) from histone messengers, which also lack the common 
hexanucleotide (33), shows that a poly(A)-tail is not an 
absolute requirement for either translation or transport of 
mRNA. 
1.3. METHYLATION 
Cap methylation 
Synthesis of the cap structure involves the addition of one, 
two or three methylgroups to the 5' end of the RNA. Certain 
mRNAs from animal and plant viruses contain m GpppXpYpZp... 
(cap 0), which is not methylated further. Other RNAs have an 
additional metylgroup at the 2' OH position of the penultimate 
residue to form the cap 1 structure, m GpppXmpYpZp... (8,9). 
With purified enzymes from Hela cells it was found that the 
minimal chain extension to make 2'-0-methylation possible is 
two nucleotides (GpppXpYp) (19). 
2'-0-methylation of the third residue of the 5' end, giving 
rise to cap 2 structures, m GpppX pY pZp.., has not been found 
to occur on hnRNA and the corresponding methylating enzyme ia 
a specific cytoplasmic enzyme (19t48-50). 
Internal methylation 
Internal methylations in hnRNA or mRNA are only found on 
adenine. The m Ар residues are not part of the poly(A)-segment 
and most RNAs contain an average of 2-3 base methylations per 
S'-terminus (49-52). In Heia cell mRNA, and in other cell types 
as well, the m A residues are preceded by a purine and followed 
exclusively by cytosine (52-55). This indicates that this 
short sequence, albeit not the only requirement (55), is an 
important part of the signal recognized by the methylating 
enzyme. 
Most of the cap structures as well as the internal adenine 
methylations seem to be maintained during processing (48,53, 
56,57). The internal methylations may be located in the protein-
coding region of the messengers (55). Until now no function 
could be ascribed to the m A residues. Some messengers may even 
lack internal methyl groups (58). Several workers have suggested 
a role for the methylated residues in marking the places for 
other processing steps (for example splicing) (55,56) a 
principle which has already been established for rRNA and tRNA 
precursors. 
1.4. SPLICING 
History 
In 1977 electron microscopic studies on the expression of 
DNA tumor viruses led to the discovery that viral mRNAs are 
composed of pieces of RNA which are transcribed from non­
contiguous regions in the DNA (59,60,61). Although originally 
several mechanisms were proposed to explain this phenomenon, 
further studies showed that the pieces of RNA, which are 
destined to constitute the messenger (exonic-regions, exons) 
are spliced with the removal of the intervening sequences 
(intronic-regions, introns) from a precursor molecule, which 
is colinear to the DNA. Soon after the discovery of splicing 
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in viral mRNAs it was also found to occur in the formation of 
cellular mRNAs, and nowadays it seems that splicing is a common 
step in the expression of eukaryotic genes. 
Evolution 
As far as evolution is concerned the general idea has arisen 
that the presence of intervening sequences in genes is a 
reflexion of a very early evolutionary state of a genome (62). 
The presence of intervening sequences may facilitate the re­
shuffling of exonic sequences by crossing-over within the 
introns (63). Combined with the idea that exons code for func­
tional units of proteins (64)1 this presents a mechanism in 
which the combination of different exons may lead to the 
formation of new proteins. In this way the intervening sequences 
give an advantageous quality to the genome and may, therefore, 
have been conserved through evolution. However, only in a few 
cases, as for instance globin (65.66), lysozyme (67), ovomucoid 
(14-Λ) and immunoglobin (68), exons can be clearly correlated 
with functional units. This discrepancy might in part be due to 
the loss of introns from genes. In such cases exons are 
composed of more than one structural unit which are called 
"modules" (69). Loss of introns from genes has been demonstrated, 
for example, in the two rat insulin genes, one of which has two 
introns and the other contains only one of the introns (70). 
Thus in eukaryotes there might exist a mechanism by which 
intervening sequences could be accurately removed from genes. 
Some pseudogenes demonstrate extreme cases of this phenomenon 
since they have lost all intervening sequences (71,72) and are 
therefore an exact copy of the mRNA. These pseudogenes simply 
may be reintegrations of cDNAs derived from reverse trans­
cription of totally spliced RNAs (73,74). This opens the 
possibility that in the case of rat insulin the gene lacking 
one intron may have arisen via the reintegration of a cDNA of 
a partly spliced RNA molecule. The surprising homology between 
ovalbumin and α 1-antitrypsin has led to the suggestion that 
their genes have evolved via the selective loss of introns 
from a duplicated ancestral gene. The хоп-sequences in both 
genes are related but the intron-sequences and their number 
(7 and 3 respectively) are not and they are present in different 
locations in the gene (75). Therefore, selective loss of introns 
may have occurred in their formation from an ancestral gene 
which contained 10 introns. A smaller degree of intron variability 
has been observed in the actin gene family. Although the genes 
of insulin, actin, ovalbumin and αϊ-antitrypsin may have been 
formed by the selective introduction of introns in intron-less 
ancestral genes (76), it is more likely that a reintegration of 
cDNAs of (partly) spliced RNAs is responsible for the loss of 
introns. The use of retroviruses as cloning vectors, in which 
loss of introns from inserts can occur, can be seen as an 
argument in favor of the latter mechanism (77). 
Ordering the exons 
The average gene constitutes approximately 20? exon- and 
80% intron-sequences. The size of introns may vary considerably 
from about 30 nucleotides, as for instance in the late SV40 
pre-mRNAs, to about 21000 nucleotides in adenoviral L5 pre-
mRNAs. The length of an intron might be related to the rapidity 
of removal of the intron but no proof exists for a direct 
relation. Irrespective of the length of an intron all the exon 
parts appear in the spliced product in the same order as they 
occur in the DNA. This obviously is a consequence of the 
mechanism by which the introna are removed. Every donor site 
(51 end of an intron) seems in some way to be linked to the 
exact acceptor site (3' end of an intron). Selecting the 
wrong donor and acceptor site would lead to the excision of 
one or more exons. Loss of an exon by aberrant splicing was 
observed in the expression of a mutant κ-immunoglobulin light 
chain gene. The absence of a donor site from one intron caused 
the removal of the V-segment since splicing occurred between 
the acceptor site of the incomplete intron, following the 
V-exon, and the donor site of the preceding intron (78). The 
simplest way for bringing the correct splice sites together 
would be via base pairing of the splice regions to one 
another. Although incidentally this might be the case (79-82) 
it is not a general mechanism since there seems to be hardly 
any complementarity between donor and acceptor regions. 
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Consensus sequences 
In comparing donor sites as well as acceptor sites it was 
found that introns start with S'QU
 &n¿
 П(І with AG^ . These 
consensus dinucleotides are referred to as the "Chambón rules" 
(83). When more gene sequences became known and the splice site 
regions were lined up the consensus could be extended to 
Pu/GUAAGU for the ideal donor site and PyPyXPyAG/ for acceptor 
sites (84,95). The nucleotides with the exception of GU and AG 
can obviously deviate from the consensus without preventing 
splicing. The importance of specific intron sequences for 
splicing was determined to some extent by studying the expression 
of mutant genes containing deletions or point mutations. The 
results indicate that most of the internal intron-(85) (and 
exon-(86)) sequences can be deleted without affecting correct 
splicing. Complete deletion of the donor site inhibits splicing 
(87) or leads to the selection of the wrong donor site (78). 
Deletion of the 5' site of an intron of the yeast actin gene 
including the U of the consensus GU dinucleotide reduces 
splicing (85). Similarly, deletion of UGAGG from GUGAGG in the 
5' splice site of the first intron of a2-globin leads to the 
absence of a2-mRNA and α-thalassemia (88). Severe reduction 
of splicing was observed in the expression of an adenovirus 
mutated region Eia (89). Here.apoint mutation changing the GU 
dinucleotide to GG prevented the formation of the 12S mRNA. 
Another change in this donor site, GUGAGG to GUGAAU, also led 
to a splicing defect probably caused by the G to A change in 
the 5th- nucleotide (90). A change from GU to GC, together with 
a six nucleotide deletion in the intervening sequence, was 
present in an ADH negative mutant of Drosophila melanogaster. 
This mutant produced no mature mRNA indicating that splicing 
was inhibited (153)· Little data are yet published concerning 
the importance of the nucleotides in the 3' splice sequence. 
It was shown that deletion of the acceptor site prevents 
splicing (122). The AG dinucleotide is very important as a 
recognition site for the splicing enzymes. This is demonstrated 
by the aberrant splicing of 0-globin transcripts in patients 
suffering from 8+-thalassemia. A single G to A base substitution 
obviously has created a recognizable acceptor site in the small 
intron, CUAUUGG/ to CUAUUAG/ (91-94). Further, there has been 
suggested that the pyrimidipe rich region, which precedes the 
consensus acceptor sequence (84.), also may contribute to the 
efficiency of splicing. Deletion of this region accompanied 
by an AG to GG change in the conserved dinucleotide prevented 
splicing in an ADH negative mutant of Drosophila melanogaster 
(153). Although at the present time the GU and AG dinucleotides 
seem to be strict requirements, one case is found in which the 
donor site is changed from GU to GC without complete inhibition 
of splicing. In mouse otA-crystallin RNA-processing such a site 
seems to be used for splicing with about 10Í efficiency (96). 
This indicates that other factors, which compensate for the 
deviation in the primary sequence, are also involved in the 
recognition of splice sites. 
Splicer-RNA mechanism 
The existence of the "Chambón" dinucleotides and the 
consensus sequences leads us to another proposed mechanism for 
bringing splice sites together, i.e. the use of a so-called 
"splicer-RNA" which base-pairs to both the donor and acceptor 
region. It was proposed that the splicer-RNA might be an 
integral part of the mRNA precursor. As such the poly(A)-tail 
was presented (97). By forming a triple RNA-helix the poly(A) 
might bring splice sites in close proximity. This mechanism, 
of course, requires that poly(A)-addition precedes splicing. 
Although it was originally supposed that polyadenylation indeed 
occurs before splicing (30), recent findings strongly suggest 
that splicing can occur on non-polyadenylated RNAs as well (ЗА, 
Chapter II of this thesis). Furthermore, inhibition of poly(A)-
addition does not prevent splicing (154)· Altogether, these 
results argue against an important role for poly(A) as splicer 
RNA. 
Instead of being part of the primary transcript the splicer 
RNA might exist as an individual RNA species. Based on hybridi­
zation experiments (98) and a base pairing model (99,100) it 
was suggested that VA-RNA(I), a I60 nucleotides long adenoviral 
RNA which is synthesized in large quantities during the late 
stage of infection, is involved as splicer-RNA in the formation 
of virus-specific late mRNAs. However, no direct evidence for 
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auch a role of VA-RNA(I) in vivo haa been obtained. Further, 
mutanta of the adenovirua which do not syntheaize VA-RNA do not 
show an alteration in splicing, but rather in the initiation of 
translation of the late mRNAs (101).Therefore, the function of 
VA(I) aa aplicer-RNA is at leaat doubtful. 
Experimenta do, however, point to a clasa of amali RNAs, 
which are present in the nucleus of eukaryotic cella aa the 
most likely candidates for splicer-RNA and probably for other 
functions in RNA-proceaaing aa well. Theae RNAs are referred to 
as anRNAs (small nuclear RNAa/ atable nuclear RNAa) and are 
aaaociated with a aet of proteins(snRNP)(102).The main anRNAa 
are called U1 to U6, of which 113 aeems to be confined to the 
nucleolus (103). When nuclei of early adenovirua infected Hela 
cells were treated with antiserum directed against the U1-
aaaociated proteina, splicing was inhibited (IO4.). Introduction 
of antibodies directed againat UI-snRNP into adenovirus infected 
Hela cella reduced the expression of two late genes (I4.O). 
Using psoralen for in vivo RNA-RNA cross-linking it was found 
that U1, and also U2, could be croas-linked to hnRNA (105,106). 
From these experiments it was deduced that U1 may function as 
splicer-RNA. A base pairing model was presented in which U1 
brings two exons together (107,108). Nuclease experimenta 
have indicated which parts of the U1-sequence are left un­
protected by the associated proteins and are, therefore, 
available for base pairing (109). It seems that the 5' end of 
U1 contains a purine-rich sequence which can form a atable 
hybrid with the pyrimidine-rich region preceding the consensus 
acceptor site (107,108). As mentioned above this base pairing 
might be involved in regulating the speed of excision of an 
intron. Although the role for U1 as aplicer-RNA ia more or 
less accepted, it may well be that other anRNAs are involved 
in RNA splicing as well together with U1 in a щог complex 
structure (110). 
Correct acceptor/donor site selection 
As mentioned above, correct splicing requires that the 
correct donor and acceptor aite are brought together. The 
splicer-RNA mechanism cannot by itself affect auch a specificity. 
One way to achieve thia apecificity ia through the binding of 
the splicing enzymes to either the donor or the acceptor site. 
Such a recognition might be provided by the secondary structure 
of the RNA around the splice point (99). The enzymes then scan 
the RNA sequence until the other end of the intron is reached. 
Subsequently, the looped-out intron sequences are cleaved off 
and the exons spliced. A triplet motion, like ribosomes pass 
over the messenger, was proposed by Ohno (111). Although the 
basic idea is very interesting, in relation to more recent 
data this triplet motion model is far from being acceptable. 
Another possibility for bringing correct splice sites together 
could be through the association of RNA with proteins. In the 
RNP structure the RNA may be folded in such a way that the 
correct donor and acceptor sites are in close contact. Studies 
on SV4.O RNA have indicated that intron sequences may be less 
comprised in an RNP structure than the exon sequences (112). 
Splicing would then simply be the digestion of the "naked" RNA 
pieces and linkage of the protein-associated sequences. Studies 
on nuclease sensitivities of adenoviral RNA have indicated a 
special RNP structure for viral pre-mRNA (113). In vivo cross-
linking experiments performed by van Eekelen et al. (Hi), 
however, do not demonstrate a clear difference in protein-
association between intron- and exon-sequences. The importance 
of the RNP structure, in particular in connection with the 
nuclear matrix, will be dealt with in this thesis. 
The exact nature of the splicing mechanism remains unclear, 
but it may well turn out to be a combination of all the aspects 
discussed above, i.e. primary-, secondary- and RNP-structure, 
splicer-RNA, and the RNA-scanning model. 
Stepwise splicing 
Introns can have the extensive length of several Kb as for 
example in the adenoviral L5 pre-mRNAs. The presence of extra 
leader sequences in certain L5 mRNAs, especially those produced 
in monkey cells, suggested that excision of (larger) introns 
might be a stepwise process (115). Further, heteroduplex mapping 
of major late adenoviral nuc1ea· RNAs has indicated that removal 
of the second intron from these pre-mRNAs probably is a step-
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wise process as well (116). Also from the study of cellular RNAs 
arguments for stepwise splicing can be obtained, as for instance 
form the ß-globin pre-mRNAs. In this case evidence has been 
presented that both introns may be excised in more than one 
step (117-119)· Other examples are the excision of introns from 
a-collagen (120) and fibroin (121) pre-mRNAs. The few experimen-
tal data obtained so far indicate that the removal of an intron 
follows the 5' to 3' direction, i.e.pieces at the 5' end of an 
intron are removed first. It may soon turn out that stepwise 
splicing is a general aspect in the removal of introns (see also 
Chapter II & III of this thesis). A stepwise splicing process 
requires the presence of splice signals located within the 
intron sequences. In the case of α-collagen and B-globin the 
internal splice sites were mapped (119,120). Most of the 
detected internal sequences deviate, however, from the consensus 
splice sequences. 
Sequential removal of introns 
The number of introns present in eukaryotic genes may extend 
50, as is the case in the α-collagen gene (120). When more than 
one intron has to be removed from a primary transcript, a 
mechanism may be involved in regulating the successive removal 
of the introns. Only a few cases are known in which a certain 
directionality can be detected in the removal of introns. The 
рг -mRNA of the adenoviral DNA-binding protein contains two 
intervening sequences. Kinetic measurements have indicated 
that the 5' located intron is removed before the 3' intron (123). 
However, heteroduplex mapping of nuclear RNA has contradicted 
data (124·). In the formation of the tripartite leader, 
present in late adenoviral messengers, two introns have to be 
removed. Kinetic analysis of the ligation reaction, involved 
in splicing the three leaders, shows that splicing follows the 
5' to 3' direction (125). (3-globin RNA molecules isolated from 
rabbit bone-marrow cells suggest that splicing of this pre-mRNA 
also follows the 5' to 3' direction (118). Of the two introns 
in the cellular pre-mRNA the 5' located intron seems to be 
removed before the 3' intron. However, results obtained from 
studying the expression of the mouse ß-globin gene contradict 
these data, sines here the 3' intron is partly removed before 
the 5' intron is attacked (117). This difference may be due to 
species-specific gene expression with the existence of alter-
native splicing pathways in the processing of 0-globin pre-
mRNAs. The structure of splicing intermediates of the Xenopus 
vitellogenin gene indicates that the splicing order in this 
gene does not follow a single direction (126). Taken together, 
a 5' to 3' direction for the removal of multiple introns seems 
likely for some genes, but cannot be established as a common 
rule. Observations in 0 -thalassemia, a defect caused by 
aberrant splicing of ß-globin pre-mRNA, indicate that the re-
moval of the small intron may facilitate the removal of the 
large intron (91)· Another example of non-random removal of 
introns was observed in ADH negative mutants of Drosophila 
melanogaster (153). Preventing the removal of one intron seemed 
to inhibit the removal of other introns. This could in general 
explain the regulation of the sequential removal of intervening 
sequences. 
Function 
In looking for a function of intervening sequences in genes 
and for the splicing process some interesting ideas have been 
proposed. As already mentioned above intervening sequences in 
genes may provide the genome with a certain flexibility since 
reshuffling of exons and the creation of new exons from introns 
(155) may lead to the formation of new polypeptides. This may 
be regarded as a positive aspect in the course of evolution (63). 
When the intron present in VP1 pre-mRNA of SV4.0 was deleted 
from the DNA, no stable mRNA accumulated in infected monkey 
cells (127). The same result was found when the intron with 
both splice junctions was deleted (128). When the expression 
of З ДО transducing viruses carrying part of the mouse 0-globin 
gene was studied, similar results were obtained. Preventing the 
splicing process prevented the accumulation of stable RNA (129). 
Splicing may, therefore, have a stabilizing influence on RNA. 
To explain these findings it has been proposed that splicing 
and nucleocytoplasmic transport are coupled processes (127, 
129). In this case splicing is regarded as the last step in 
25 
RNA-maturation. The laat event of splicing would be performed 
near the nucleopores. With the removal of the last intron-
sequences the completed product of processing would be ejected 
in the cytoplasm (1291130). However, preventing splicing in 
adenoviral Eia RNAs did lead to the accumulation of unspliced 
products in the cytoplasm rather than in the nucleus (122). In 
the expression of a gene chimaera of SV4.0 and mouse ß-globin, 
in which the donor site of SV^O is spliced to the acceptor site 
of globin, the spliced RNA was not transported to the cytoplasm 
(131). This indicates that splicing is not a requirement for 
transportation of messengers. Still, it is likely that there 
is some linkage between processing and transport since normally 
pre-mRNAs are confined to the nucleus while processed mRNAs 
are predominantly cytoplasmic (132). Further, in patients 
suffering from ß -thalassemia there seems to be a delay in the 
transport of p-globin mRNA to the cytoplasm (133). The existence 
of unspliced messengers is a problem in finding a specific 
function for RNA splicing. Since this class of messengers does 
not undergo splicing it demonstrates that the cell can handle 
mRNA-sequences efficiently without the involvement of the 
splicing process. Examples of unspliced messengers are the mRNAs 
of histone (13Д), interferon (135,136), cytochrome-c (137) and 
the adenoviral polypeptide IX (138). Of these mRNAs the histone 
messengers differ in another processing step because they also 
lack the poly(A)-tail (139). The possibility exists that the 
cell treats histone messengers, and unspliced messengers in 
general, in a way different from spliced mRNAs with respect to 
RNA processing, transport and cytoplasmic localization. A 
comparison of the transport-rates of spliced and unspliced 
adenoviral messengers will be described in this thesis (Chapter 
VI). 
Diversity of gene expression 
Rather than functioning in the mechanism of processing and 
transport, splicing contributes to the diversity of gene 
expression. Splicing is the linkage of two pieces of RNA with 
the removal of the intervening sequences. The diversity of gene 
expression arises when a рг -mRNA can be spliced in several ways. 
Four situations can be distinguished as shown in Figure 3. 
pA pA 
Fig. 3· Diversity of gene хрг еіоп via alternative splicing 
patterns. Four situations can be distinguished in which mRNAs 
may differ in their 51» 3' and/or internal nucleotide sequences. 
P1 and P2, alternative promotor sites. pA, polyadenylation site. 
Boxes represent exon sequences while caret symbols represent 
the excised intervening sequences. 
A. mRNAs can have the same 5' and 3' end but may differ 
internally. This kind of alternative processing patterns is 
known to exist in the expression of many DNA- and RNA-viruses, 
but also of cellular genes. Examples are chicken ovomucoid (141, 
HA),rat 7-fibrinogen (H5), human growth hormone (H6) and 
aA-crystallin (96). 
B. Common 5' located exons are spliced to different 3' exone. 
The polyadenylation site of one mRNA is located in the intron 
of another mRNA. Examples of genes in which the expression 
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follows this pattern are the adenovirus major late tranoription 
unit, adenovirus early regions IIa and lib, formation of μ- and 
δ-heavy chains in GCL2.8 cells (H7), formation of u-chains of 
the membrane-bound (u ) and secreted (u ) forms of IgM in В 
m s 
lymphocytes (1Д8). 
С Different 5' exons can be spliced to common 3' exons. In the 
formation of these messengers transcription starts from different 
promotors, but the mRNAs use the same polyadenylation site. 
Known examples are adenovirus regions EIIb/IVa2, regions Elb/pIX, 
region Ella early/late and a-amylase (14.2,143). 
D. 5' and 3' exons can differ resulting from the use of different 
promotors and different polyadenylation sites, but the mRNAs 
have some internal sequences in common. An example is formed 
by the adenovirus EHI and L5 mRNAs. 
Tissue-specificity. 
The proteins produced from mRNAs formed via alternative 
splicing patterns may either have a closely related function 
or may be functionally different. Alternative splicing patterns 
are also observed in the expression of the calcitonin gene 
(H9.150). Although it is not yet clear how the splicing 
patterns differ, different splicing pathways correspond to 
different cell types. In the thyroid the calcitonin mRNA pre­
dominates while the calcitonin gene-related peptide (CGRP) is 
the major product from this gene in the hypothalamus. These 
findings demonstrate that tissue-specific gene expression can 
occur as a result of different splicing pathways. Another 
example is the formation of mouse a-amylase mRNAs in liver and 
salivary gland. Results suggest that here in each tissue a 
different promotor is active and that a promotor-proximal 
leader sequence and common body sequences are spliced. The mRNAs 
from each tissue have therefore a different 5' untranslated 
region (U2,U3). 
Species-specificity. 
As already mentioned above, in SV40 transducing viruses 
which contain part of the 0-globin gene of mouse the globin 
part is spliced correctly in monkey cells (129). In the 
expression of a gene chimaera of З ДО and mouse ß-globin the 
donor site of SV4.0 is used with the acceptor site of mouse 
globin (131). Similar resulta were obtained with an Ad2-SV40 
hybrid virus, Ad2 ND4. Although splicing can be tissue specific 
as observed in some cases ! these results suggest that the 
mechanism of splicing іэ the same for all cell types. However, 
there seems to be some species-specificity in respect of splicing 
among eukaryotes since transformation in yeast cells of gene 
pieces from other species showed an abnormal expression and 
splicing did not occur (151,156). Therefore, it may well be 
that yeast cells differ from other eukaryotep regarding the 
mechanism of splicing. 
2. HnRNP AND THE NUCLEAR MATRIX 
2.1, HnRNP 
From the preceding paragraphs it may be clear that the 
primary sequence of a рг -mRNA molecule by itself is not enough 
to permit correct processing, in particular RNA splicing. 
Other factors are obviously involved as well. The structural 
organization of heterogeneous nuclear RNA (reviewed in 157, 
158) has been studied extensively in order to understand the 
mechanism of RNA processing and its regulatory role in the 
control of gene expression (159). All hnRNA»containing mRNA 
sequences or not, is associated with protein to form ribo-
nucleoprotein particles (157,158,160). HnRNA-protein complexes, 
generally referred to as hnRNP particles, can be isolated from 
nuclei by extraction at elevated pH or sonication. The size 
of the isolated particles depends on the extent of ribonuclease 
degradation during the isolation procedure. Under nuclease-
free conditions large 30-250 S hnRNP particles (polyparticlee) 
can be recovered, whereas after mild nuclease digestion 30-
40 S monoparticles accumulate (113,158). The polypeptide com­
position of the isolated complexes is also dependent on the 
isolation procedure used. Polypeptide compositions ranging 
from almost all non-hiptone nuclear proteins to a few distinct 
polypeptides have been reported (157,158,161-165). The protein 
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composition of purified monoparticles, which are considered as 
the structural building blocks of hnRNP, is relatively simple. 
30 S particles from Hela cells contain 6 major polypeptides, 
subdivided into three groups called А,В and С proteins and 
ranging in molecular weight from 32,000 - 44,000 dalton (165-
167). Each group consists of two polypeptides. 
An important experimental approach in studying hnRNP struc­
ture involves limited nuclease digestion, which has been applied 
to determine the RNA sequences protected by and thus associated 
with proteins. Although no discrete sequence specificity was 
found using a total cellular hnRNP population (168), Munroe 
and Pederson (169) found, following this strategy, that mRNA 
sequences in hnRNP are complexed with proteins. No discrete 
lengths of protein-protected RNA were obtained upon limited nu­
clease digestion distinguishing hnRNP organization from the 
repeating subunit structure of chromatin (170). Even after mild 
nuclease treatment of hnRNP, pre-mRNA is preferentially present 
in large hnRNP particles and not randomly distributed over small 
and large particles (113). Large particles might therefore be a 
distinct subclass of hnRNP in which splicing takes place, where­
as monoparticles contain RNA confined to the nucleus. 
In order to study hnRNP specifically and not be limited to 
the detection of only structural features, it is mandatory to 
isolate hnRNA-protein complexes containing specific RNA se­
quences. It is technically feasable to isolate intact pre-mRNA 
from hnRNP particles (171,172) and from nuclear matrix prepa­
rations, in which the hnRNA is also associated with a specific 
set of hnRNP proteins (173, chapter V of this thesis). One 
approach follows the purification of photochemically cross-
linked hnRNA-protein complexes by hybridization to immobilized 
DNA probes (171,174,175). 
Electron microscopy has also been used to study the struc­
tural organization of specific transcripts. Chromatin actively 
transcribed by RNA polymerase II obviously contains fibrillar 
hnRNP structures resembling "beads on a string" which extend 
away from the DNA-protein axis. The RNP configuration for 
products from the same transcription unit is similar and non-
random with respect to the RNA sequence (176,177). 
Steitz and Kamen (112) have studied RNP organization in 30S 
particles containing late polyoma transcripta and found that 
from these particles the polyoma intervening sequences were 
preferentially lost upon nuclease digestion. Also the experiments 
of Ohlsson et al. (171) indicate that within a specific adeno­
viral RNA precursor there is a non-random protection of RNA se­
quences by RNP proteins. Similar results have been obtained by 
van Eekelen et al. (114) who demonstrated that the cross-linked 
hnRNP proteins are non-randomly distributed over late adenoviral 
рг -mRNA sequences. No difference in protein-association between 
exon- and intron-sequencest however, could be found. 
The secondary structure of hnRNA has also been studied. 
Double-stranded RNA regions were found to exist in native hnRNP 
and to be relatively accessible to enzymatic digestion (178-
180). The function of these double-stranded structures is still 
unresolved. 
2.2. THE NUCLEAR MATRIX 
A higher level of structural organization of hnRNA has also 
been encountered. When isolated nuclei are depleted of their 
membranes, soluble molecules and chromatin by subsequent treat­
ments with detergents, nucleases and high salt, a structural 
framework, referred to as nuclear matrix, remains (181,183). 
The isolated nuclear matrix consists of three morphologically 
distinguishable structural elements: (a) a peripheral layer, 
which represents the remainder of the nuclear envelope and 
contains pore complexes in association with a lamina, (b) re­
sidual nucleoli and (c) internal grano-fibrillar structures. 
It has been suggested that aggregation or precipitation of 
nuclear proteins or disulphide bridge formation between nuclear 
protein during cell fractionation could cause the artificial 
formation of the internal matrix structures (184,185). However, 
evidence is now accumulating that the internal matrix represents 
a predominantly proteinaceous structure existing in the intact 
cell (186-194). Important arguments in favor of the existence 
of the nuclear matrix in vivo are that the internal matrix 
does not depend on disulphide bridge formation and that specific 
proteins are localized internally in the isolated matrix in a 
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similar way аз in the intact cell. Recent studies in which the 
three-dimensional structural organization of isolated matrices 
is viewed using electron microscopy on whole mount preparations 
instead of thin sections ι corroborate the conclusion that the 
internal nuclear protein structure is a reality (187). 
Additional indications for the existence of an intranuclear 
structural framework can be deduced from studies of its func­
tional aspects. One of these possible functions is the attach­
ment of replicating DNA to fixed sites inside the nucleus 
which is now amply documented (195-200). The association of 
specific receptor proteins for hormones that modulate gene 
expression to the matrix seems to support the idea that trans­
criptional activity is localized at fixed sites inside the 
nucleus, for the hormone-receptor complexes are presumed to 
bind to specific sites near genes that regulate transcription 
(201-203). Nuclear "cage" associated RNA synthesis has been 
reported by Jackson et al. (204.205). Based on their studies 
they propose a model, in which RNA transcription takes place 
at fixed sites, implicating that the transcibed DNA moves 
through these fixed complexes. Several years before, it had 
already been reported that completed transcripts, i.e. hnRNA 
as well as nuclear (pre)ribosomal RNA, were not present in 
freely floating RNP particles in nuclei, but are bound to 
nuclear structures. When RNAse treatment during matrix iso­
lation was omitted hnRNA and nuclear rRNA could almost quanti­
tatively be recovered from the isolated structures (186,190, 
206,209). 
All these data indicate that several important processes in 
the nucleus do not take place in the nucleoplasm but are loca­
lized at fixed sites inside the nucleus. Regarding gene expres­
sion, it is likely to assume that the nuclear matrix is not 
only involved in transcription but also in mRNA maturation, a 
process which is confined to the nucleus, since only precursors 
of RNA are tightly bound to this structure (109,110), 
3. ADENOVIRUS SEROTYPE 2 
The adenoviruses form a subgroup of the DNA viruses. The 
viral genome consists of a linear, double-stranded DNA molecule 
with a molecular weight of about 23 x 10 . The ends of the DNA 
are marked by an inverted repeat of about 150 base pairs. (211). 
To each 5' end a protein of 55 kD is covalently linked (212). 
this protein or its 80 kD precursor may function as a primer 
for DNA replication (213). Both strands are transcribed and 
are referred to as r- and 1-strand according to the direction 
in which they are transcribed. Conventionally the DNA is divi­
ded in 100 map units (m.u.) starting with 0 at the 5' end of 
the 1-strand and ending with 100 at the 3' end of this strand. 
Coordinate 0 is called the "left end" of the genome, while 100 
is referred to as the "right end". Each map unit represents 1 % 
of the DNA and equals + ЗбО base pairs. The division of the 
genome in map units is used to locate the transcription units 
on the genome. 
The major disease caused by human adenoviruses is an acute 
infection of the respiratory tract. Nearly a hundred different 
serotypes have now been characterized (214)· Based on a number 
of properties of the virus, as for instance oncogenicity, the 
different serotypes have been divided in six groups A to F 
(214). Although none of the virus strains is associated with 
human malignancy, at least some of them can cause tumors in 
rodents. 
The adenovirus has been widely used to study the processing 
of pre-mRNA to mRNA in vivo as well as in vitro. The use of 
adenovirus infected cells has certain advantages over the use 
of uninfected eukaryotic cells. In the past, before cloning 
techniques were well developed, viral systems were chosen be­
cause at the late phase of infection large quantities of virus-
specific рг -mRNAs and mRNAs are produced, which can be indi­
vidually identified by hybridization methods in which restric­
tion fragments of the viral genome are used as a probe. The 
relative "simplicity" of the viral genome can be considered to 
as an advantage since the virus contains a limited number of 
transcription units. The rather extensive knowledge that al­
ready has been gathered on both the transcription and the 
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translation products contribute to the usefulness of the adeno-
virus in studying RNA processing. 
The working hypothesis for using eukaryotic DNA viruses to 
study RNA processing is that the virus makes use of the host 
processing machinery and host enzymes for its replication (215)· 
Therefore, conclusions about RNA processing obtained from viral 
systems are assumed to provide general information about the 
processing of cellular pre-mRNAs. Until now all results obtained 
from the study of the expression of cellular genes have con-
firmed the validity of this hypothesis. However, it has become 
clear that certain steps in adenovirus replication, which were 
thought to be performed exclusively by cellular enzymes, as for 
example DNA replication (215), may well be catalyzed by virus-
coded enzymes (213). 
The infectious cycle is divided into three periods: early, 
intermediate and late phase of infection. Each phase is cha-
racterized by the activation of certain RNA-polymerase II pro-
moters and consequently the appearance of a new set of mRNAs 
and the synthesis of new proteina in the cytoplasm. 
3.1. EARLY PHASE 
The early phase begins with the introduction of the viral 
DNA in the cell and lasts till the start of the Ad-DNA repli-
cation about 8 h after infection. During this stage the cell 
seems to maintain its normal functions. The Ad-specific mRNA 
amounts to only about 1 % of the total cytoplasmic mRNA. The 
viral proteins which are produced seem to play a regulatory 
role in the infectious cycle rather than being structural com-
ponents of the virion (216,217,218,219). Host DNA synthesis 
starts to decline and gradually keeps declining during the 
infectious cycle (220). 
Three transcription units are located on the r-strand: Eia 
(1.4-4.8 m.u.), Elb (4.9-11.2 m.u.) and EHI (76.6-86.0 m.u.). 
Both Eia and Elb are responsible for the transforming activity 
of the virus (221,222,223). Three other transcription units 
are located on the 1-strand: Ella (75.1-61.6 m.u.), EHb (75.1-
11.2 m.u.) and EIV (99.1-91.5 m.u.). Region Ella codes for the 
72 kD DNA-binding protein which may be involved in the turn-on 
of the Ad-DNA replication (224). Region Ellb codes a.o. for the 
"Bellet" protein which is covalently linked to the 5' end of the 
DNA. 
3.2. INTERMEDIATE PHASE 
The intermediate phase lasts from 8 h to 12 h after infec-
tion. During this period the Ad-DNA replication begins and two 
promoters are activated. One transcription unit on the 1-strand 
(15.8-11.2 ra.u.) codes for polypeptide IVa2, while the other 
transcription unit on the r-strand (9.7-11.2 m.u.) is involved 
in the synthesis of polypeptide IX, a structural component of 
the viral capsid. Some characteristics of the expression of the 
pIX transcription unit, which is located in the early region Elb, 
are that the expression of this gene is not inhibited by the 
drug DRB (dichloro-Éí-D-ribofuranosylbenzimidazole (225)), which 
is known to promote premature termination of transcription,and that 
the pIX mRNA is colinear to the DNA, i.e. that the messenger is 
not formed via splicing (138), 
3.3. LATE PHASE 
The late phase of infection is the final period in the in-
fectious cycle. It starts about 12 h after infection and ends 
with the lysis of the infected cell. At this stage the cellular 
functions are inhibited. Host proteins are no longer synthesized 
and although transcription of host genes seems to continue, 
only virus-specific mRNAs enter the cytoplasm (226). This sug-
gests that transportation of host messengers and/or processing 
of host pre-mRNAs are blocked, It may also be that these func-
tions are still normally performed, but that host mRNA is ra-
pidly degraded as soon as it enters the cytoplasm. Ribosomal 
18 and 28 S RNAs are no longer produced which gradually leads 
to a decrease in the number of ribosomal aubunits In the cyto-
plasm. The production of tRNAs seems unchanged. 
Two promoters are activated in this stage. One region, 
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transcribed from the 1-strand, is called Ella/late (72.0-61.6 
m.u.) since the messengers contain the same information as 
those produced from the early region Ella, but differ in the 
5' leader sequence which is derived from coordinate 72.0 in­
stead of 75.1 (Ella/early) (227). At coordinate 16.2 on the r-
strand another promoter, called the major late promoter, is 
activated. Transcription extends all the way to the right end 
of the genome. The major late transcription unit (16.2-100.0 
m.u.) directs the production of structural proteins most of 
which make up the building blocks of the viral capsid, as for 
instance pentons, hexons and fibers. 
Fig. Д. Accumulation of newly formed adenovirus in the Hela 
cell nucleus 18 h after infection. Bar represents 1 ym. Inset 
shows virus particles, enlargement 5Д,000х. Electron micro­
graphs made by Drs. P. Sillekens. 
Other proteins derived from the major late transcription unit 
may function on the post-translational modification of structural 
proteins. Encapsidation of newly replicated Ad-DNA, starting 
with the left end, is performed in the nucleus. The progeny virions 
which are assembled in the nucleus (Fig. 4·) are released by the 
lysis of the expiring host cell. 
In Figure 5 the locations of the promoters and the trans-
cription units are summarized. Since most of the results pre-
sented in this thesis are obtained with RNA derived from the 
major late transcription unit the expression of this region 
will be described in more detail. 
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Fig. 5. Expression of the adenovirus transcription units. 
Ad2 RNA polymerase II promoters (P) for early (thin solid arrow), 
intermediate (open arrow) and late (thick solid arrow) trans­
cription units are shown together with the major mRNA species 
produced by each transcription unit. Promoter subcripts indicate 
the cap site coordinate. 
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The major late tranecrlption unit 
At the late stage of Infection a promoter, located at coor­
dinate 16.2 on the r-etrand, is activated. In the nucleotide 
sequence at this location a TATA-box was found to precede the 
5' ultimate nucleotide of the RNA, to which the cap is added 
(23,228). Transcription proceeds to the right end of the genome, 
where termination occurs somewhere between coordinates 98.2 and 
100.0 (229). However, premature termination of transcription, 
also referred to as attenuation, was found to occur with the 
major late promoter as well. Termination then occurs within the 
first 2000 nucleotides (230), but not at a single distinct location 
so that multiple discrete RNA species can be detected (231). 
The drug DRB enhances attenuation in such a way that more trans­
cripts are prematurely terminated and that termination occurs 
even closer to the promotor site as compared to drug-free con-
ditons (231)· The products of premature termination are already 
capped (11,12,231). This and other findings (10) indicate that 
capping is a very early event in RNA processing and is closely 
linked to the initiation of transcription. In the nucleus the 
late transcripts are internally methylated and these methyl-
groups are conserved during processing (56). 
When attenuation does not occur, each transcription initia­
tion event leads to the formation of one out of several possible 
messengers (30). About 15 different mRNAs can be derived from 
the major late transcription unit and as already mentioned most 
of these mRNAs code for structural components of the virion. 
The messengers can be divided in five classes according to the 
map location of their 3' end. These 3' co-terminal mRNA families 
are formed by polyadenylation of the precursor RNA at one of 5 
different polyadenylation sites and are referred to as: LI mRNAs 
(38.5 m.u.), L2 mRNAs Ц9.5 m.u.), L3 mRNAs (61.5 m.u.), Ц mRNAs 
(78.3 m.u.) and L5 mRNAs (91.5 m.u.) (232). Polyadenylation 
occurs very rapidly (233). As soon as the RNA-polyraerase has 
passed a few thousands of nucleotides beyond a polyadenylation 
site the nascent transcript is cleaved at this site and on the 
newly formed 3' end a poly(A)-stretch is added (30). Polyadenyl­
ation is assumed to be performed before splicing (30). However, 
the structure of certain LS-specific nuclear RNAs (36) and the 
study on in vitro transcription and processing (ЗА) indicate 
that this may not always be the case (see also Chapter II of 
this thesis). Although L2 to L5 RNAs seem to be polyadenylated 
by cleavage of the nascent transcript, in vitro studies have 
suggested that in the formation of LI mRNAs termination of trans­
cription may occur at 38.5 m.u. accompanied by rapid polyadenyl-
ation of the 3' terminus (34). This finding is not unlikely 
since at the early stage of infection transcription from the 
major late promoter seems to be terminated before coordinate 
61.5 (234i235). It is possible that the major late transcription 
unit contains more than 5 polyadenylation sites. An L5-specific 
nuclear RNA has been reported which was found to be polyadenyl­
ated at 96.9 m.u., downstream from the L5 co-terminal poly(A)-
site (36). Polyadenylation at this site, as there may be others, 
is confined to nuclear RNA. These species may be intermediates 
in the production of L5 mRNA. 
Polyadenylation is the mechanism which determines to which 
family the matured mRNA will belong. Nothing is known yet by 
which mechanism a particular polyadenylation site is selected. 
All the messengers derived from the major late transcription 
unit have three common leader segments linked to the protein-
coding body (Fig 5). The length of the leaders are 41 nt (leader 
1), 72 nt (leader 2) and 90 nt (leader 3)» and their map loca­
tions are 16.2, 19.3 and 26.3 m.u., respectively (236). Kinetic 
measurements of the ligation reaction between the leaders as 
part of RNA splicing has shown that leader 1 is rapidly linked 
to leader 2 before linkage of leader 2 to leader 3 (125). The 
cap is added to leader 1 and, further, this segment contains 
thenShine and Dalgarno sequence" (24-3). Both features are known 
to be involved in the initiation of translation. No functions 
have yet been ascribed to leaders 2 and 3. Cross-linking experi­
ments performed by van Eekelen et al. (114) have shown that 
especially leader 3 sequences are closely associated with hnRNP 
proteins. As such leader 3 may be involved in the binding of 
late RNAs to a nuclear matrix and possibly also to the cyto-
skeletal framework. 
The messengers of a 3' co-terminal family differ in the length 
of their body sequences. This length depends on the splicing 
pattern of the RNA family. Between two polyadenylation sites 
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of succesive co-terminal families a number of acceptor sites 
for splicing can be found. In the formation of a particular 
messenger one acceptor site is selected to which the tripartite 
leader will be spliced and in this way splicing determines which 
messenger will be formed within a particular 3' co-terminal 
family. The longer messengers thus have a number of non-used 
acceptor sequences. Except from their own protein-coding region 
the longer messengers encompass all the coding regions of the 
smaller messengers belonging to the same family. Therefore, most 
of the major late mRNAs are polycistronic, only the smallest 
ones being monocistronic. Only the 5' protein-coding region 
seems to be translated. This may be due to the fact that this 
region is nearest to the tripartite leader, which contains the 
requirements for the initiation of translation (79). 
In short, both polyadenylation and splicing determine which 
messenger and consequently which protein will be formed in each 
transcription event. Polyadenylation selects the co-terminal 
family. Splicing selects which member of a particular family 
will be produced. Both processing steps are, therefore, involved 
in the regulation of adenovirus gene expression. 
In some messengers additional leader segments may be present. 
In predominantly LI-specific messengers a sequence called the 
"i-leader" (21.5-22.6 m.u.) may be inserted between leaders 2 
and 3 (236). In particular, the i-leader is present in those 
LI mRNAs which are the most important products during the early 
expression of the major late transcription unit (234). The i-
leader contains an open reading frame which extends into leader 
З. Since the i-leader is closer to leader 1 than the protein-
coding body, polycistronic messengers which have the i-leader 
probably are translated into a 16 kD viral protein (237). Up 
to three extra leader sequences may be present between leader 3 
and the body of L5 mRNAs. These leader segments are called X, 
Ï and Ζ (238) and are also involved in the formation of EHI 
messengers (236). It has been suggested that these leaders may 
be residual parts of the larger intervening sequence separating 
leader 3 and the body sequences, which have not been excised 
in a stepwise splicing process. A further indication in favor 
of this hypothesis is the existence of L5 messengers, especially 
in Ad-infected monkey cells, which contain even larger regions 
of the intron between coordinates 66 and 78 (115). 
ЗД. VA-RNA 
Except for RNA-polymerase II transcription unita two RNA-
polymeraae III genes are located on the genome near coordinates 
29 and 30, respectively (239). The genes are encompassed by the 
major late transcription unit and transcription is from the r-
strand. The RNA products are referred to as virus-associated 
RNAs (VA-RNAs). The major ones are called VA(I) and VA(II) and 
are about 160 nucleotides in length. VA(I) is accumulated in 
large quantities during the late stage of infection. Both RNAs 
have an extensive secondary structure (240) and part of the VA­
RNA is associated with a protein of about 50 kD (175). A third 
virus-associated RNA, V200, is a read-through product of the 
VA(I) gene in which about 40 nucleotides are added to the 3' 
end (230). 
The function of the VA-RNAs remains unknown. It has been 
suggested that they might be active as splicer-RNA in the pro­
cessing of рг -mRNAs transcribed from the major late transcrip­
tion unit (98,99,100). Recent results do, however, point to a 
role in the initiation of translation rather than in splicing 
(101,2Д1). 
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U. A BRIEF SURVEY OF THIS THESIS 
Splicing aa a step in pre-raRNA procesaing was reported in 
1977. Although since that time many data have been gathered, in 
many of its aspects the splicing phenomenon remains obscure. 
The aim of this study is to contribute to the understanding of 
RNA splicing. At the start of this study, DNA cloning facilities 
were not readily available. Therefore, based on the working hy-
pothesis that viral genes are expressed similarly as cellular 
genes, we studied splicing in vivo as one of the steps in adeno-
virus gene expression. 
The pattern of cleavages occurring during the excision of 
introns 1 and 2 from viral pre-mRNAs is described in Chapter II. 
In Chapter III the excision of intron 1 is studied in more de-
tail. Baaed on the results of Chapters II and III a model for 
RNA aplicing is presented. This model and the data obtained from 
studying the excision of intron 3, as described in Chapter IV, 
underline the need for a higher organization of the pre-mRNA. 
A possible answer to this requirement is presented in Chapter 
V, where the interaction between hnRNA and a nuclear matrix 
during splicing is examined. The possibility that an inter-
action with a nuclear matrix could be essential only for RNA 
molecules which have to be spliced and the idea that splicing 
might be coupled with nucleocytoplasmic transport have been 
considered in Chapter VI, in which the localization and nucleo-
cytoplaamic transport rates of spliced and unspliced viral 
RNAs are compared. 
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Total rapidly labeled RNA was extracted from nuclei of HeLa cells late after 
infection with adenovirus type 2 Most of this nuclear RNA is transcribed from the 
major late transcription unit (16 2 to 100-0 map units (m u )) To study the cleavage 
reactions that are involved in RNA splicing we used the S, nuclease mapping 
technique with WindlH В (16 8 to 31 5 m u ) and AAol F (15 5 to 2 2 4 m u ) 
restriction fragments as DNA probes The S, mapping data showed that both 
intron 1 (16 3 to 19 1 m u ) and intron 2 (19 4 to 26 2 m u ) can be excised in more 
than one step Kinetic labeling and pulse-thaae experiments demonstrated that 
certain cleavage sites in the RNA are used within three minutes after the start of 
transcription, while other cleavages occur only after a significant time lag The use 
of 5,6-dichloro 1 β D nbofuranosylbenzimidazole enabled us to label the nuclear 
RNA exclusively from the 5' end Such an approach showed t h a t the first cleavages 
are introduced in the nascent RNA before the RNA polymerase has passed more 
than 2000 nucleotides beyond the clea\ age site The с hronology of the appearanc e 
of processing intermediates that results from cleavage of the RNA indicates that 
preferentially intron 1 is removed before intron 2 This is m agreement with the 
finding that leader 1 is ligated to leader 2 before ligation of leader 2 to leader 3 
takes place However, we have found that alternative splicing pathways exist in 
the excision of introns 1 and 2, demonstrating that cleavage in intron 2 may occur 
before intron 1 is attacked by the splicing enzymes 
1. Introduct ion 
E u k a r y o t i c messenger R N A s a r e usual ly derived from large p r i m a r y t r a n s c r i p t s 
Several p o s t t r a n s c r i p t i o n a l modif icat ions a r e needed t o t r a n s f o r m t h e p r i m a r y 
t r a n s c r i p t i n t o a m a t u r e messenger One of these modif icat ions is R N A splicing 
( S h a r p , 1981 , Nev ins , 1982) I n t e r n a l nucleot ide sequence*) a r e r e m o v e d from t h e 
t r a n s c r i p t in a process t h a t involves cleavage of t h e R N A chain a t t h e 5' a n d 3' e n d s 
of a n i n t r o n , followed b y l igat ion of t h e e x t e r n a l pieces of R N A I n t h i s w a y a n 
R N A molecule is formed t h a t is n o n colinear wi th t h e D N A N o t m u c h is k n o w n 
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about the way in which the intervening sequences are removed. Although it is 
as.sumed that introns can be removed in one piece, it has been rejxjrted that 
removal of an intron can be a stepwise process (Berget & Sharp, 1979: 
Avvedimento et al., 1980: Grosveld el al., 1981). In this case the intervening 
sequences are removed in parts. When a transcript contains more than one intron, 
the introns may be excised in an orderly fashion (Goldenberg & Ra.skas, 1979: Tsai 
el al.. 1980: Grosveld el al., 1981 ; Keohavong et al.. 1982). 
Late after infection of human cells with adenovirus tyjie 2, mRXAs are produced 
that mainly code for viral coat proteins. Most of these messengers are derived from 
the major late transcription unit, which is located between Hv2 and 1000 map units 
on the viral genome (the genome is divided in 100 m.u.f). All messengers that are 
transcribed from the major late transcription unit have the same three leaders 
spliced to the 5' end of their body sequences (Fig. 1(a); Gelinas & Roberts, 1977; 
Chow et al., 1977). Using hetcroduplex and S, nuclease mapping, Berget & Sharp 
(1979) have suggested that splicing between the leaders occurs in an orderly 
fashion. The intron between leader 1 and leafier 2 is removed before the intron that 
separates leader 2 from leader 3 is excised. Recently this was confirmed by 
Keohavong et al. (1982), who found that ligation of leader 1 to leader 2 occurs 
before ligation of leader 2 to leader 3. 
We have used the S, nuclease mapping procedure to study the cleavage reactions 
that are involved in the splicing of the late leader sequences. Our S, mapping data 
indicate that there are alternative splicing pathways for the excision of the first and 
second intron from RNAs that are derived from the major late transcription unit. 
Although the kinetic analysis of the cleavage reactions is in agreement with the 
chronology of the ligation of the leaders (Keohavong et al., 1982), we found that 
cleavage can occur in the second intron before the first intron is attacked. 
2. Materials and Methods 
(a) Infection and labeling of cells 
HeLa S3 cells were inferteri with adenovirus type 2 (2000 particles per cell) at a density of 
5 χ 106 celLs/ml in Eagles minimal essential medium (MEM) containing 1 тм-arginine. After 
adsorption of the virus to the cells during 1 h at 370C, the («Us were diluted to 
0-3 χ 106 cells/ml with MEM containing 5" 0 newborn calf serum. Cells were harvested at 18 h 
post-infection. To obtain rapidly labeled nuclear RNA 18 h after infection, cells were 
concentrated to 20 χ IO6 cells/ml and incubated with 20μ0ί of |5-3H]cytidine/ml 
(31 ('i/mmol; Amersham, England). 20 μΓί of |ñ'-3Hlguanosine/ml (22 Ci/mmol; Arnersham, 
England) and 20μ(Ί of |5.6-3H]uridine/ml (45 ('i/mmol: Amersham. England). The labeling 
times were as indicated in the text. The pulse-chase experiment was performed without 
guanosine in the labeling mixture. 
(b) Preparaiion of nuclear ИХА 
At 18 h after infection cells were harvested on frozen Na/K/Mg solution (013 м-ХаС1, 
005 Μ-ΚΓ1, 1-5 mM-MgCl2) and centrifuged for 5 min at 800^ The cells were washed once 
with Na/K/Mg solution and after pelleting they were resusi>ended in reticulocyte suspension 
t Abbreviations used in u , map units; DRB. ñ.H-Hichloro-l-^ -D-nbofuranosylbenzimidazole; A<12, 
adenovirus type 2. 
МЧЛ( l \ ( ¡ OK ADKNOMKAL LAIE XITLEAR RNA -MI 
budei (KSB KlmMNdl'l ІОтмТпч pH 7 4 1 5 т м Mgf'l2) After addition of 0 1 \ol o l a 
мнhum dcowi holate/Nonidct IMO rimtuie (5" ( ) each) the tells were disrupted by intensne 
\оі1е\тц The nui lei «ere інЧІеІесІ uashed once with RSB and resuspended in the same 
buffel Xudeai RNA was then isolated by extraction with phenol at 55°0 as de&(ribed bj 
Umn et ni (1079) 
(( ) Isolation of cloned rWnWío« Jrni/menls 
The λ hoi V iiagment of Ad2 DXA was lifjated in the ,Sn/I site of pBR322 pBR322 
containing the HimUll В restriction fiagment in the //indili site »as a generous gift from 
R Ohlsson Plasmids were grown in Escherichia coli strain .IA221 Extraction and 
purification of plasmici DXA were performed as described by Alestrom et al (1980) After 
isolation the punhed plasmids were linearized by digestion with firoRI 
(d) Hestnction епаописіеале digestumi 
All resti irtion enzymes were purchased from Bethesda Research Laboratories Ine 
Digestions were performed at 370Г for 4 h using 1 unit of enzyme per fig of DNA Standard 
conditions for KcoRl and //jwdlll were 50 т м Tris (pH 7 4), 7 т м Mg0l2, 50тмХаС1, 
3 т м di thiothreitol Digestion conditions for Sstl and BamHI were 20 т м Тпь (pH 7 4), 
6 т м Mg('l2, 80 т м ХаП Ь т м dithiothreitol Kpnì digestions were performed under low 
salt conditions (b т м Tris pH 7 4 6 т м MgC^, 6 т м NaCl, 6 т м dithiothreitol) Bovine 
serum albumin was added to the digestion mixtures to a final concentration of 1 mg/ml 
Restriction fragments were separated by agarose gel electrophoresis 0 8% agarose gels were 
run for 20 h at 80 V in Tns/Xa/EDTA buffer (40 т м Tris, pH 80, 8 т м sodium acetate 
2 т м EDTA) The DXA was recovered from agarose gel slices by electrophoretic elution 
(e) S, nuclease mapping and analysis of S, resistant hybrids 
RNA was hybridized to DXA under conditions in which DNA DNA hybridization was 
minimized using the procedure described by Manley et al (1979) A sample (1 ^g) of nuclear 
RNA was hybridised to 2 5fig equivalent of a restriction fragment of Ad2 DNA 
Hybridization concentration was 0 3 5 μ ρ RNA/μΙ After til nuclease digestion the hybrids 
were precipitated with ethanol, the pellet was solubilized in Tns/Na/EDTA buffer and 
applied to a I 2 0 0 agarose gel Electrophoresis was performed under the same conditions as 
weie used for the separation of DNA restriction fragments Gels were subsequently treated 
with 5 0 0 trichloroacetic acid methanol, methanol containing 10% PPO, and water After 
drying they were exposed to Kodak XR 5 film for an appropriate penod of time (3 to 7 
clajb) 
3. Results 
(a) 5 , nuclease mapping иліпд the HmdJII В restriction fragment 
The HimlHI В restriction fragment of Ad2 D N A ( lb 8 to 31 5 m u ) covers the 
/
 second and third leadei sequences as well as part of the first, the second and (part 
of) the third intervening sequences (Fig 1(a)) Also the 5' ends of the larger LI 
messengers are located in this region (Akusjàrvi 4 Persson, 1981) Therefore, we 
considered the Himilll В fragment to be a useful D N A probe to study R N A 
splicing between the late leaders via the K1 mapping procedure. Rapidly labeled 
nuclear R N A was extracted from HeLa cells late after infection with Ad2 and 
hybridized to the /Zmdl l l В fragment When the Si-resistant hybrids were 
resolved on agarose gel as described m Materials and Methods, a complex pattern of 
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Fie. 1 (a)Position of theSleiidersequenres and mterveningsequenresof major lato adenoviral RXAeon 
the viral genome The genome ш divided into 100 m u The exact positions of the leaders, as indicated, art' 
deduced from the nucleotide sequence of the //indili В restriction fragment (Peter Aleström, personal 
communication) Also shown arc the restriction fragments that were used as DNA probes in S, mapping 
experiments (b) Summary of the S, mapping data that were obtained via S, апаіуын of rapidly labeled 
nuclear RNA using the restriction fragments depicted in (a) as DNA probes. The RNAs have been 
numbered (1 to 7) for relerence. (^^^™) Leader (Le) sequence, ( ) intervening sequence 
hybrids was obtained. This was to be expected, according to the findings of Berget 
& Sharp (1979), who have detected a complex population of RNA molecules that 
map with their 5' end in this region of the genome and have their 3' end to the right 
of co-ordinate 31 ·5. These RNA species were assumed to be processing 
intermediates in the formation of adenoviral late messengers. We have used 
subfragments of tfràdili В (Fig. 1(a)) to identify the most prominent labeled RNA 
species and map their 5' end in this region. Figure 2 shows the result of such an 
analysis in which 15-minute-labeled late nuclear RNA was hybridized to 
/ / r à d i l i В (lane 1) and to the subfragments (lanes 2 to 5). Hybrids in lane 1 are 
S P L I C I N G O F A D E N O V I R A L L A T E N U C L E A R R N A 243 
1 2 3 4 5 % (kb) 
1> 
2> 
_ 
- 23-5 (8-2) 
_ 14-7 (5-3) 
— 9-1 (3-2) 
_ 7-7 (2-7) 
6-3 ( 2 - 2 ) 
5-8 ( 2 - 0 ) 
• 
3-7 (1-3) 
_ 2-7 (0-95) 
• * 
. 
Flu. 2. S! nuclease analysis of total nuclear RNA in the region of // indi l i В. HeLa cells 18 h after 
infection were labeled for 15 min with 3H-labeIed nucleosides. After labeling total nuclear RNA was 
prepared as described in Materials and Methods. The RNA {2 χ IO6 cts/min) was hybridized to various 
DNA fragments (Fig. 1(a)) and analyzed according to the Sl mapping procedure {Materials and 
Methods). The Figure shows the Sj-resistant hybrids of nuclear RNA with lane 1, //indi l i В; lane 2, 
subfragmenta; lane 3, subfragment b ; lane 4, subfragmente; lane 5, subfragment d. EcoHl and 
// indi l i digests of Ad2 DNA were used as molecular weight markers. The positions of the // indi l i 
markers are indicated. The hybrid bands in lane 1 have been numbered for reference, kb, 103 base-pairs. 
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numbered for reference. Hand number 1 (14·(>00; 1% equals 3(i0 base-pairs) was 
visible only after prolonged exposure times. This band represents the primary 
transcript molecules that extend beyond both ends of //indili В and. therefore. 
protect the DXA fragment totally against degradation by the S, nuclease. A 12·3 0 0 
hybrid band (number 2) is formed from RNA species that have their 5' ends 
localized at 19-2 m.u. In agreement, hybrids of 9 ·9 0 0 or 4-0"o were found when 
subfragments a or с were used (lanes 2 and 4). These hybrids represent processing 
intermediates from which intron 1 has been removed (Berget & Sharp, 1979; 
Manley et al, 1979). Hybrid bands 3, 4 and 5, with lengths of (5-0, 5 3 and 50 0,,, 
respectively, were detected with HimWW В (lane 1) as well as with fragment d 
(lane 5) but not with any of the other fragments. These colinear pieces of RNA, 
therefore, have their 5' ends at co-ordinates 25-5. 26-2 and 2fr5, respectively, and 
extend to the right of 31-5 m.u. They were described by Berget efe Sharp (1979), who 
identified six presumptive processing intermediates mapping in the region between 
24-8 and 2(i-9 m.u. With subfragment с a band of 2-l0,') was found (lane 4), which 
could not be detected with any of the other fragments. The RXA in this hybrid 
maps with its 5' end at co-ordinate 21-1 and extends beyond 23-2 m.u. 
Except for RXA molecules that extend beyond 31-5 m.u. in this experiment, we 
identified two s}>ecies that seemed to extend to the left of 16-8 m.u. Bands β and 7, 
3-9 and 2-3 0 0 in length, were found when HimWW В or subfragments a or с were 
used to hybridize (lanes 1. 2 and 4). These RNA species extend from the lelt of 
108 m.u. to co-ordinates 20 7 and 191. respectively. In further experiments we 
identified a third species that extends beyond 1β·8 m.u. It is indicated by an arrow 
and numbered 8 for reference. From the data presented in this section it cannot be 
concluded that these three RNAs are derived from the major late promoter. Their 
identity will be discuss«! further, below. 
Figure 1(b) summarizes the S, mapping data and shows the UNA species that 
were identified in the rapidly labeled total nuclear RNA. The positions of the 
leaders, as indicated, are deduced from the nucleotide sequence of the //indili В 
restriction fragment (Peter Aleström, personal communication). 
(b) Kinetics of the cleavage reactions as part of RNA spliciru] 
To study the formation of the RXA species a kinetic labeling experiment was 
performed in the following manner. Four portions of 18-hour-infected HeLa cells 
(100 x 106 cells each) were labeled with 3 Η-labeled nucleosides for 3, 7, 15 and 30 
minutes, res¡)octively (see Materials and Methods). After labeling, nuclear RXA 
was prepared and analyzed via the S, nuclease procedure. From each portion of 
cells 2 χ 106 cts/min of nuclear RXA were hybridized to //indili В. Thus, the 
pattern of Si-resistant hybrids (Fig. 3) shows the relative accumulation of label in 
the individual RXA species. After three minutes of labeling RNAs 1 and 2 were 
already labeled, while no label could be detected in RNA 4 (Fig. 3, lane 1). Only 
after 15 minutes of labeling did radioactivity begin to accumulate in RNA 4 
(Fig. 3, lane 3). which became the most predominant band after a labeling time of 
30 minutes (Fig. 3, lane 4) or longer. The method of analysis that we have used can 
detect only where the ends of a colinear RXA chain are located. Our results show 
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1> 
2> 
3> 
4> 
5> 
_ 2 3 · 5 (8-2) 
— 14-7 (5-3) 
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FlCî. 3. 8j nuclease analysis of nuclear RNA labeled for various periods of time. HeLa cells 18 h after 
infection were labeled for 3. 7, 15 or 30 min with 3H-Iabeled nucleosides. After labeling total nuclear 
RNA was prepared as described in Materials and Methods. Thé RNA (2 χ IO6 cts/min) was hybridized to 
the Hindlìl В restriction fragment and analyzed according to the Sj mapping procedure (Materials and 
Methods). The Figure shows the Si-resistant hybrids. EcoRl and //indil i digests of Ad2 DNA were used 
as molecular weight markers. The positions of the Hindlll markers are indicated. Lane 1, 3 min 
labeling; lane 2, 7 min labeling; lane 3, 15 min labeling; lane 4, 30 min labeling. The hybrid bands have 
been numbered for reference. 
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that within three minutes after the start of transcription the UNA is cleaved at the 
acceptor site between intron 1 and leader 2 (19-2 т.н.)- while it takes almost 15 
minutes before cleavage occurs at the acceptor site between intron 2 and leader 3 
(2(v2 m.u.). In all labeling experiments that we have performed RNA 3 appeared 
also to accumulate label within three minutes (Fig. 3. lane I). From this we 
concluded that intron 2 may be rapidly cleaved at 25-5 m.u. Therefore, it seems 
likely that intron 2 can be removed in at least two steps, in which RNA 3 is created 
as an early intermediate of this splicing event. 
(с) Р Ые-сНале analysis of nuclear UNA 
We were interested to know if RNA 4 is derived from the primary transcript or 
from a rapidly formed processing intermediate. Therefore, pulse -chase type 
experiments were performed. HeLa cells 18 hours after infection were pulse-labeled 
(5 min) with 3 H-labeled nucleosides (see Materials and Methods). After labeling, the 
cells were rapidly cooled to 0 (', pelleted and suspended in medium containing 
10 тм-gluco.samine and 0 1 mg of cytidine and uridine/ml (Scholtissek. 1971). This 
procedure is known to reduce the uridine pool in the nucleus dramatically. After a 
chase of 5. 10, 20 or 30 minutes at 370C, samples containing 100 χ IO6 HeLa cells 
were collected, cooled rapidly to 0 4 ' and nuclear RNA was prepared as described in 
Materials and Methods. By this procedure accumulation of label was stopped in less 
than ten minutes of chasing. Nuclear RNA (2 x IO6 ets/min) was hybridized to 
//indili В. The Spiesistant hybrids, as shown in Figure 4. demonstrated that after 
a five-minute chase RNAs 1. 2 and 3 were labeled (lane 1). The primary transcript 
RNA 1 contained only a very low amount of label while RNA 2 was the most 
predominant band. This agrees with our findings that the primary transcript is 
very rapidly processed by cleavage at 19-2 m.u. to form RNA 2. Therefore. RNA 2 
accumulates rather than RNA 1. RNA 4 began to accumulate label after a 10-
minute chase and became the most predominant band after a 30-niinute chasing 
period. On the score of the relative intensities of the hybrid bands we concluded 
that RNA 4 is a processing product of RNA 2. The primary transcript is cleaved at 
19-2 and 2(i-2 m.u. in the 5' to 3' direction. These findings are in full agreement with 
the results of Keohavong et al. (1982), who found that ligation of leader 1 to 
leader 2 precedes ligation of leader 2 to leader 3. Removal of intron 1 seems to 
occur before removal of intron 2 
(d) S, nudease mapping ичт/ the Xho/ F restriction frayment 
As can be seen from Figure 3 (lane I ) RNAs 6. 7 and 8 are labeled within three 
minutes. To find out if these three species were derived from (he major late 
transcription unit, we have performed S, mapping using the ΛΆοΙ F restriction 
fragment (15-5 to 224 m.u.) as a probe for hybridization. However, for accurate 
mapping 20-minute-labeled late nuclear RNA was not only hybridized to full-
length A'Aol V (Fig. 5, lane 1), but also to the DNA fragment after its digestion 
with Salì (Fig. 5, lane 2) or with / / imll l l (Fig. 5. lane 3 for restriction sites see 
Fig. (i(a)). To identify RNA species *i. 7 and 8 the RNA was hybridized to 
/ / ind i l i В as well and scored for S,-resistant hybrids (Fig. 5, lane 4). 
1 2 3 4 % (kb) 
— 23-5 ( 8 - 2 ) 
14-7 (5-3) 
— 9-1 (3-2) 
8 — 
6> 
— 7-7 ( 2 - 7 ) 
— 6-3 ( 2 - 2 ) 
— 5-8 ( 2 - 0 ) 
— 3-7 (1-3) 
7> Щ** m mi 
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F I G . 4. Pulae-chaee analysis of nuclear RNA. HeLa cells 18 h after infection were labeled for 5 min 
with 3H-labeled nucleosides (Materials and Methods). After labeling the cells were rapidly cooled to 0oC, 
pelleted and resuspended in chase medium as described in Results, section (c). Chasing was performed 
for 5, 10, 20 and 30 min, respectively. After chasing total nuclear RNA was extracted and analyzed 
according to the Sj mapping procedure (Materials and Methods) using Hinúlll В as DNA probe. The 
Figure shows the S^resistant hybrids. EcoRl and //indi l i digests of Ad2 DNA were used as molecular 
weight markers. The positions of the //iridili markers are indicated. Lane 1, 5 min chasing; lane 2, 
10 min chasing; lane 3, 20 min chasing; lane 4, 30 min chasing. The hybrids have been numbered for 
reference. 
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Fu¡. 5. S, nuclease analysis of total nuclear RNA in the region of A'Aol F. HeLa cells 18 h after 
infection were labeled for 20 min with 3H-labele(l nucleosides. After labeling total nuclear RNA was 
prepared as described in Materials and Methods. The RNA (2 χ IO6 cts/min) was hybridized to A'AoI F 
and to the same restriction fragment after its digestion with »S1.s/I or flindlll (Fig. в(а)). Further analysis 
was performed according to the Sj mapping procedure (Materials and Methods). The Figure shows the 
K,-resistant hybrids of nuclear RNA with . lane I, A'Aol F : lane 2, ЛЛ-digested A'Afll F ; ІапеЗ, WrádlII-
digested А'ЛнГ F; lane 4, HindìW В. EeoRl and //mdl l l digests of Ad2 DNA were used as molecular 
weight markers The positions of the Windlll markers are indicated. The lengths of hybrids in lane I are 
indicated for reference. 
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Fie H (a) Position of the leader xequenres and intervening Kequences of major late adenoviral RNA« 
on the viral genome Also xhown are the position of the Л ho\ F геніпсіюп fragment and the location of 
the cleavage Hites in this fragment for the rest rut ion enzymes that were used in the S, mapping 
expenmentH (b) Summary of the S, mapping data that were obtained via Si апаіунів of rapidly labeled 
nuclear RNA umng the Λ'ΑοΙ F fragment and digested Λ'ΑοΙ F DNA as probes for hybridization (a) The 
RNAs have been numbered for referent« Le, leader 
With Xho\ F a 6-2% band was found (lane 1), which represents the primary 
transcript extending from 16-2 to beyond 22·4 m u. Similarly, a hybrid of 4-4% was 
found when the iS.v/I-digested fragment was used (lane 2). The most predominant 
band was 3-2% long (lane 1). This hybrid was also found with the //mdlll-digested 
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fragment (lane 3), but not with the Ss/I-digested fragment (lane 2), in which ease a 
predominant 1-4% hybrid was detected. The 5' end of this RNA maps at 19-2 m.u. 
and extends beyond 22-4 m.u. I t was earlier identified as RNA 2 (Fig. 1(b)). Two 
smaller bands 1-7% and 1-3% in length, respectively, were detected with A'Aol F 
(lane 1). Both bands were also present in the hybrid pattern obtained with the 
//»'ndlll-digested fragment (lane 3). The 1·7 0 0 hybrid was not found with the Sntl-
digested probe (lane 2). A slightly smaller band of about 1·60'
Ο
 was probably 
derived from RNA that hybridized to the small Ssll-Xhol fragment (208 to 
22-4 m.u.). In this case, however, we cannot explain why this band was only faint 
instead of predominant as would be expected. The RNA in the 1-7% hybrid maps 
with its 5' end a t 20-7 m.u. and extends beyond 22-4 m.u. This was confirmed by the 
presence of a weak 2-5% long hybrid in the pattern obtained with subfragment с 
(Fig. 2, lane 4). When subfragment с was used as a probe for hybridization we 
identified an RNA species with its 5' end at co-ordinate 21-1 (see section (a), above). 
This species corresponded to the 1·3% hybrid found with Xhol F (lane 1) as well as 
with the digested restriction fragments (lanes 2 and 3). A band of 5-6% was 
detected with Xhol F (lane 1), while a 3-8% long hybrid was found with the Sstl-
digested fragment (lane 2). These hybrids were formed from RNA molecules that 
map with their 5' end at 16-8 m.u. and extend beyond co-ordinate 22-4. 
Except for the RNAs that have their 3' end to the right of 224 m.u., we have 
mapped the RNA molecules that extend beyond 16-8 m.u. A 4-9% long hybrid was 
found with Xhol F (lane 1), but not with the SMI -digested fragment (lane 2). I t 
corresponds to the hybrid of 4-3%, which was detected with the Wiwdlll-digested 
fragment (lane 3) and was earlier numbered 8 for reference (Fig. 3, lane 1 ; Fig. 4, 
lane 1). This RNA extends from the promotor region at 16-2 m.u. to co­
ordinate 21.1. 
RNA ϋ gave rise to a hybrid of 3-9% with #¿ndI I I В (lane 4) and was also 
detected with the //¿«dill-digested Xhol F fragment (lane 3). In accordance with 
the supposition that this RNA extends from 16-2 to 20-7 m.u., a hybrid of length 
4-4% was found with the Xhol F fragment (lane 1). 
RNA 7, which was found with Hindlll В (lane 4) and with the //¿ndlll-digested 
A'Aol F fragment (lane 3), was earlier mapped with one end at 191 m.u. and 
extending to the left of 16-8 m.u. (see section (a), above). This appeared to be 
correct since a band of 2-9% was found when À'AoI F or the Seil -digested fragment 
was used as DNA probe (lanes 1 and 2). Thus this RNA maps between 16-2 and 
19·1 m.u. Since this RNA could represent the spliced-out intron 1, we have verified 
the presence of leader 1 in this RNA by separating the hybrids on agarose gel and 
transferring them to nitrocellulose. The blot was incubated with 32P-labeled 
complementary DNA of the fiber messenger (Zain et al., 19796), a generous gift 
from M. Mathews. After incubation and washing, the 2-9% hybrid appeared as a 
32P-labeled band (data not shown). Thus, RNA 7 contains leader 1 sequences. 
Figure 6(b) summarizes the Sj mapping data described above. Two conclusions 
can be drawn. First, there are two cleavage sites in intron 1 at 16-8 and 19-1 m.u., 
respectively, demonstrating that excision of intron 1 may be a stepwise process. 
Second, RNAs 6, 7 and 8 map with their 5' end at the start site of transcription 
(16'2 m.u.). Most striking, however, is the fact that their 3' ends map a t locations 
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where other colinear RXAs have their 5' end. It is. therefore, reasonable to assume 
that pairs of these RXAs (e.g. RXAs 2 and 7) are created l>y the cleavage of the 
primary transcript at 191, 20-7. or 21-1 т .н. , respectively. This finding also makes 
it unlikely that RXAs 6, 7 and 8 might be the result of premature termination of 
transcription, a phenomenon that has been reported to occur in the major late 
transcription unit ( К vans et al.. 197!)); for in that case one should not expect to 
detect the 3' RXA pieces. Furthermore, we have labeled HeLa cells at the late stage 
of infection in the presence of DRR for 20 minutes. When the nuclear RXA was 
extracted and analysed according to the S, mapping procedure the RXAs 6. 7 and 8 
were not detectable as labeled sj>ecies. DRB seems to inhibit the formation of these 
three RXAs to the same extent as the synthesis of promoter-distal RXA se(|uences. 
Since products of premature termination are continued to be formed in the 
presence of DRB (Fraser et al., 1978,1979) this indicates that RXAs (i. 7 and 8 are 
not the result of premature termination but rather of cleavage activities. 
(e) Analysis of naxcent RNA илігщ DHB-trealed cells 
The kinetic labeling experiment described in section (b), above, showed that after 
three minutes of labeling both RXAs 2 and 7 were already labeled (Fig. 3, lane 1). 
Thus, the primary transcript is cleaved at 19-1 m.u. within three minutes after the 
start of transcription. To obtain more information about the moment of cleavage of 
the RXA we have performed a kinetic labeling experiment in which the RNA was 
labeled from the 5' end. Therefore, HeLa cells were treated with 75pM-I)RB 
(Fraser et al, 1978; Tamm et al.. 1980; Cheng-Kiang et al., 1982) from 17 to 18 
hours after infection. DRB allows initiation of transcription to take place, but 
inhibits the elongation of RNA synthesis. At 18 hours after infection the cells were 
rapidly cooled to 0CC, pelleted, washed in Xa/K/Mg solution and resuspended in 
medium to label the cells as described in Materials and Methods. Oils were labeled 
for 5, 10, 20 and 45 minutes, respectively. The nuclear RXA was extracted and 
analyzed via the S, nuclease procedure. The RNA (2 χ IO6 cts/min) was hybridized 
to the //indili В restriction fragment and S|-resistant hybrids were scored as 
shown in Figure 7. The effect of DRB seemed not to be reversed instantly upon its 
removal, since after a labeling time of five minutes hardly any labeled RNA 1 or 2 
could be detected. Elongation of transcription seemed to be slowed down, possibly 
by the presence of a small residual amount of DRB in the cells. However, RNAsO, 7 
and 8 were clearly labeled after five minutes (lane 1). This indicates that cleavage 
can occur in the nascent transcript, preferentially at 191. but also at 20-7 and 
21 1 m.u. The RXA was cleaved before transcription had passed beyond co­
ordinate 31-5. As soon as transcription had passed beyond this co-ordinate RNA 3 
appeared as a labeled species in the hybrid pattern (lane 2). Again this suggests 
that the nascent RXA transcript is cleaved at 25-5 m.u. as soon as the RXA 
polymerase has passed beyond this co-ordinate. Only after 20 minutes of labeling 
did RXA 4 appear (lane 3), in agreement with the relatively slow cleavage of the 
RNA at 262 m.u. It should be noted, however, that the altered rate of 
transcription in DRB-treated cells may lead to the accumulation of nascent 
transcripts and a higher efficiency of cleavage as compared to non-treated cells. 
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F I G . 7. S! analysis of nascent RNA HeLa cells were treated with DRB (75 μΜ) from 17 to 18 h alter 
infection. Thereafter the cells were rapidly cooled to OX*, pelleted, washed with Na/K/Mg solution and 
resuspended in medium to label the cells with 3H-labeled nucleosides for 5. 10, 20 or 45 min (see 
Materials anil Methods). After labeling total nuclear RNA was prepared as described in Materials and 
Methods. The RNA (2X IO6 ets/min) was hybridized to the //гтІІІІ В restriction fragment and 
analyzed according to the Si mapping procedure (see Materials and Methods). The Figure shows the i>i-
resistant hybrids. .ÉVoRI and ¿fóndili restriction digests of Ad2 DNA were used as molecular weight 
markers The positions of the /limilll markers are indicated. Lane 1, 5 min labeling; lane 2. 10 mm 
labeling, lane 3, 20 min labeling; lane 4. 45 min labeling. The hybrid bands have been numbered for 
reference. 
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4. Discussion 
Splicing іы one of the post-transoriptional modifications that are part of the 
production process of eukaryotic messengers. Although not much is known about 
the mechanism of splicing it evidently involves cleavage of the RNA chain at the 5' 
and 3' ends of an intervening sequence, followed by the ligation of the external 
RNA pieces. Using the S, mapping procedure (Manley et al., 1979) we have studied 
the cleavage reactions that occur during splicing of the tripartite leader sequences 
in RNAs that are derived from the major late transcription unit of adenovirus 
type 2 (Celinas & Roberts, 1977; Chow et al., 1977). We have analyzed pulse-
labeled nuclear RNA rather than steady-state RNA. This has enabled us to draw 
the following conclusions. 
(1) Both intron 1 and intron 2 can be spliced out in more than one step. 
(2) Certain cleavages are rapidly introduced in the primary transcript, while 
other cleavage sites are used only after a significant time-lag. In this case the 
cleavages occur in a processing intermediate rather than in the primary 
transcript. 
(3) The rapid cleavages can occur in the nascent transcript. In such cases the 
first acts of splicing can occur before polyadenylation or termination of 
transcription. 
(4) Alternative splicing pathways exist in the excision of intron 1 as well as 
intron 2. 
In the case of excision of introns as a whole one should expect to detect only two 
processing intermediates with the $! mapping technique. Removal of intron 1 
should lead to an intermediate with its 5' end at co-ordinate 19-2, while removal of 
intron 2 should create a colinear RNA with its 5' end localized at 26-2 m.u. Indeed, 
both intermediates, RNAs 2 and 4, were detected. Except for these RNAs, which 
extend from leader 2 or leader 3, other RNA species were found that have their 5' 
ends a t 16-8 m.u. In intron 2 three species were mapped with their 5' ends a t 207, 
21-1 and 25-5 m.u., respectively. RNA molecules mapping with their 5' ends in 
intron 2 were reported to be present in steady-state nuclear RNA (Berget & Sharp, 
1979; Manley et al., 1979) and were regarded as intermediates in a stepwise splicing 
process. Our results thus indicate that not only intron 2, but also intron 1, can be 
excised in a stepwise manner. Not all of the intermediates that we have found agree 
with those first described by Berget & Sharp (1979). This may be ascribed to the 
fact that we analyzed rapidly labeled RNA instead of steady-state RNA. Rapidly 
formed intermediates do not necessarily have to correspond to the most abundant 
species present in nuclear RNA. 
As shown by a pulse-chase experiment (Fig. 4), the intermediate that extends 
from leader 3 (26-2 m.u.) is derived from another processing intermediate extending 
from leader 2 (19-2 m.u.). Cleavage a t 26-2 m.u. occurs at about 15 minutes after the 
start of transcription. Keohavong et al. (1982) have reported that in ligation of 
leader 2 to leader 3 there is a time-lag of 12 minutes. This suggests that the time-lag 
is due to the slow cleavage reaction at the 3' end of intron 2. Cleavage at 26-2 m.u. 
seems to be one of the last events in splicing of leader 2 to leader 3, followed by rapid 
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ligation of these exons. Further, they have reported that ligation of leader 1 to 
leader 2 occurs without detectable delay. Accordingly, we have found that intron 1 
is cleaved at its 3' end (19-1 m.u.) as soon as transcription has proceeded some 
distance beyond this site. These results indicate that cleavage at the 3' end of an 
intron may be involved in the regulation of splicing. 
Labeling from the 5' end (Fig. 7) has shown that the primary transcript may be 
cleaved at certain places while transcription is still proceeding. These cleavage sites 
are located at 19·1, 20-7, 21-1 and 25-5 m.u., suggesting that the RNA polymerase 
has added not more than 2000 nucleotides to the growing RNA chain before it is 
cleaved. For the first three cleavage sites we were able to detect both the 5' and 3' 
pieces resulting from cleavage of the primary transcript. In case of cleavage of the 
primary transcript at co-ordinate 25-5 one should expect to find an RNA molecule 
that extends from 16-2 to 25-5 m.u. Until now we have not been able to detect such 
a species, indicating that the cleavage at 25-5 m.u. occurs in a more rapidly 
produced processing intermediate rather than in the primary transcript. Recent 
results obtained by Manley et al. (1982), who have studied transcription and 
processing in isolated nuclei of late-infected HeLa cells, also point to the rapid 
excision of intron 1 from the nascent transcript. 
Our S, mapping data have demonstrated at least two processing intermediates 
arising from splicing of intron 1 (Fig. 6(b)). One intermediate has its 5' end at 
16-8 m.u. and extends beyond leader 2. The other preferentially formed 
intermediate extends from the 5' end of leader 1 and has its 3' end at 19-1 m.u. 
These processing intermediates cannot be derived from one another. Therefore, 
alternative splicing pathways seem to exist for the excision of intron 1. We have 
found also that the first cleavage of the primary transcript can occur at either of 
two locations in intron 2, at 20-7 or 21-1 m.u. Thus, alternative pathways for the 
excision of intron 2 also seem to exist. I t is possible that one splicing pathway is 
used to introduce the i-leader into mature messengers (Akusjärvi & Persson, 1981). 
Our data indicate that the preferred splicing pathway follows the removal of 
intron 1 before intron 2. However, cleavage may occur in intron 2 before intron 1 is 
attacked. These findings do not contradict the resulta of Keohavong et al. (1982), 
since in this case ligation of leader 1 to leader 2 may still precede the ligation of 
leader 2 to leader 3. 
Although our data demonstrate that the primary transcript is preferentially 
cleaved at 19-1 m.u., there are a small number of molecules (band number 1, Fig. 3) 
that seem to escape rapid cleavage at a site within the HinAAW В region. I t is 
possible that the first event of splicing in these molecules may occur at the right of 
31-5 m.u. Another explanation could be that splicing in these molecules is delayed, 
for instance, because they miss the correct processing proteins. I t is also possible 
that these unattacked molecules for some reason are not determined or not fit to be 
processed into mRNA. 
Until now we could never identify pieces of RNA that could be ascribed to 
spliced-out intervening sequences (Mariman et al., 1982). We have demonstrated 
the presence of leader 1 sequences in RNA 7 (16-2 to 19-1 m.u.). However, since 
leader 1 is only 41 nucleotides in length (Zain et al., 1979α) it cannot be ruled out 
that the hybrid bands derived from RNA 7 are actually derived from a mixture of 
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R N A molecules t h a t con ta in leader 1 (16 2 to 19 1 m u ), a n d s>plieed-out in t ron 1 of 
a b o u t t he ь а т е size (10 3 t o 19 1 m u ) I t is also possible t h a t rapid d e g r a d a t i o n 
m a y p r e v e n t t h e a c c u m u l a t i o n of s p l u e d - o u t in te rvening sequences t o a d e t e c t a b l e 
c o n c e n t r a t i o n 
We h a v e r e p o r t e d t h e ex i s tence of a l t e r n a t i v e splu ing p a t h w a y s in t h e f o r m a t i o n 
of t h e t r i p a r t i t e leader sequences of late adenov i ra l m R N A s T h i s m a y be a m o r e 
general feature of R N A splicing in e u k a r y o t u ееііь F u r t h e r s tudies a r e d i rected t o 
d e t e r m i n e t h e splicing p a t h w a y s in more deta i l , s ince th i s m a y he lp t o e luc idate t h e 
m e c h a n i s m of t h e regulat ion of R N A spin inp 
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CHAPTER III 
A MODEL FOR THE EXCISION OF INTRONS 1 AND 2 FROM ADENOVIRAL 
MAJOR LATE PRE-mRNAa 

A model for the excision of introns 1 6 2 from adenoviral 
major late pre-mRNAs. 
E.C.M. Mariman, R.J. van Beek-Reinders and W.J. van Venrooy 
Department of Biochemistry, University of Nijmegen, 
The Netherlands. 
SUMMARY 
Total steady state RNA was extracted from nuclei of Hela 
cells late after infection with adenovirus type 2. Most of the 
nuclear RNA is transcribed from the major late transcription 
unit (16.2 to 100.0 map units (m.u.)). To study the cleavage 
reactions involved in the splicing of leaders 1 and 2, we have 
used the S1 nuclease mapping technique with restriction frag­
ments located in the region of intron 1 аз DNA probes. The S1-
mapping data showed that RNA species accumulate in total 
nuclear RNA from which the 5' part of intron 1 has been removed 
but still contain the 3' part. This indicates that intron 1 
can be removed in a stepwise fashion following the 5' to 3' 
direction. We have located the ends of these putative proces­
sing intermediates in the nucleotide sequence. It seems that 
they do not resemble consensus acceptor on donor sites. Reverse 
transcription experiments have been performed in which a primer, 
located with its left end in leader 2, is extended into intron 
1. The results show that a major cleavage site is located 
about 35 nucleotides before the acceptor site. Cleavage at the 
acceptor site seems to be rapidly followed by ligation of 
leader 1 to leader 2. A model for RNA splicing is presented. 
INTRODUCTION 
At the late stage of infection of Hela cells with adeno­
virus type 2 most of the viral RNAs are transcribed from the 
major late transcription unit. Three intervening sequences 
are present in the primary transcript (1). The first two, 
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introna 1 and 2, are located between leadere, while the third 
intron іэ looated between leader 3 and the body of the mRNA. 
Analysis of the steady state nuolear RNA extracted from Hela 
cells at the late phase of infection has revealed the existence 
of a get virus-speoifio RNAs which lack the 5' part of the se­
cond intron (2). Those RNAs may be intermediates in a stepwise 
excision of intron 2 in the 5' to 3' direction. Since our former 
results (3) indicated that the removal of intron 1 may, at 
least for some of the primary transcripts ι also be performed in 
a stepwise fashion, we have tried to find further indications 
for such a process. Therefore, steady state nuclear RNA from 
Hela cells 18 h after infection was analysed with the S1-mapping 
procedure using DNA fragments of 813 and 555 base pairs in length, 
which overlap the 5' and 3' half of intron 1, respectively. 
Our results are consistent with splicing in which the intron 
is excised in the 5' to 3' direction. Reverse transcription 
experiments have been performed to explore the situation close 
to the acceptor site. A major cleavage site was found to be 
located about 35 nucleotides before the acceptor site. Our 
results suggest that cleavage at the actual acceptor site is 
rapidly followed by ligation of leader 1 to leader 2. 
MATERIALS AND METHODS 
a) Infection of cells 
Hela S3 cells were infected with adenovirus type 2 (2000 
particles per cell) at a density of 5x10 cells/ml in Eagles 
minimal essential medium containing 1 mM arginine (MEM). After 
adsorption of the virus to the cells during 1 h at 37 0C, the 
cells were diluted to 0,3x10 сеііэ/ml with MEM containing 5% 
newborn calf serum. Cells were harvested 18 h after infection. 
b) Isolation of nuclear RNA 
Nuclear RNA was isolated as previously described (5). At 18 
h after infection cells were harvested on frozen Na/K/Mg solution 
(0,13 M NaCl, 0,05 M KCl, 1,5 mM MgClg) and centrifuged for 5 
min at 800 g. The cells were washed once with Na/K/Mg solution 
and after pelleting they were resuspended in reticulocyte 
Suspension buffer (RSB: 10 mM NaCl, IO mM Tris,pH 7.Л, 1.5 тМ 
MgCl 3). After addition of 0,1 volume of a sodium deoxycholate/ 
Nonidet P4.O mixture (5? each) the cells were disrupted by in­
tensive vortexing. The nuclei were pelleted, washed once with 
RSB and resuspended in the same buffer. Nuclear RNA was then 
isolated by extraction with phenol at 55 С as described by 
Long et al. (6). 
c) Isolation of restriction fragments 
PBR 322 containing the adenoviral Xho I fragment F (15.5-
22.4 m.u.) in the Sal I site was propagated in E.coli strain 
JA221 and extracted and purified as described by Aleström et 
al. (4). All the DNA fragmente used in this study were obtained 
from this plasmid DNA by restriction digestion and separation 
of the digestion products. The restriction enzymes used are 
depicted in Figure 1. All the enzymes were purchased from 
Bethesda Research Laboratories, Inc. and digestions were per-
formed under the conditions prescribed by this company. DNA 
fragments were separated on mixed agarose/polyacrylamide gels 
(0.5it /5i). After electrophoresis the DNA was isolated from 
gel slices by the method of electrophoretic elution. When a 
particular fragment was obtained from a single digestion of 
the plasmid DNA, as for instance Taq I fragment 813» the eluted 
DNA was further purified by a second gel run and elution. 
When a DNA fragment was obtained by subdigestion of a restric-
tion fragment such an extra purification step was omitted. 
d) Labeling of DNA fragments 
DNA restriction fragments were labeled via nick translation. 
A quantity of the fragment equivalent to 5 \ig of Ad DNA was 
dissolved in 25 ul NT buffer (50 mM Tris, pH 7.5. 25 mM MgCl», 
10 mM DTT, 50 Mg/ml BSA, dGTP, dATP, dTTP (2 μΜ each), U0 yCi 
(a-^2p)-dCTP). To this solution 5 units Kornberg DNA-polymerase 
(Bethesda Res. Lab. Inc.) were added. The mixture was incubated 
for 1.5 h at 15 0C and then diluted to 200 Ul with water, run 
32 
over G50-coarse to remove the excess P-dCTP and extracted 
with one volume of phenol followed by two extractions with 
chloroform. After addition of 10 \ig of RNA and NaCl to 0.3 M 
the nucleic acids were precipitated with ethanol. This method 
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of labeling uses the nicks already present in the DNA. Although 
the 3' end would be labeled more efficiently than the 5' end, 
adding DNAae I (1 yg/ml) to the labeling mixture did not alter 
the pattern of S1 hybrids. Moreover, labeling without DNAse I 
seemed to improve the SI results by removing nicks from the 
DNA strands. 
e) SI-nuclease mapping and analysis of SI-resistant hybrids 
RNA was hybridized to DNA under conditions in which DNA:DNA 
hybridization was minimized, using the procedure described by 
Manley et al. (7). Nuclear RNA (10 μ g) was hybridized with a 
quantity of a restriction fragment equivalent to 5 Ug Ad2 DNA. 
Hybridization concentrations was 0,35 Ug RNA/yl. After S1 nu­
clease digestion the hybrids were precipitated with ethanol, 
the pellet was solubilized in TE buffer (10 mM Tris, pH 7Д, 
1 mM EDTA), and applied on a 1 mm thick 5% Polyacrylamide gel. 
Electrophoresis was for 20 h at 100 V in Trie/Na/EDTA buffer 
UO mM Tris, pH θ.О, 8 mM sodium acetate, 2 mM EDTA). After 
electrophoresis the gels were directly exposed to Kodak XR-5 
film for an appropiate period of time (3 to 16 h), 
f) Reverse transcription 
A quantity of fragment 366 equivalent to 5 g of Ad2 DNA 
was hybridized to 10 ug of nuclear RNA as described above. After 
hybridization the nucleic acid mixture was precipitated with 
ethanol, pelleted and solubilized in 20 μΐ RT buffer (50 mM 
Tris, pH 8.0, 8 mM MgCl2, 10 mM DTT, dATP, dCTP, dGTP, dTTP 
(1 mM each)). To this solution 20 units reverse transcriptase 
(Dr J.W. Beard, Life Science Inc., Florida) were added and 
incubation was for 1.5 h at Д20С. Then SDS, EDTA and NaOH were 
added to a final concentration of 0.5Í» 10 mM and 200 mM, res-
pectively. Incubation for 30 min at 70oC was appropriate to 
degrade the RNA but to leave the DNA intact. After neutrali-
zation with 10? acetic acid the cDNA was precipitated with 
ethanol, pelleted and dissolved in TE buffer. The solution was 
applied on a 5% Polyacrylamide gel containing 7M urea. Electro-
phoresis was for 16 h/120 V, 30 h/120 V or 10 h/220 V. After 
gel electrophoresis the cDNA was electrophoretically transferred 
to Gene Screen (New England Nuclear) using a Biorad Transblot 
Cell (8). Віо з were baked at 80 С for 4 h in a vacuum oven, 
prehybridized for 3 h at 42 0C in 50% formamide, 5x SSC, 250 yg/ 
ml asDNA, 5* Denhardts mix, 0.1? SDS, 10 mM phosphate buffer, pH 
32 6.5, and hybridized for 16 h with ^ P-labeled Xho I fragment F 
under the same conditions. After extensive washing the cDNA 
bands were visualized by exposing the blots to Kodak XR-5 film 
for 3 to 16 h. 
RESULTS 
a) SI nuclease mapping in the region 1 (Tag I) - 813 (Tag I). 
In order to explore the mechanism involved in the removal of 
the first intron from RNAs which are transcribed from the adeno­
viral major late transcription unit, we have used the SI nuclease 
mapping procedure to locate ends of major components of viral 
RNA in the region of intron 1. First the situation in the 5' 
32 half of intron 1 was analysed using P-labeled DNA fragments 
813 and 662 (Figure 1). 
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Fig. 1. DNA fragments used for S1-mapping and reverse trans-
cription. Location of the restriction fragments used in this 
study relative to the left end of the Xho I fragment F (15.5 -
22.4 m.u.) from which they were derived. The length of the frag-
ments (r-strand) is indicated in number of nucleotides. The 
nucleotide sequence is numbered from left to right starting with 
1 at the r-strand nucleotide Τ of the Taq I restriction site at 
15.5 m.u. in the genome (nucleotide 5782 of the Ad2 DNA (9)). 
The restriction sites used are: Taq I: 1, 814; Hinc II: 663, 
1227; Sau3A: 1369, 1735. The position of the leaders and introns 
of the major late рг -mRNAs in this region are as depicted. 
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The labeled restriction fragments were hybridized to nuclear 
RNA which was isolated from Hela cells 18 h after infection 
(Materials 6 Methods). After hybridization the SI-resistant hy-
brids were resolved on a 5% Polyacrylamide gel and visualized 
by direct autoradiography of the gel as described in the Material 
& Methods section. The deviation in the length of hybrid bands 
as determined in this way was estimated to be about 20 base 
pairs. When, as a control, labeled DNA fragments were treated 
in the same way as the DNA/RNA mixtures, no labeled bands could 
be detected showing that under these hybridization conditions 
no DNA:DNA hybridization occurred. 
The results are shown in Figure 2A. When fragment 813 was used 
three major bands were observed with lengts of 540, 4.25 and 350 
base pairs, respectively (lane 1). None of those, as most of 
the minor hybrid bands, could be detected when fragment 662 was 
used (lane 2). This demonstrates that the corresponding RNA 
species map with one end in the region of fragment 662 and ex-
tend to the right beyond nucleotide 662. Related to the 54.0 
base pairs long hybrid the most prominent band obtained with 
fragment 662 was found to be 400 base pairs in length (lane 2). 
The RNA thus maps with its end near nucleotide 265. It is most 
likely that this RNA represents the primary transcript, starting 
with nucleotide 258. To match the hybrid of 425 a band of 295 
base pairs was detected in the hybrid pattern obtained with 
fragment 662 (lane 2). These hybrids are derived from an RNA 
species which has its end near nucleotide 380. In agreement 
with the length of the 350 base pairs long hybrid a band of 
about 210 base pairs was detected using fragment 662 for S1-
mapping. The corresponding RNA species has its end near nucleo-
tide 460 and extends to the right beyond nucleotide 813. This 
RNA may wéLl be the same species as we previously observed as 
the result of cleavage of viral pre-mRNA at coordinate 16.8 (7). 
If the primary transcript would be cleaved at the donor site 
of intron 1 bands of 515 (299 - 813) and Э64 (299 - 662) base 
pairs should be detectable with fragments 813 and 662, respec­
tively. Indeed, bands of 505 and 365 base pairs (indicated by 
the arrow in lanes 1 and 2) can be seen as minor components of 
the hybrid patterns. This could mean that cleavage at the donor 
site does not preferentially occur in transcripts longer than 
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further processing. 
Except for the hybrid bands discussed above, minor bands can 
be observed some of which, on the basis of their length, seem 
to run over the site of initiation of transcription of the major 
late RNAs. We suspect that these species are transcribed from 
the 1-strand and belong to the E2b or IVa2 transcription units (9)· 
b) SI nuclease mapping in the region 814 (Tag I) - 1368 (Sau3A). 
In a second series of SI-experiments we have tried to look 
into the situation at the 3' half of intron 1 regarding possible 
processing intermediates. We have used DNA fragments 564·, 555 
and ^13 as depicted in Figure 1. Fragments 564 and Д13 share 
the right end (nucleotide 1226), while fragments 555 and 413 
share the left end (nucleotide 814)-This should enable us to 
locate all the RNAs which map with one or both ends in the region 
between nucleo-tides 814 and 1226. Figure 2B shows the hybrid 
32 
patterns obtained in a typical SI experiment using P-labeled 
DNA fragments and late steady state nuclear RNA (Materials & 
Methods). In the size range of 413 to 200 base pairs fragments 
564 and 41З give a similar gel pattern (lanes 2 and 3) different 
from the pattern obtained with fragment 555 (lane 1). This in­
dicates that nearly all the RNA species detected with fragment 
41З, map with one end in this region and extend to the right 
of nucleotide 1226. Lengths of such bands that can be distinguished 
are 365, 300, 250 and 200 base pairs. The last two of these 
are rather diffuse bands probably because their size is too small 
to yield discrete bands on 5% Polyacrylamide gels. In accor­
dance with these bands hybrids of 500, 440, 380 and 340 base 
pairs can be detected with fragment 555, showing that the 
corresponding RNAs extend beyond nucleotide 1368 and thus con­
tain sequences of leader 2. The cleavage sites are located 
near nucleotides 865, 925, 980 and 1025, respectively. 
With fragment 564 hybrids longer than 413 base pairs were 
detected. However, with the restriction fragments that we have 
used these species cannot be accurately mapped. 
The acceptor site of intron 1 is located within the region 
of fragment 555. In case of cleavage at the acceptor site one 
would expect to find a band of 506 base pairs. (814-1319) and, 
indeed, a band of 500 base pairs is a major component of the 
gel pattern (lane 1). However, based on the relative intensities 
of hybrid bands the 500 base pairs long hybrid rather seems to 
originate from cleavage of the RNA near nucleotide 865 than from 
cleavage at the acceptor site. Although cleavage of long RNAs 
at the acceptor site cannot be excluded, such a 3' cleavage pro­
duct would be a very minor species in steady state nuclear RNA. 
As already mentioned a similar result was found for cleavage 
products generated from the donor site. 
с) Reverse transcription of virus-specific steady state nuclear 
RNA. 
In a previous study (3) we have described that nascent trans­
cripts can be cleaved at coordinate 19.1 ι i.e. at or near the 
acceptor site (19.2 m.u.) of intron 1. Although in rapidly 
labeled nuclear RNA the 3' cleavage product (16.2-19.1 m.u.) 
can be easily identified, labeling the RNA for 45 min or longer 
makes it impossible to detect this species among the labeled 
RNA via S1-mapping using Xho I restriction fragment F (15.5-
22.Λ m.u.). This and the results described in section (b) of 
this chapter indicate that the 3' cleavage product does not 
accumulate in steady state nuclear RNA. We were interested to 
know if we could detect the 5' cleavage product resulting 
from cleavage at coordinate 19.1. Therefore, steady state nuclear 
RNA extracted from Hela cells 18 h after infection was hy­
bridized to DNA fragment 366 (1369-1734, Figure 1), from which 
the left end is located in leader 2. After hybridization the 
nucleic acid mixture was treated with reverse transcriptase, 
as described in the Materials & Methods section, in order to 
obtain cDNAs by the extension of fragment 366 into intron 1. 
Then the mixture was treated with NaOH to degrade the RNA and, 
after neutralization and precipitation, the cDNA mixture was 
resolved on a 5% Polyacrylamide gel containing 7M urea. The 
cDNAs were transferred to Gene Screen and visualized by hy-
32 bridization of the blots with P-labeled Xho I fragment F 
followed by autoradiography. The results of two such experiments 
are shown in Figure 3· Reverse transcription seemed to proceed 
up to the 5' end of leader 1 in the primary RNA transcript 
resulting in a cDNA of H77 nucleotides in length (258-1734.). 
The most prominent band is the 366 primer since this fragment 
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nt 
Fig. 3· Reverse transcription into intron 1. 
DNA fragment 366, of which the location is depicted in Figure 1, 
was hybridized with steady state nuclear RNA extracted from 
Hela cells 18 h after infection. After hybridization the mix­
ture was treated with reverse transcriptase. Then, RNA was de­
graded and the cDNAs were separated on a 5% Polyacrylamide gel 
containing 7 M urea. The cDNA bands were electrophoretically 
transferred to Gene Screen and visualized by hybridization with 
32p-labeled Xho I restriction fragment F (Materials 8: Methods). 
The results of two experiments are shown. In Experiment 1 elec­
trophoresis was for 16 h at 120 V, while in Experiment 2 elec­
trophoresis was for 10 h at 220 V. Taq I and Hinc II digests 
of the adenoviral Hindlll restriction fragment В and Taq I digest 
of PBR 322 were used as molecular weight markers. The position 
of the Hinc II marker bands was as indicated. 
was added in excess over the RNA. The most prominent cDNA band 
observed in experiment 1 has a length of about ^50 nucleotides 
which agrees with what would be expected for the splicing pro­
duct in which leader 1 is linked to leader 2, i.e. 4-56 nucleo­
tides. However, this band appeared to consist of two different 
species, which could be separated by running the gel for longer 
times or at a higher voltage. In the latter case the heat which 
is generated in the gel may promote the denaturing effect. Ex­
periment 2 in Figure 3 shows the bands separated, 
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Fig. Д. Cleavage sites in intron 1. 
Summary of the data obtained in the present study. The ends of 
the putative processing intermediates are located near the in­
dicated nucleotide. The preferred (heavy arrow) and non-preferred 
(thin arrow) cleavage sites in the primary transcript are shown. 
Heavy bar: exon sequences, thin bar: intron sequences. The RNA 
placed in parentheses is the species which would result from 
cleavage at the acceptor site but which cannot be detected in 
steady state RNA. 
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They differ only 5 to 10 nucleotides in length. The upper band 
could be identified as the splicing product, because with a 
specific probe the precence of leader 1 sequences could be de­
monstrated in this RNA species (data not shown). The lower band 
represents an RNA species which seeras to contain the 3' ultimate 
30 - 35 nucleotides of intron 1. Since this species exists in 
steady state RNA in about the same concentration as the splicing 
product, it suggests that there is a major cleavage site some 
35 nucleotides before the acceptor site in intron 1. Cleavage 
at the acceptor site would result in a reverse transcription 
product of 415 nucleotides (1320-1734). At this location in the 
gel only a faint band can be detected showing that in 
total RNA the 5' cleavage product resulting from cleavage at 
the actual acceptor site does not accumulate. Cleavage at this 
site seems to be followed rapidly by ligation of leader 1 to 
leader 2. These data together suggest that rapid cleavage of 
the nascent transcript occurs near nucleotide 1285 in intron 1 
(19.1 m.u.) rather than at the actual acceptor site (19.2 m.u.). 
Next to the bands described above, some additional minor 
cDNA bands can be observed. Some of them could be derived from 
reverse transcription of processing intermediates, such as 
those described in sections (a) and (b) of this paragraph, but 
the low intensity of these bands does not allow accurate 
identification. 
Figure Д summarizes the data obtained in the present study. 
As earlier proposed for intron 2, our results suggest that re­
moval of intron 1 is a stepwise process as well and proceeds 
in the 5' to 3' direction. 
DISCUSSION 
Earlier studies on steady state nuclear RNA isolated from 
Hela cells at the late phase of infection with adenovirus 2 
have revealed the existence of RNAs which lack part of intron 
2 (2). These RNAs can be regarded as intermediates of a spli­
cing process in which the intron is removed in a stepwise 
fashion following the 5' to 3' direction. In the present study 
we have analysed steady state nuclear RNA via SI-mapping and 
reverse transcription in the region of intron 1. Our data show 
that RNA species which have lost the 5' part of intron 1 but 
still contain the 3' part accumulate in the nucleus. Thus, a 
similar mechanism seems to be operative in both introns 1 6 2, 
i.e. stepwise excision in the 5' to 3' direction. 
Previously we have identified two major cleavage sites in 
intron 1, at 16.8 and 19.1 m.u., respectively (3). In case of 
cleavage at 19.1 both the 5' and 3' cleavage products could be 
detected in rapidly labeled RNA. In steady state RNA, however, 
only the 5' cleavage products seem to be present. One way to 
explain this observation is that the removal of an intron follows 
discrete steps in the 5' to 3' direction, while the intron se­
quences of the 3' cleavage product are gradually degraded. In 
this way no discrete 3' cleavage products can be detected in 
steady state RNA. Stepwise splicing could also explain why 
large spliced-out intron sequences have not been found yet. 
When the hybrid patterns obtained with fragments 413, 555 and 
56Д are compared (Figure 2B) there seems to be no common hybrid 
band longer than 200 base pairs. Below this size some similarity 
in the patterns can be seen which might indicate that spliced-
out intron-pieces are about 150 nucleotides or shorter. It 
should be noted that we have not detected RNAs which could be 
the result of premature termination of transcription. Since 
these RNAs seem to be rather heterogeneous in length they may 
contribute to the background of the gel patterns instead of 
appearing as discrete major bands. (10). 
Rapid cleavage of the primary transcript can occur at coor­
dinates 16.θ and 19.1, respectively (3). According to cleavage 
at 16.8 m.u. an RNA species is present in steady state nuclear 
RNA with its 5' end near nucleotide ¿60. In case of cleavage 
at 19·1 m.u. SI-mapping using the Xho I fragment F did not allow 
to distinguish between cleavage close to or at the acceptor 
site (19·2 m.u.). Reverse transcription experiments indicate, 
however, that a major component of steady state RNA results 
from cleavage of the RNA some 35 nucleotides before the acceptor 
site. Therefore, it seems likely that the site for rapid cleavage 
is located about 35 nucleotides before the actual acceptor 
site in intron 1 near nucleotide 1285. All the rapid cleavages 
which are introduced in the (nascent) primary transcript seem 
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to be located at an internal site in the intron. These results 
argue against a simple RNA scanning model for splicing (11). in 
which the excision starts at one of the ends of the intron. 
Rather the excision starts somewhere within the intron sequence. 
Other arguments against a simple intron scanning model have been 
reported by Kühne et al. (12). Combining the former and present 
results, our data suggest that in intron 1 preferred and non-
preferred cleavage sites can be distinguished (Figure 4). 
With reverse transcription hardly any RNA species can be 
found which has its 5' end at nucleotide 1320, the acceptor 
site. This indicates that cleavage at the acceptor site is 
rapidly followed or coupled with ligation of leader 1 to leader 
2. Kinetic labeling experiments have shown that a similar si-
tuation might exist for splicing of leader 2 to leader 3 (3,13). 
Cleavage at the acceptor site seems to be the last step in the 
excision of the introns and is rapidly followed by the ligation 
of the leaders. This may be a more general phenomenon of RNA 
splicing. 
The S1-mapping experiments described above enabled us to 
compare the nucleotide sequences around the 5' end of the pu-
tative processing intermediates (1Д). As far as we can decide, 
the internal cleavage sites do not resemble the consensus donor 
or acceptor sequences (15) suggesting that cleavage in an intron 
is not determined by the primary nucleotide sequence but rather 
by other factors such as RNP-structure or secondary structure. 
The following model can be proposed to fit all our results 
(Figure 5)· The primary transcript is rapidly cleaved at a 
preferred site within the intron. The intron sequences of the 
3' cleavage product are gradually degraded up to the 3' end of 
the first exon. The 5' cleavage product is further processed 
by cleavage of the RNA at non-preferred sites removing the 
intron via discrete steps in the 5' to 3' direction. The last 
cleavage event takes place at the acceptor site and is rapidly 
followed by ligation of the exons. The model requires a higher 
ordered structure to hold the 5' and 3' cleavage products to­
gether. The RNP structure, or the nuclear matrix as an intra­
nuclear ultraatructure (16), may meet such a requirement (5). 
We have analysed rapidly labeled nuclear matrix RNA via the S1-
mapping procedure using the Xho I restriction fragment F. Both 
I * 3' 
2 
3 
4 
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6 
Fig. 5. A model for RNA splicing. 
The model as depicted in this figure fits all the presently and 
previously obtained data on splicing involved in the formation 
oi' the tripartite leader. A description of the model is given 
in the text of the Discussion section. Heavy bar: exon sequences, 
thin bar: intron sequences. The arrows indicate preferred 
(heavy) and non-preferred (thin) cleavage sites. 
the 5' and 3' cleavage product generated by cleavage of the RNA 
at coordinate 19.1» 20.7 and 21.1, respectively, could be de­
tected showing that the cleavage products are indeed associated 
with the nuclear matrix (data not shown). Also the results of 
van Eekelen et al. (θ) who showed that both intron and exon 
sequences are associated via the C-proteins to the nuclear 
matrix support the hypothesis that higher ordered structures 
might be an essential element in the process of RNA splicing. 
The procedure of SI-mapping as we have used it, can only 
locate the ends of RNA molecules which are colinear to the DNA 
and longer than 150 base pairs. Therefore, it is possible that 
ligation of leader 1 occurs to the end of each 5' cleavage 
product. However, the shortest intermediate was readily de­
tected by the reverse transcription and contains only about 
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35 nucleotides linked to leader 2, not derived from leader 1. 
Further, the nucleotide sequence at the 5' end of the cleavage 
products does not resemble the consensus donor sequence. Although 
these findings argue against such a process of repeated ligation, 
it is one of the many aspects of RNA processing which are subject 
of future studies. 
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CHAPTER IV 
SOME ASPECTS OF THE EXCISION OF INTRON 3 FROM ADENOVIRAL 
MAJOR LATE PRE-mRNAs 

Some aspects of the excision of intron 3 from adenoviral major 
late pre-mRNAs. 
E.C.M. Mariman, R.J. van Beek-Reinders and W.J. van Venrooij 
Department of Biochemistry, University of Ntjraegen, 
The Netherlands. 
SUMMARY 
We have used different methods of rapid RNA labeling to study 
cleavage reactions, which are involved in the removal of intron 
3 from adenoviral pre-mRNAs produced from the major late trans-
cription unit. The labeled RNA was analysed via the SI-mapping 
procedure. Our results show that cleavage as part of RNA splicing 
can occur at the acceptor site of intron 3 before the tripartite 
leader is completed. Cleavage at the donor site of intron 3 
cannot occur before intron 2 ie excised, suggesting that liga-
tion of the four exons which constitute the major late mRNAs 
follows the 5' to 3' direction. 
INTRODUCTION 
At the late stage of infection of human cells with adeno-
virus type 2 most of the viral RNA is transcribed from the ma-
jor late transcription unit (16.2 - 100.0 m.u.; the genome is 
divided in 100 map units (m.u.), 1 % of the genome equals 360 
nucleotides). Via polyadenylation and splicing the primary 
transcript is processed to one out of several possible poly-
adenylated mRNAs, which are divided into five 3' coterminal 
families LI to L5 (1). Polyadenylation is assumed to be an early 
step in the processing of pre-mRNA and can occur in about one 
minute after the RNA-polymerase has passed the polyadenylation 
site (2). Splicing involves the linkage of three leader se-
quences to form the tripartite leader, and linkage of the last 
leader to the protein coding sequence. Keohavong et al. (3) 
have shown that completion of the tripartite leader takes about 
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15 min. Since splicing із relatively slow and rapid polyadenyl-
ation seems to occur on non-spliced molecules (2), one would 
expect long polyadenylated pre-mRNAs to accumulate in the hnRNA 
of infected cells, the more, while late after infection 50% of 
the nuclear RNA appears to be virus-specific (4·)· In uninfected 
Hela cells about 15 - 20% of the hnRNA is polyadenylated (5). 
In spite of the expectation, however, in late infected Hela 
cells not more than 6jt of the hnRNA can be selected via its 
poly (A)-tail (6). We have tried to find an explanation for this 
relatively low amount of polyadenylated рг -mRNA. Earlier we 
have found that rapid cleavages can be introduced in the primary 
transcript (7). The sites for cleavage are located at coordinates 
16.8, 19.1, in intron 1, and 20.7, 21.1, 25.5, in intron 2, res­
pectively. Since these sites are relatively close to the site 
for initiation of transcription, thip cannot by itself be the 
cause for the low percentage of poly(A)-containing RNA. There­
fore, we hypothesized that rapid cleavage as part of RNA splicing 
might be introduced in the promotor distal part of the pre-mRNA 
as well, i.e. in intron 3 between the third leader and the pro­
tein coding sequence. We have used the S1-mapping procedure 
with restriction fragments Hindlll В (16.8 - 31.5 rn.u.; Fig 1A) 
and EcoRI В (58.5 -70.7 m.u.; Fig IB) to analyse nuclear RNA 
which was labeled in different ways. Our results show that 
rapid cleavage can occur at an acceptor site in intron 3. 
Cleavage at the donor site of intron 3 can occur only if cleavage 
at the acceptor site of intron 2 has taken place, suggesting 
that ligation of the four exons which constitute the mRNA fol­
lows the 5' to 3' direction. 
MATERIALS AND METHODS 
a) Infection and labeling of cells 
Hela S3 cells were infected with adenovirus type 2 (2000 
particles per cell) at a density of 5 x 10 cells/ml in Eagles 
minimal essential medium (MEM) containing 1 mM arginine. After 
adsorption of the virus to the cells during 1 h at 370C, the 
cells were diluted to 0.3 x 10 cells/ml with MEM containing 
5% newborn calf serum. Cells were harvested at 18 h after 
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Fig. 1. Location of the RNA species relative to the Hindlll 
and EcoRI restriction fragments B. 
A. Hindlll restriction fragment В is colinear to the 3' part 
of intron 1, leader 2, intron 2, leader 3 and the 5! part of 
intron 3. The heavy double-pointed bars represent the DNA:RNA 
hybrids obtained in S1 experiments as discussed in the text. 
95 
The length of each hybrid is indicated in percentages of the 
genome. 14·.7Í: primary transcript; 12.3%'· splicing intermediate 
from which intron 1 is excised; 5·3%'· intermediate from which 
intron 2 is excised; 5.Oí:intermediate resulting from cleavage 
at the donor site of intron 3. 
В. EcoRI restriction fragment В is colinear to the 3' part of 
L3-RNAS, precursors for ЬД- and L5-RNAs and the 5' part of ЬД-
mRNA body sequences. The region E2a RNAs are not shown. 
The length of each hybrid is indicated in percentages of the 
genome. 12.2%: precursors for L4- and L5-specific RNAs; 2.9%'· 
the 3' part of L3-specific RNAs which are cleaved at the L3-
polyadenylation site (61.4- m.u.); 4··1?! body sequence of the 
longest L^-mRNA (starting at 66.6 m.u.); 2.7%: body sequence 
of the shorter ІД-mRNA in this region (starting at 68.0 m.u.). 
infection. To obtain rapidly labeled nuclear RNA 18 h after 
infection, cells were concentrated to 20 χ 10 cells/ml and 
•a 
incubated with 20 yci/ml (5- H)-cytidine (31 Ci/mmol, Amersham, 
England),20 UCi/ml (5'-3H)-guanosine (22 Ci/mmol, Amersham, 
England) and 20 yCi/ml (5,6- H)-uridine (45 Ci/mmol, Amersham, 
England). The labeling times were as indicated in the text. 
b) Preparation of nuclear RNA 
18 h after infection cells were harvested on frozen NKM 
solution (0,13 M NaCl, 0.05 M KCl, 1.5 mM MgCl2) and centri­
fugea for 5 min at 800 g. The cells were washed once with NKM 
and after pelleting they were resuspended in RSB (10 mM NaCl, 
10 mM Tris, pH 7.4, 1.5 mM MgClg). After addition of 0.1 vol. 
of a sodium deoxycholate/Nonidet P40 mixture (5Í each) the 
cells were disrupted by intensive vortexing. The nuclei were 
pelleted, washed once with RSB and resuspended in the same 
buffer. Nuclear RNA was then isolated by phenol extraction at 
550C as described by Long et al. (8). 
c) Isolation of restriction fragments 
pBR322 containing either the Hindlll A or В restriction 
fragments in the Hindlll site (generous gift.sof R. Ohlsson and 
M. Mathews) were propagated in E.coli strain JA221. Extraction 
and purification of plasmid DNA were performed as described by 
Aleström et al (9). Fragment Hindlll В was isolated by digestion 
of the cloned DNA with Hindlll. Fragment EcoRI В was obtained 
from the cloned Hindlll A fragment. Restriction digestions 
with Hindlll and EcoRI were performed at 370C for 4 h using 
1 unit of enzyme per ug of DNA. Standard conditions were 
50 mM Tris, pH 7.К, 7 raM MgCl?, 50 тМ NaCl, 3 тМ dithiothreitol. 
BSA was added to the digestion mixtures to a final concentration 
of 1 mg/ml. Restriction fragments were separated by agarose gel 
electrophoresis; 0,8? agarose gels were run for 20 h at 80 V in 
TNE buffer (Д0 mM Tris, pH 8.0, 8mM sodium acetate, 2 mM EDTA). 
The DNA was recovered from agarose gel slices by electrophoretic 
elution. 
d) SI-nuclease mapping and analysis of SI-resistant hybrids 
RNA was hybridized to DNA under conditions in which DNA:DNA 
hybridization was minimized, using the procedure described by 
Manley et al(10). 1 pg of nuclear RNA was hybridized to 2.5 yg 
equivalent of a restriction fragment of Ad2 DNA. Hybridization 
concentration was 0.35 \ig RNA/ul. After SI nuclease digestion 
the hybrids were precipitated with ethanol, the pellet was 
solubilized in TNE buffer and applied on a 1.2% agarose gel. 
Electrophoresis was performed under the same conditions as were 
used for the separation of DNA restriction fragments. Gels were 
subsequently treated with 5/6 TCA, methanol, methanol containing 
ΙΟί ΡΡ0 and water. After drying they were exposed to Kodak XR-5 
film for an appropriate period of time (3 to 7 days). 
RESULTS 
a) SI nuclease analysis of rapidly labeled nuclear RNA. 
Previously we have analysed nuclear RNA extracted from Hela 
cells at the late stage of infection (17). Using restriction 
fragment EcoRI В and steady state labeled polyA(+) nuclear RNA 
two S1 resistant hybrids, Д.І? and 2.7Í in length (Fig IB), 
could be identified which appeared to represent the 5' part of 
the body of two ЬД-тННАз. These species were also found with 
20 min labeled nuclear matrix RNA. In a first attempt to find 
out how fast cleavage at the acceptor site of intron 3 could 
occur, we analysed 8 min labeled total nuclear RNA via Si-
mapping. As can be seen in Figure 2, a 2.9Í long hybrid repre-
senting the 3' end of L3-specific sequences which end at the 
L3-polyadenylation site (61.Д m.u.) was clearly visible as 
should be expected in case of a rapid polyadenylation process (2). 
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Fig. 2. S1 analysis of 8 min labeled total nuclear RNA. 
felá cells, 18 h after infection, were labeled for 8 min with 
Η-nucleosides and total nuclear RNA was isolated as described 
in the Materials & Methods section. The RNA was analysed via 
the SI-mapping procedure using Hindlll В as a probe. SI resis­
tant hybrids were resolved on agarose gels and visualized via 
fluorography (Materials & Methods)'. EcoRI and Hindlll digests 
of Ad2 DNA were used as molecular weight markers. The positions 
of the Hindlll markers are indicated. 
As minor components of the labeled RNA, the 5' part of both 
L4. body sequences located in the region of EcoRI b could be 
detected (Fig. 2). This demonstrated that 8 min after the start 
of the RNA labeling cleavage at the acceptor site of intron 3 
already had occurred. The leader sequences are not colinear to 
the EcoRI В restriction fragment (58.5 - 70.7 m.u.). Therefore, 
we cannot distinguish wether these hybrids are formed from the 
splicing product, in which leader 3 is ligated to the body 
sequences, or from a splicing intermediate, derived from cleavage 
of the RNA at the acceptor site of intron 3, at 66.6 m.u. or 
68.0 m.u., respectively. 
b)S1 analysis of labeled nuclear RNA isolated from DRB-treated 
cells. 
It has been demonstrated that cleavage at the acceptor site 
of intron 2 and ligation of leader 2 to leader 3 occurs about 
12-15 min after the start of tranocription (3,7). We were 
interested to know if cleavage at the acceptor sites of the 
L^-mRNA bodies in intron 3 occurred before or after completion 
of the tripartite leader. The site for initiation of transcrip-
tion (16.2 m.u.) and the acceptor site of the longest L4-inRNA 
body (66.6 m.u.) are separated by more than 50% of the genome. 
Taking the speed of the RNA polymerase to be 50 -100 nucleo-
tides per second (11-13) it may last about 6 min before the 
enzyme reaches the L^-specific region. Therefore, the 8 min la-
beled RNA contains L^-^pecies which are being synthesized and 
processed for at least 6 and maximally 14 min. Since in this 
time period the leaders could have been spliced, analysis of 
the 8 min labeled RNA cannot give an answer to the question 
asked. Shorter labeling times are not adequate because then 
the RNA in this region does not accumulate enough label to 
enable accurate SI analysis. Therefore, we performed a kinetic 
labeling experiment in which the RNA is labeled exclusively 
from the 5' end. Hela cells 18 h after infection were treated 
for 1 h with 70 uM DRB ( 5,6-dichloro-1 -ß-D-ribof uranosylbenzimi-
dazole). Then the cells were cooled to 0 C, pelleted and washed, 
to remove the drug, and resuspended in culture medium containing 
3 
H-uridine, -cytidine and -guanosine in order to label the RNA 
at 370C. DRB synchronizes the RNA-polymerases close to the 
promotor site (7,14,15). It seems to inhibit the elongation of 
transcription, maybe by promoting premature termination (16), 
but not the initiation of transcription. Removal of the drug 
restores the elongation activity so that accumulation of label 
in the RNA follows the 5' to 3' direction. When labeling in 
this way is performed for 8 min the labeled RNA contains species 
which have been synthesized and processed for not longer than 
8 min. Since previous experiments suggested that the elongation 
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SI analysis of nuclear RNA extracted from DRB treated 
rom 17 to 18 h after infection Hela cells were treated 
by adding the drug to the culture medium to a final 
ation of 70 μΜ, At 18 h after infection the drug was 
and the cells were labeled with Зн-nucleosides in cul-
ium at 370C for 10, 20, 30 and 45 min, respectively. 
tal nuclear RNA was isolated and analysed via the S1-
procedure using HindJII В (lanes 1 to 4) and EcoRI В 
to 8) fragments as probes. SI resistant hybrids were 
on agarose gels and visualized by fluorography (Materials 
s). Lanes 1 & 5: 10 min labeling; lanes 2 & 6: 20 min 
lanes 3 & 7: 30 min labeling; lanes Л & 8: Д5 min 
EcoRI and HindIII digests of Ad2 DNA were used as 
r weight markers. The position of the Hindlll markers 
ated. 
of transcription after DRB treatment is somewhat slower, we 
choose a minimum labeling time of 10 min. The RNA was labeled 
for 10, 20, 30 and U5 min, г ар с і іу, and analysed via Si-
mapping using Hindlll and EcoRI restriction fragments В as DNA 
probes (see Materials к Methods). The results are shown in 
Figure 3· With the Hindlll В fragment as a probe, cleavage at 
the acceptor site of intron 2 will yield an RNA:DNA hybrid of 
5.3% in length (26.2 - 31.5 m.u.) (Fig 1A). In the pattern ob­
tained with 10 min labeled RNA this hybrid cannot be detected 
(Fig 3, lane 1). The hybrid band only appears after 20 min of 
labeling (Fig 3, lane 2). This demonstrates again (see chapter 
II) that 10 min after the start of transcription cleavage at 
the acceptor site of intron 2 has not yet occurred. Analysis 
of the RNA with fragment EcoRI В (58,5 - 70.7 m.u.; Fig 1B) 
showed that, when after DRB treatment the RNA was labeled for 
20 min or longer, all the RNA species known to be present in 
steady state polyA(+) RNA or in 8 min labeled total RNA could 
be detected (Fig 3, lanes 6 to 8). The pattern of hybrids ob­
tained with RNA labeled for 10 min, after the DRB treatment, 
however, differs significantly (Fig 3» lane 5). The most pro­
minent band is derived from cleavage of the RNA at the poly-
adenylation site of the L3-coterminal family (61.4- m.u.). 
Polyadenylation can be a very rapid processing step. Looking 
for the hybrids of 4.1Í and 2.7% in length, representing the 
LA-mRNA bodies in this region, we can detect the longer species, 
but not the shorter one. So, cleavage at the acceptor site of 
intron 3 to give the longest L4-mRNA (66.6 m.u.) can occur 
rapidly, that is before cleavage at the acceptor site of intron 
2 and before ligation of leaders 2 and 3. Cleavage at the other 
acceptor site (68.0 m.u.) to produce the shorter ІД-mRNA seems 
to be a later event. 
When rapid cleavages introduced in introna 1 and 2 were 
studied both the 5' and 3' cleavage products could be identified 
in rapidly labeled RNA (see chapters II and III). Using the 
EcoRI В fragment (58.5 -70.7 m.u.) a hybrid of 8.1$ in length 
(58.5 - 66.6 m.u.) would be expected from cleavage of the RNA 
at coordinate 66.6. Indeed, such a band can be detected with 
10 min labeled RNA (Fig 3, lane 5) as indicated by the arrow. 
Although some -additional bands can be observed, the identity 
of these RNA species remains to be elucidated. 
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с) Kinetics of the cleavage reaotiona around leader 3. 
We have seen that cleavage at the acceptor рі of Intron 3 
can occur before splicing of the tripartite leader is completed. 
Then we asked the same question for cleavage at the donor site 
of intron 3s Does that cleavage occur before completion of the 
tripartite leader. In a previous study (7) we identified an RNA 
species that yielded a hybrid of 5.0$ in SI-experiments with 
Hind III В as ap-obe.Using pubfragments of Hindlll В the RNA 
was accurately mapped. It has its 5' end et coordinate 26,5 and 
extends to the right beyond 31,5 m.u. It is produced by cleavage 
of рг -mRNA at the donor site of intron 3 (26.5 m.u.I Fig 1A). 
We have performed kinetic labeling experiments to learn how 
fast this species is produced. Hela cells 18 h after infection 
were labeled for 3, 7, 15» 30 or 5» 15. 25. 35 min, respectively, 
After labeling total nuclear RNA was isolated (Materials & 
Methods). The RNA was analysed via the SI-mapping procedure 
using Hindlll В (16.8 - 31.5 m.u.) as described in the Materials 
& Methods section. Earlier we have depicted the results obtained 
with RNA labeled for 3 to 30 min (7), Here we show the resulta 
of an experiment in which the RNA was labeled for 5 to 35 min 
(Figure 4). In both types of labeling experiments the appearance 
of the 5.0Í long hybrid follows that of the 5.3Í long band. 
This suggests that cleavage at the acceptor site of intron 2 
(26,2 m.u.), which itself is a late event in the splicing of 
intron 2, precedes the cleavage at tha donor site of intron 3, 
Cleavages around leader 3 thus seem to oocur in an ordered 
fashion. Despite the rapid acceptor site cleavage of intron 3» 
cleavage at the donor site of intron 3. and thus ^і о ligation 
of leader 3 to the mRNA body, has to wait for the cleavage at 
the acceptor site of intron 2 and is therefore, a late event 
in the splicing process, 
DISCUSSION 
The adenoviral major late mRNAp can be divided into five 3' 
cotermlnal families, referred to as Ы to LS (1)» The members 
of one family differ in the length of the body sequences and 
thus in the location of the 5' end of the mRNA-body. 
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Consequently, intron 3 which is situated between leader 3 and 
the raRNA-body, can have different lengths. In removing intron 
3 always the same donor site is used which is located at the 
3' end of leader 3 (26.5 m.u.; Fig 1A). Depending on which 
member of which coterminal family will be produced, one out 
of several acceptor sites is selected. We have attempted to 
gain more knowledge about the excision of intron 3· Therefore, 
we analysed nuclear RNA extracted from Hela cells at the late 
stage of infection via the Si-mapping procedure. The RNA was 
labeled in several ways. As DNA probes the Hindlll В restric­
tion fragment, which overlaps leader 3 and the 5' part of 
intron 3, and fragment EcoRI B, which overlaps the 3' part of 
intron 3 and the 5' part of two L4.-mRNA bodies, were used 
(Fig. 1A and IB). Our conclusions can be summarized as follows: 
- cleavage at the acceptor site of the longest L4-mRNA body 
(66.6 m.u.) can occur before the tripartite leader is com­
pleted. 
- the fast cleavage at the donor site at the 3' end of leader 
3 is in the processing pathway a late event, because it has 
to wait for cleavage of the acceptor site of intron 2 at 
the 5' end of leader 3· 
Cleavage at the acceptor site of intron 3 can either be 
rapid (at 66.6 m.u.) or relatively late (at 68.0 m.u.). Rapid 
cleavages are introduced in introns 1 and 2 at the level of 
the nascent transcript (7). Cleavage at the acceptor site for 
the longest L4.-mRNA body can occur before complete removal of 
intron 2, which takes about 12 to 15 min (3,7). This indicates 
that cleavage events may take place simultaneously at sites 
which are separated by 505? of the genome, i.e. about 18000 
nucleotides. The cleaved-off RNA pieces have to be kept to­
gether in the right orientation in order to allow further pro­
cessing and ligation of the exons. The nuclear matrix as a 
higher ordered intranuclear structure meets this requirement 
since all cleavage products are found to be associated with 
the matrix (17, chapter III and V). It is, therefore, possible 
that the nuclear matrix indeed plays an essential role in RNA 
splicing. 
It should be noted that, although rapid cleavages in the 
leader region occur in the majority of the primary transcripts 
(7) t there are some гапвсгір в which seem to be exempted from 
rapid cleavage in this region. Therefore, the possibility 
remains that rapid cleavage at an acceptor site of intron 3 
occurs only in primary transcripts which are not yet cleaved in 
the leader region. In this case, however, there has to exist 
a mechanism which can discriminate between early and Inte 
cleavage at a particular acceptor site of intron 3 · 
The cleavage reactions around the third leader occur in an 
ordered fashion. The acceptor site of intron 2 is cleaved be­
fore the donor site of intron 3. Together with the data of 
Keohavong et al (3) our earlier results indicated that cleavage 
at the acceptor site of intron 2, 12 to 15 min after the start 
of transcription, is the last step in the excision of this in­
tron and is rapidly followed by the ligation of leaders 2 and 
3. Accordingly, our present results suggest that intron 2 is 
removed before intron 3 and that ligation of leaders 2 and 3 
precedes ligation of leader 3 to the body of the mRNA. Since 
ligation of leaders 1 and 2 occurs without detectable delay 
after the start of transcription, the ligation reactions in­
volved in the production of the major late mRNAs seem to 
follow the 5' to 3' direction. 
When the excision of intron 3 is considered, acceptor site 
cleavage can precede cleavage of the donor site. Rapid cleavage 
at the acceptor site and possible other rapid cleavages occuring 
in intron 3, provides an explanation for the relatively low 
amount of poly(A)-containing RNA in rapidly labeled nuclear 
RNA isolated from late infected cells. Further it shows that 
removal of intron 3 may start at the 3' end of the intron. 
However, when splicing patterns of Ad2 RNA in monkey cells 
were studied, L5-specific RNAs were found to accumulate, which 
still contained the ЬД-вр сіГіс sequences between 66 and 78 
m.u. (18). Although such RNA species were not observed in 
human cells, they may be regarded as intermediates of splicing. 
Therefore, the site located at 66.6 may either be used as an 
acceptor site for L4.-mRNA8 or as an internal cleavage site 
for the production of L5-mRNAs and rapid cleavage at 66.6 m.u. 
may be related to one of these functions. 
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After infection of HeLa cells with adenovirus type 2, virus specific heterogeneous 
nuclear RNA is quantitatively associated with a higher ordered structure, the 
nuclear matrix Analysis of this matrix associated RNA by 8, nuclease mapping 
showed that precursors as well as processed messenger RNAs from the late region 
L4 were present By irradiation of intact cells with ultraviolet light, proteins 
tightly associated with heterogeneous nuclear RNA can be induced to cross link 
with the RNA Characterization of the cross linked RNA-protein complexes 
showed that all viral polyadenylated RNAs (precursors products and processing 
intermediates) could be cross linked to two host proteins, earlier found to be 
involved in the association of host specific heterogeneous nuclear RNA to the 
nuclear matrix (van Eekelen & van Venrooij, 1981) Our results thus further 
support the concept that the nuclear matrix may function m the localization and 
the structural organization of (viral) heterogeneous nuclear RNA during its 
processing 
1. Introduction 
Adenovirus infected cells have proven to be an efficient tool in the study of 
h n R N A f processing The virus specific R N A is capped, methylated, 
polyadenylated and spliced in much the same way as the h n R N A of eukaryotic 
cells (Darnell, 1979, Ziff, 1980) By methods of hybridization with specific parts of 
the viral genomic D N A , individual m R N A precursors can be identified and pursued 
during processing In this way the various steps of processing of pre-mRNA to 
mature m R N A can be studied independently (Blanchard et al , 1978, Babich et al , 
1980, Nevins et al, 1980) 
There is not much known about the localization and the structural organization 
of h n R N A in the nucleus h n R N A is associated with a characteristic subset of 
nuclear proteins and it can be isolated as h n R N P particles In addition, the cell 
nucleus seems to contain a higher ordered protemaceous structure (Herman et al, 
f Abbreviations used hnRNA, heterogeneous nuclear RNA, hnRNP heterogeneous nuclear 
ribonucleoprotein, DBP, DNA binding protein snRNA email nuclear RNA 
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1978: Kaufmann et al., 1981; Miller et al., 1978α; van Eekelen & van Venrooij, 
1981), usually referred to as the nuclear matrix. Heterogeneous nuclear R N A is 
associated with the nuclear matrix (Herman et ni., 1978; Miller et al., 1978α), and it 
has been reported that two specific h n R X P proteins are involved in this association 
(van Eekelen & van Venrooij, 1981). In this study we present evidence that 
adenoviral-specific nuclear matrix R N A contains precursors, intermediates and 
products of R N A processing, indicating that pre-mRNA is associated with the 
nuclear matrix during its processing to m R N A . 
2. Materials and Methods 
(a) Infection and labelling of cella 
HeLa iS3 cells were infected with adenovirus type 2 (2000 particles/cell) at a density of 
5 χ 106 cells/ml in MEM (Eagles minimal essential medium containing 1 тм-arginine). After 
adsorption Of virus to the cells during 1 h at 37°C, the cells were diluted to 0 3 χ IO6 cells/ml 
with MEM containing 5 % (v/v) newborn calf serum. Cells were harvested at 18 h post 
infection. To obtain steady-state labelled RNA, cells were concentrated to a density of 
5 χ 10é/ml and incubated with 10(xCi [5,6-3H|uridine/ml (45 Ci/mmol; Amersham, England) 
from 16 to 18 h after infection. To obtain rapidly labelled hnRNA 18 h post infection, cells 
were concentrated to 20 χ 106/ml and incubated for 10 min with 20/¿Ci [5,6-3H]uridine/ml 
and 20jiCi [5-3H]cytidine/ml (31 Ci/mmol; Amersham, England). 
(b) Purification and oligo(dT)-cellulose chromatography of cytoplasmic and nuclear RNA 
At 18 h after infection, cells were harvested on frozen NKM solution (013 M-NaCl, 0-05 м-
KC1, 1-5 тм-MgClj) and centrifuged for 5 min at 800f. The cells were washed once with 
NKM solution and, after pelleting, they were resuspended in RSB (10 тм-NaCI, 10 тм-Тгіз 
(pH 7-4), l-ömM-MgC^)· After addition of 0-1 vol. 5% sodium deoxycholate, 5% (w/v) 
Nonidet P40 (Fluka, Buchs, Switzerland), the cells were disrupted by intensive vortexing. 
The nuclei were pelleted and, from the supernatant, cytoplasmic RNA was isolated by 
extraction with phenol/chloroform as described by Palmiter (1973). The nuclei were washed 
once in RSB and resuspended in the same buffer. Nuclear RNA was then isolated by 
extraction with phenol at 55°C as described by Long et al. (1Θ7Θ). To select the poly (A)-
containing RNA, oligo(dT)-cellulose chromatography (Collaborative Research Inc.; grade 
T2) was performed as described by Aviv & Leder (1972). 
(с) Preparation of nuclear matrix RNA 
At 18 h after infection of HeLa cells with adenovirus type 2, nuclei were isolated as 
described above. The nuclei were resuspended in RSB containing 0 1 м-NaCI and treated 
with DNAase I for 30 min at 10oC (500 ng/ml). After digestion with DNAase I, the nuclei 
were pelleted through a 3 0 % (w/v) sucrose layer. The pelleted material was extracted once 
with 0-4 M - ( N H 4 ) 2 S 0 4 . After repelleting, the nuclear matrices were washed with RSB, 
suspended in RSB containing 1% (w/v) sodium dodecyl sulphate and incubated at 100°C for 
3 min. The boiled mixture was adjusted to 0-2 м-NaCl and extracted with saturated 
phenol/chloroform (1.1, v/v). After 2 additional extractions with chloroform, the RNA was 
precipitated with 2 vol. ethanol. 
(d) RNA-protein сгоая-ііпкіпд in vivo and subsequent isolation of the cross-linked RNA 
RNA was cross-linked to its associated proteins by irradiation of the cells for 5 min with 
ultraviolet light (254 nm) at CC according to the procedure described in detail by 
Wagenmakers et al. (1980). After irradiation, the nuclear matrices were isolated as described 
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above. The covalently linked RNA-protein complexes were isolated using the 
phenol/chloroform extraction procedure as described (van Eekelen & van Venrooij, 1981 ; 
Wagenmakers et al., 1980). 
(e) Characterization of the proteins cross-linked to RNA 
The covalently linked RNA-protein complexes were isolated as described above and the 
RNA moiety was digested with a mixture of ribonuclease A and micrococcal nuclease The 
proteins were analyzed by sodium dodeeyl sulphate/polyacrylamide gel electrophoresis as 
described (van Eekelen & van Venrooij, 1981) 
(f) Adenoviral DNA isolation and restriction endonuclease digestions 
Viral DNA was isolated from the purified virions as described by Petterson & Sambrook 
(1973). Restriction digestions were performed at 37°C for 4 h using 1 unit of enzyme per /ig 
DNA. Standard conditions of icoRI, //iredlll and BglW (Boehringer, Mannheim) digestions 
were 50 mM-Tris (pH 7-4), 7 mM-MgCl2, 50 тм-NaCl, 3 тм-dithiothreitol. Kjml digestion 
(Bethesda Research Laboratories Ine ) was performed under low salt conditions (10 mм Tris 
(pH 7-4), 7 mM-MgCl2, 10 тм-КС1, 3 тм-dithiothreitol). Restriction fragments were 
separated by agarose gel electrophoresis ; 08% (w/v) agarose gels were run for 20 h at 80 V in 
TNE buffer (40 тм-Tris (pH 8), 8 тм-sodium acetate, 2 тм-EDTA). 
(g) Sondease map-ping and analysis oj S,-resistant hybrids 
RNA was hybridized to DNA under conditions in which DNA-DNA hybridization was 
minimized, using the procedure described by Manley et al. (1979). After digestion with §[ 
nuclease, the hybrids were precipitated with ethanol, the pellet was solubilized in TNE 
buffer and applied to a 1·2% (w/v) agarose gel. Electrophoresis was performed under the 
same conditions as those used for the separation of DNA restriction fragments. Gels were 
subsequently treated with 5% (w/v) trichloroacetic acid, methanol, methanol containing 
10% (w/v) PPO, and water. After drying, they were exposed to Kodak XR-5 film for an 
appropriate period of time (3 to 7 days). 
3. Results 
(a) The nuclear matrix 
The nuclear matrix of HeLa cells is a higher ordered proteinaceous structure to 
which the rapidly labelled hnRNA is quantitatively bound (Herman et al., 1978; 
Miller et al., 1978ο; van Eekelen & van Venrooij, 1981). The isolation of the 
nuclear matrix generally involves digestion of the DNA with purified DNAase I 
and removal of the digested DNA together with its associated proteins. In our 
procedure, this is achieved by sedimenting the digested nuclei through a 30% (w/v) 
sucrose layer followed by an extraction with a high salt buffer. Late after infection, 
the nuclei are somewhat more fragile as compared to nuclei from uninfected cells. 
This is probably due to the structural changes caused by the accumulation of virus 
particles. Although more fragile, intact nuclei and matrices can be isolated 18 hours 
post infection. The newly replicated viral DNA that has already been encapsidated 
by the viral protein coat seems to be relatively resistant to the DNAase I. Most of 
the virions, however, are removed by the high salt extraction, so that the resulting 
matrices contain only a small number of virus particles as determined by electron 
microscopy (van Eekelen et al., 1981). Less than 1% of the host DNA is left in the 
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matrices. А in uninfected cells, hnRNA from infected cells remains associated with 
the nuclear matrix. About 9 5 % of the viral-specific RNA is associated with the 
nuclear matrix. In agreement with earlier observations, we have found that the 
presence of inhibitors of proteolytic activities is a prerequisite for the isolation of 
intact matrices and undegraded hnRNA. The integrity of the nuclear matrix seems 
to protect the RNA against degradation. 
It has been reported by Beltz & Flint (1979) that after infection of HeLa cells 
with adenovirus the nuclear RNA becomes only partly viral specific, because 
transcription of cellular sequences continues. Liquid hybridization studies have 
confirmed that nuclear matrix-associated hnRNA of infected cells is a mixture of 
viral and host RNA. It was found that, although 18 hours post infection the 
concentration of host poly(A)+ mRNA in the cytoplasm has decreased to less than 
20% of the level found in the uninfected cell, the nuclear poly(A)+ hnRNA still 
contains about the same proportion of host mRNA sequences (van Eekelen et al., 
1981). 
The gradient profiles of total nuclear and nuclear matrix RNA show a close 
resemblance (Fig. 1 (a)). We have verified the presence of viral-specific sequences in 
nuclear matrix RNA by hybridization with adenovirus DNA fragments. Figure 
1(b) shows the profile of matrix RNA containing nucleotide sequences 
complementary to the DNA strands of the £coRI restriction fragment В (58-5 to 
707 map units). RNA species as large as 45 S could be detected, probably 
representing the precursors for the region L5 messenger RNAs, extending from 
16-45 map units towards the right end of the viral genome. 
(b) 8, nuclease mapping ofpoly(A) + cytoplasmic and nuclear RNA with the EcoRI В 
restriction fragment 
In order to determine the complement of RNA molecules bound to the nuclear 
matrix, it was necessary to analyse first the complement of RNA species present in 
cytoplasmic and nuclear extracts. For this purpose, an § ! nuclease mapping 
procedure was used, as described in Materials and Methods. When poly(A) + 
cytoplasmic RNA, labelled from 16 to 18 hours post infection, was hybridized to 
the fímdlll A fragment of adenoviral DNA, two major bands were detected, which 
were 11-3% and 6 3 % in length (Fig. 2(a), lane 1 ; 1% equals 350 base-pairs). This 
would correspond to the length of hybrids derived from L3 and L4 messengers 
(Berget et al., 1977 ; Chow et al., 1977 ; Chow & Broker, 1978; Berget & Sharp, 1979). 
Additional evidence was obtained when smaller DNA fragments, as depicted in 
Figure 2(b), were used for hybridization. The EcoRI В fragment gives two major 
bands, numbered 5 and 6 (Fig. 2(a), lane 2). The larger one, band number 5, is 4-1% 
in length and was also found when subfragment b or e was used (Fig. 2(a), lanes 3 
and 7). This hybrid thus contains the 5' end of the L4 messenger RNA and should 
therefore start at 66-6 ±0·2 map units. The co-ordinate of the 5' end of the 
messenger RNA for the DNA binding protein, which is transcribed from the 
opposite strand, has been determined to reside at 66-5 map units (Chow et al., 1979). 
Obviously, the 5' ends of the L4 and DBP messenger RNAs are very close, 
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Bottom 16 24 30 Top 
Fraction number 
Fie 1 Sucrose gradient profiles of rapidly labelled hnRXA isolated from nuclei and nuclear matrices 
Nuclei were isolated from 10 mm labelled He La cells (see Materials and Methods) 18 h after infection 
One portion of the nuclei »as used for the isolation of hnRXA From the other batch of nuclei nuclear 
matrices were isolated and the RNA was purified from the matrices as described in .Materials and 
Methods The R\A was dissolved in a buffer of low ionic strength (10 т ч 'Ins (pH 7 4) 2 т м KDTA 
0 2 % (w/v) sodium doden I sulphate) heated to 100 С for a few minutes and after rapid cooling the 
solution was layered on top of a 16% to 43 5% (w v) isokinetic sucrose gradient containing the same 
buffer Centnfugation was for about 16 Ьяі2(УС in an IK('SH2HÎ rotor at 200 000£ The gradiente were 
fractionated and radioactivity was counted using Pico fluor™ 15 (Packard Inst ) (a) ( 9 ) Nuclear RNA, 
( χ ) nuclear matrix RNA After frac tionation the nuclear matrix RNA was prec ipitated and redissolved 
in 2(X)/il of SxSSC containing l т м KDTA 0 1% (w/v) sodium doclec\l sulphate 5 0 % foimamide In 
this solution a nitrocellulose filter to which 2 ^g equivalents of KcoRl H fragment was immobilized 
(Gillespie & Gillespie, 1071 ) was incubated for 2 mm at Ь5 С and subsequentU for 60 h at 47 С Filters 
were washed several times with 2 χ SSO dried and the radinaetiv it\ of the h\ bndi/ed RNA was counted 
in a toluene based scintillant (SSO is 0 15 м NaCI 0-015 ч sodium citrate, pH 7 ) (b) ( · ) Nuclear 
matrix RNA, ( χ ) matrix RNA hybridized to the A'collI В fragment 
1 2 3 4 5 % (kb) 5 6 7 8 
(α ) 
A A A 
— 23-5 (8-2) 
— Ι4·5 (5·Ι) 
9·Ι (3-2) 
7-7 (2-7) 
6·3 (2·2) 
5-8 (2·0) 
Γ " 
3-7 (ι·3) _ „ a , ' 
6 »- щ р 
7 » - _ 2-7 (0·95) — 
50·Ι 72-8 
ί Ь) V Д * 
Him m ι 1 
58-5 70-7 
* Β * 
fcoRI Ι 1 
ΚρηΙ 
BglU 
609 
° * 
59-8 63-5 
μ ΐ ϊ U ϊ _ 
F I G . 2. S, nuclease analysis of poly(A)-containing cytoplastnic RNA. HeLa cells were labelled with 
| 3 H]uridinefrom 16 to 18 h after infection. Cytoplasmic extracts were prepared as described in Materials 
and Methods, and cytoplasmic mRNA purified viti oligo(dT)-cellulose chromatography (Aviv & Leder. 
1972). The poly(A)+ mRNA was hybridized to various DNA fragments ((b)) and analysed according to 
the Si mapping procedure as described in Materials and Methods. The Figure shows the St-resistant 
hybrids of polv(A)+ mRNA with lane I. Hindïïl A: lane 2, A>foRI В; ІапеЗ, subfragment b ; lane 4. 
subfragment a: lane 6. subfragment d; lane 7, subfragment e; lane 8, subfragment с; lane 5 
shows the Hindlll restriction fragments of adenovirus type 2 DNA as molecular weight markers. 
The hybrids in lane 2 (arrows) have been numbered for reference, kb, IO3 bases, (b) Location of 
restriction fragments and subfragments of AVoRI В on the adenovirus type 2 genome. The molecular 
weight of the subfragments were determined on agarose gels with Hindlll and fCcoKl restriction digests 
of adenovirus type 2 DNA as molecular weight markers. From these molecular weights, the restriction 
sites within the AVoRI В fragment were calculated. 
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induat i i ig t h a t th( \i ial р о п о т е чечцкчк es aio most с ч о п о т к аІІ\ имчі wi thout 
Іаідс s])a(tM legions ІкЧиічмі i m l m d i i a l frenes Tins has lecontK been (onfimied l)\ 
s(4|iien(e studies lepoi ted h\ \kus ja i\ i d ni (lOSl) T h e second hand obta ined 
with the ftVoHI В f i a g n u n t (Fig 2(a) lane 2 band nuinhei (i) which is 2 H" ( ) long 
was not found with a m of the suhf iagments Theiefore it piobablv te juesents the 
H end of the legion L.'î inessengei Н \ Л which m a p s within t h e legion of 
siil)tiaginent d at <)1 4 + 0 2 ina|> units (Fig 2(a) lane t>) 
I 'xcept fot these majoi c o m p o n e n t s a few ininoi K \ \ sjnnies weie found to 
h \ h i i d i / e to t h e Л оВІ В fiagnient \ h\l)iid пшпЬегсч) 7 of 2 7 % can be 
identified with s i ibf iagments b and e (Fig 2(a) lanes .'$ and 7) but not with H indili 
\ (Fig 2(a) lane 1 ) Theiefote this I n b r i d conta ins t h e ô end of the legion L4 
inessengei R \ \ whic h has been mapped at 68 0 m a p uni ts (Chow et dl 1077 Chow 
λ Btokei 1078) I s i n g oui p m c e d u i e t h e .V end of this R \ A was found to be 
located at the same co ord inate 08(1 + 0 2 may) units Band n u m b e r 4' (Fig 2(a) 
lane 2) tepiosenl ing a h \ b i i d of 4 4°,, is piobablv d e n v e d fiom one of t h e 
descubed D B F i n B W s ( b i b to (¡(¡Γ) m a p units Chow el ai 1!)7!)) but t h e 
concent ia t ion of this K \ \ m t h e cytoplasm late aftei infection is too low for 
ace m a t e mapping with oui procedure This h v b n d has t h e same length as a h v b n d 
fonned fiom a tv pical т к leai R N A species ( b a n d 4 n see below) but can be 
distmguislied fiorn the nuclear species ah will be desi мbed below When long 
exposure t imes weie used some addit ional h v b n d s of relativ el ν low molecular 
weight weie detected These piobablv contain R N A sj>ecies present in t h e 
cvtoplasm in \erv low quant i t ie s T h e existence of one such inessengei RXA has 
been decine ed fiom séquence da t a of the AVoRI В f iagnient of adenovirus tv pe 2 
( \kiisjaiv ι el al 1()81 ) T h e hoch of this L3 messenger m a p s between 5!) !) and (H 8 
m a p units 
Y\ e then uncleitook t h e a n a h s i s of tota l nuclear RX \ \s expected a moie 
complex p a t t e r n of h v b n d s was obta ined a l though the spec íes piesent in the 
ι ν toplasmic R \ \ (band n u m b e r s 4 ö (> and 7) could also be detected in bteadv 
s ta te nucleai R \ \ (compare Figs 2(a) and 3) It should be ment ioned here that we 
nevei lound a m diffeience between the pa t te rn of to ta l nuclear RNA and t h a t of 
polv ( \ ) selected RX \ Most ex|X'riments howevei were performed with p o h (A) 
containing nucleai R X . \ The long p ieeuisois ol the legion L4 and Lo niRX \ s 
p iotect the fiVoRI В f iagnient totallv against degradat ion bv the S! nuclease 
(122 ( , ( ) Fig '.) lane 2 band numbei 1) In the case of the D B F piecuisor RXA one 
expects t o find a h v b n d t h a t is !) I o , , (61 (> to 7 0 7 m a p units) Indeed a b a n d of 
8 4 ± ( ) 2 ( ) 0 was detected with the KtoKl В f iagnient (Fig 3 lane 2 band n u m b e r 2) 
oi subfiagment b as p iobe (Fig 3 lane 3) 
Besides h v b n d s t h a t can be ascribed to known pre m R X A s (bands 1 and 2) and 
niRX \ (bands 4<: 5 (> and 7) a few moie h v b n d b a n d s (numbeied 3A + B and 4") 
were detected These weie not t h e lesult of c o n t a m i n a t i o n of AYoRI В with o t h e r 
AVoRI testile t u m f iagments since these bands were not found when o t h e r EroRl 
f iagments weie hv bridi/ed t o nucleai RXA (Fig 4 lanes 2 to ö) Fur the rmore the 
AVoRI В fiagnient isolated fiom cloned f/indili A a generous gift from Dr M 
M a t t h e w s gives an identical p a t t e r n of h v b n d s as t h e fragment isolated fiom 
agarose gels (data not shown) This indicates t h a t t h e t h i e e bands ( n u m b e i s 4 n 
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F I G . 3. Si nuclease analysis of poly(A)-containing nuclear RNA. HeLa cells were labelled with 
| 3 H]uridine from )6 to 18 h after infection Nuclei were isolated as described in Materials and Methods. 
Nuclear RNA was prepared by extraction with hot phenol (bong el al.. 1979) and purified via oligo(dT)-
cellulose chromatography (Aviv & loeder, 1972). The polv(A)+ nuclear RNA was hybridized to various 
DNA fragments (Fig. 2(b)) and analysed according to the S] mapping procedure as described in 
Materials and Methods. The Figure shows the S,-resistant hybrids of polv(A)+ nuclear RNA with 
lane 1. Hindlll A ; lane 2. EcoRl В ; lane 3. subfragment b : lane 4. subfragment a ; lane 6. subfragment 
с ; lane 7. subfragment e ; lane 8. subfragment d ; lane 5 shows the Hindlll molecular weight markers. 
The hybrids in lane 2 (arrows) have been numbered for reference, kb. 103 bases. 
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F I G . 4. S, nuclease analysis of poly(A)-contammg nuclear RNA with various ËcoRI restriction 
fragments. Infected HeLa cells were labelled and poly(A)* nuclear RNA was isolated as indicated in the 
legend to Fig. 3. The polv(A)+ nuclear RNA was hybridized to various A'coRI restriction fragments of 
adenovirus type 2 DNA and analysed according to the S1 mapping procedure as described in Materials 
and Methods. The Figure shows the .Sj-resistant hybrids of polv(A)+ nuclear RNA with lane 1. EcoRl 
B; lane 2, KcoRl C; lane S. fc'coRI I); lane 4. A'coRI K; lane 5, A'coRI F ; lane 6 shows the / / i n d i l i 
molecular weight markers. The hybrids in lane 1 (arrows) have been numbered for reference, kb, 103 
bases. 
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3A+B) leproNt'nt HNA molei ules from whiih at least one end maps within the 
A'roKI H fiapnunt Hvbiidi/ation of niulear HXA to the KiiAW В siihfi.ifjinents 
(Fig 2(1))) pio\ides a bettei localization of these bpeucs The hand of Ь 8",, was 
found to (onsist of two (oinponents 'λ\ and 3B The RXA in Inbnd 3 \ Melded 
with subfiagment h a band of 4.4",, uhic h is not found with AVoHl B(Kip 3 lanes 
2 and 3) This indicates that the ИХ \ extends fiom left of 58 5 to 05 2 + 0 2 map 
units This is fuithei substantiated b\ h\ budi/ation with subfi.ifiment e which 
Melded the expected fiagment of 1 8" 0 (Fig 3 Iane7) It is possible that this 
species lepiesents a parth spliced p()l\(A)+ R \ \ molecule from which an intion 
extending betw een (>.> 2 and а с o oidinate to the right of 70 7 has been lernen ed \n 
alteinati\e |H)ssibilit\ is the existence of an additional pol\ aden slat ion site at (>•") 2 
map units H\hiid band 3B was also found with subfiagment b (Fig 3 ІапеЗ) 
The«foie this Inbnd most hkeh ιepresents a splicing intermediate which is 
geneiated b\ the excision of the 5 nitron of the DBP piee ursor IÍN \ (hi 0 to <>8 Ь 
map units Blanc hard el al 1978 Goldenberg Ä. Kaskas 197!)) Howe\er accurate 
mapping was not possible because of the relatneh low concentratron of this 
intermediate 
The 4 9% long hybrid band number 4n (Fig 3 lane 2) is probablj not due to 
accumulation of processed DBP R \ \ in the nucleus because no .$()"„ band could 
be detected with subfiagment e (Fig 3 lane?) Furthermore band number 4" is 
also found with subfiagments b and e but not with IhndWl λ (Frg 3 lanes 1 3 and 
7) Thus the R\A extends from b.r>8 + 02 map units to be\oncl 70 7 and could 
therefoie represent processing inter mediates from region L5 RX \s Thev resemble 
molecules that constrtirte a large part of region Lf) messenger RX \s in abortive 
rnfeetron (Klessrg L Chow 1980) Fmallv the hv bnd numbered 6 (2 8% Frg 3 
lane 2) is probablv geneiated both from the 3 end of the region L3 messenger's as 
discussed above as well as from then polvadenvlated preeursois which extend 
between 1()4.') and di ó map unrts The results of our analvses are summarr/ed in 
Frgure ó 
(t) S, пшіінье янаіі/ъп of nuclear mahn fí\ 4 usinqtÌH EioRI Bfiaqment as a piobe 
The data summarr/ed in Figure 5 show that precursors (bands number 1 and 2) 
and processing intermediates (bands number ЗА 3B and 4") and mRXAs (bands 
number 4C 5 b and 7) are present rn nue leai RX \ It would be interesting to know 
which of these RX \ SJXH ICS aie assoeiated with the nue lear matrix Foi this reason 
rapidlv labelled nuclear matrix RXA was isolated and hvbiidi/ed to the various 
DXA fragments shown in Figure 2(b) As dt ter mined for RXA seepiences that aie 
transcribed from the genome between co ordmates f)0 1 and 72 8 the S! nuclease 
mapping lesults indicate (compaie Figs 3 and b) that the matrix RXA most likelv 
has the same composition assteadv state poh (A)+ nuc lear RXA Therefore all the 
R \ \ s|X4 íes present m the poh (A)+ nuclear R \ Α ι e precursors mtermediates 
and products of RX \ processing aie associated in some vvav with the nuclear 
matrix 'lo exclude the possibihtv that the products of proeessmg that were found 
in the matrix RNA were the result of с>toplasmie contamination the polv(A) + 
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Pi«, 5. Summary of the data obtained via S, mapping experiments. RNA species complementary to 
the /îroRl lì fragment found in the nucleus of Heba cells at the late stage of infection with adenovirus 
typeS. Detection was performed by means of the K, nuclease mapping procedure as described in 
Materials and Methods. The hatched bars represent the mKNA se(|uence. the lines indicate the 
intervening sequence 
cvtoplasmk· RXA from the same batch of cells was analysed as well. Xo labelled Kj-
resistant hybrids could be detected (Fig. 6, lane 8). Even after labelling the cells for 
20 minutes, only very low levels of labelled mRXAs were present in the cytoplasm. 
This excludes the possibility of contamination and strongly suggests that pre-
mKXA is associated with the nuclear matrix during its processing. 
(dj Viral RXA ix usmHated with host proteins dining processing 
Recent studies have indicated that hnRXA is bound to the nuclear matrix ria 
two proteins of M, 41.5<K) and 43.(X)0. The evidence underlying this conclusion was 
based on the findings that these proteins were tightly bound to rapidly labelled 
hnRXA in rivo, and that they were not released from the matrices during 
exhaustive treatment with ribonuclease. which does remove other hnRXA-
associated proteins (van Eekelen & van Venrooij. 1981). In order to show that 
adenovirus-specific sequences were bound to the nuclear matrix in a similar way as 
host hnRXA. the ultraviolet light cross-linking method (Wagenmakers et al., 1980) 
was applied to infected cells. The covalently linked RXA- protein complexes were 
separated from non-cross-linked complexes by boiling the matrices in I",, (w/v) 
sodium dodecvl sulphate followed by extraction with phenol/chloroform. Free 
RXA remains in the aqueous phase, while covalent RXA-protein complexes move 
I l l 
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Fia, 6. S t nuclease analysis of nuclear matrix RNA. HeLa cells were labelled for 10 min with 
[3H|iiri(line and j J H [cvtidine 18 h after infection. Nuclear matrices were prepared as described in 
Materials and Methods. The associated RNA was isolated by boiling the matrices in 1% (w/v) sodium 
dodecvl sulphate for a few minutes, followed by extraction with phenol, chloroform and 2 extractions 
with chloroform. The RNA was precipitated with ethanol. |)elleted and hybridized to various DNA 
fragments (Fig. 2(b)}. Analysis was according to the Si mapping procedure as described in Materials and 
Methods. The Figure shows the S1-resistant hybrids of total nuclear matrix RNA with: lane 1, 
subfragment, с: lane 2. subfragment e: lane.'ï. subfragment d: lane 5. subfragment a: lane 6. 
subfragment b ; lane 7. AVoRI H: lane 8. S1-resistant hybride of poly(A)+ cytoplasmic RNA from 10 min 
labelled infected HeLa cells, hybridized to AVoRI B. Lane 4 shows the ¿fóndili molecular weight 
markers. The hybrids in lane 7 have been numbered (arrows) for reference, kb. 103 bases. 
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into the interphase. After irradiating the eells lor five minutes. 55 to SO",, of the 
nucleai' matrix RXA «as found in the interphase fraction. In control experiments 
in which the cells were not irradiated, only .4 to 7",, of the RXA was found in the 
interphase. To determine which RNA species were cross-linked, the RXA-protein 
complexes in the interphase and organic laver were precipitated with ethanol and 
deproteinized by extensive treatment with proteinase K. The RXA was then 
analysed by the S, nuclease mapping procedure using KcoRl В as a probe. Our 
results showed that all the RXA species that were originally present in the nuclear 
matrix RXA preparation (Fig. β) were also present in the cross-linked RXA 
fraction (Fig. 7(a)). 
We also analysed the proteins that were cross-linked to the matrix-associated 
RXA of infected cells. For this purpose, at 18 hours after infection cells were 
labelled for ten minutes with | 3H]uridine and | 3 H ]cvtidine, harvested and 
irradiated. The nuclear matrices were dissolved in sodium dodecyl sulphate and the 
covalent hnRXA-protein complexes were isolated by oligo(dT)-celliilose 
chromatography and digested extensively with nucleases (van Kekelen & van 
Venrooij. 1981). By virtue of the few remaining 3H-labelled nucleotides, the 
proteins that were cross-linked to polv(A)+ hnRXA were identified by gel 
electrophoresis and fluorography (Wagenmakers el al., ЮНО). The result of such an 
analysis is depicted in Figure 7(1)). which shows that two proteins (M, 41.SOU and 
43,000) were cross-linked to rapidly labelled hnRXA from infected cells. Since the 
cross-linked RXA probably is a mixture of viral and host-specific sequences (Beltz 
& Flint. 1979), and the cross-linked proteins comigrate exactly with the proteins 
cross-linked to hnRXA (van Kekelen & van Venrooij, 1981). we also have selected 
the viral-specific complexes by hybridizing the RXA-protein complexes to viral 
DXA immobilized on Sepharose. The analysis of these viral-specific RXA-protein 
complexes gave the same result as is shown in Figure 7(b). 
In conclusion, we may state that all viral RXA species (precursors, intermediates 
and processed mRXAs) in the nucleus are bound to the nuclear matrix. They can be 
cross-linked in vivo to host proteins, which are well-described components of the 
30 S hnRXP core particles (Beyer et α/., 1977) and which cannot l>e removed from 
the matrix by digestion with ribonuclease. in contrast to other core proteins (van 
Kekelen & van Venrooij. 1981). This suggests that they are implicated in the 
binding of viral and host RXA to the nuclear matrix. 
4. Discussion 
The nucleus of eukaryotic cells contains a structure, generally referred to as 
nuclear matrix, which can be isolated after removal of the DXA and DXA-
associated proteins by treatment with DXAase I and various extraction 
procedures. It has been described by several workers (Herman et al., 1978; Miller 
et al., 1978α; Long et al., 1979; van Kekelen & van Venrooij, 1981) that 
heterogeneous nuclear RXA is tightly associated with this nuclear framework. 
However, no attempt has been made so far to analyse the RXA moiety that is 
associated with the matrix. Such an analysis might provide important information 
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FlG. 7. Cross-linking of hiiKXA to proteins in vivo by irradiation with ultraviolet light. Infected HeLa 
cells were labelled for IO min with | 3 H [uridine and [3H |cvtidine and irradiated with ultraviolet light in 
order to cross-link RNA to its associated proteins ('ovalentlv linked RNA—protein complexes were 
prepared from the isolated nuclear matrices by extraction with phenol/chloroform (see Materials and 
Methods), (a) The KXA was isolated from the complexes by removal of the covalently linked proteins 
with proteinase K. hybridized to ¿fcoRI В and analysed with the Sj nuclease mapping procedure. The 
Figure shows the S l-resistant hybrids The positions of the HimilW molecular weight markers are as 
indicated, kb. IO3 bases, (b) The proteins were freed from covalently linked RNA by extensive digestion 
with nucleases and analysed by sodium dodeeyl sulphate/polyacrylamide gel electrophoresis as 
indicated in Materials and Methods. 
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on the topology of RNA processing in the nucleus. Using adenovirus-infected cells, 
we have tried to answer some of these questions and our main conclusions can be 
summarized as follows. 
(1) Viral-specific hnRNA is associated quantitatively with the nuclear matrix. 
In the viral-specific nuclear matrix RXA. precursors, processing 
intermediates and processed mRXAs can be distinguished. 
(2) Precursors, intermediates and products of RNA processing can be cross-
linked in vivo, by means of irradiation with ultraviolet light, to host proteins 
of Л/, 41,500 and 43,000. 
The results underlying the first conclusion depend on the integrity of the nuclear 
matrix. The structural integrity seems to protect the associated RNA against 
degradation. Using an S, nuclease mapping procedure, we found that viral-specific 
nuclear matrix RNA contains precursors and products of RNA splicing. This result 
strongly suggests that the splicing process occurs while the RNA is associated with 
the nuclear matrix. It could be envisaged that all components necessary for the 
splicing process are assembled in a splicing complex localized on the nuclear matrix 
structure. Since it has been proposed that certain snRNAs may function as "splicer 
R N A " ; i.e. to hold neighbouring exons together during splicing (Lerner el al., 1980), 
it is interesting to note that some snRNA species have also been found in 
association with the matrix (Miller el al., 1978ft). 
The fate of the spliced-out intervening sequences is unclear. Our S, nuclease 
analyses never showed differences between hybrid patterns of poly(A)-containing 
RNA and total RNA, not selected for poly(A), from nuclei or matrices, indicating 
that hybrids that could be ascribed to spliced-out intervening sequences were not 
present in detectable quantities. I t is possible that the intervening sequences, after 
being spliced out, are degraded rapidly, so that appreciable accumulation does not 
occur. Alternatively, the intervening sequences could be excised in a stepwise 
manner by removal of oligonucleotides too small to be detected. In accordance with 
the latter model, it has been reported that splicing of the globin pre-mRNA 
(Kinniburgh & Ross, 1979: Reymond et al., 1980) seems to take place in a stepwise 
mode. 
S 1 nuclease mapping further shows the presence of RNA species that seem to be 
intermediates of RNA processing. Probably, the viral-specific hnRNA becomes 
attached to the nuclear matrix shortly after the start of transcription and remains 
associated with the matrix during all steps of processing. I t seems reasonable to 
expect that this is a general phenomenon of hnRNA of eukaryotic cells, and that 
the adenovirus makes use of the host processing machinery. 
The photo-induced cross-linking method, mentioned in conclusion (2), has a very 
high degree of specificity, because a firm association between RNA and protein 
must be present in vivo at the time of irradiation of the cells in order to achieve 
covalent cross-linkage (Wagenmakers et al., 1980). In previous studies, it was 
shown that only two proteins can be efficiently cross-linked to host nuclear matrix 
RNA (van Eekelen & van Venrooij, 1981). I t was proposed that these proteins 
could be involved in the binding of hnRNA to the matrix, since they were, in 
contrast to other hnRNA-associated core proteins, not released from the matrix by 
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extensive treatment with RNAase After infection, viral-specific nuclear matrix 
RNA, including precursors, intermediates and products of RNA processing, can be 
efficiently cross linked to the same host proteins, suggesting that the association of 
these RNA species with these proteins is not significantly influenced by the 
processing of pre-mRNA to mRNA Although our method of analysis does not 
allow a conclusion to be reached as to whether both proteins are randomly 
associated with all identified RNA species, or if there is specificity between some 
RNA species and one of the proteins, we believe that our data support the 
hypothesis that, during its processing, viral hnRNA is associated with nuclear 
matrix host proteins 
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ABSTRACT 
In the nucleus of HeLa cells late after Infection with adenovirus type 2 
mRNA-sequences which are processed via RNA splicing are attached to the 
nuclear matrix (Mariman et al., 1982). Although the mRNA, which codes for 
polypeptide IX, is not formed via splicing, about 70% of the non-poly-
adenylated pre-mRNA and the polyadenylated pIX mRNA are bound to the matrix 
structure, indicating that polyadenylation 1s performed while the RNA Is 
associated with the matrix. Binding to the nuclear matrix seems to be a 
common property of all mRNA-sequences in the nucleus. At the late stage of 
infection most of the newly synthesized mRNAs which appear In the cytoplasm 
are viral specific (Beltz & Flint, 1979). Kinetic analysis of the newly 
synthesized poly(A)-containing mRNA on sucrose gradients reveals that 7-12 S 
messengers appear more rapidly In the cytoplasm than messengers larger than 
13 S. More specifically, the nuclear exit time of the pIX-mRNA, which 1s the 
major 9 S adenoviral messenger late after Infection, was determined to be 
about 4 min, while messengers transcribed from the late region 3 need more 
than 16 min to arrive in the cytoplasm. In the cytoplasm about 70% of the 
mRNA Is bound to the cytoskeletal framework, while 30% remains as free mRNP. 
Analysis of the mRNA in both fractions reveals that L3-, E1B- and plX-speciflc 
polyadenylated mRNA preferably exist as cytoskeleton-búund mRNA. However, 
significant differences occur in the partition of specific messengers over 
free and cytoskeletal RNA fractions. 
INTRODUCTION 
It has been reported that hnRNA is quantitatively associated with a higher 
ordered proteinaceous structure, generally referred to as the nuclear matrix 
(1-4). At the late stage of Infection of HeLa cells with adenovirus type 2 
the viral specific hnRNA is also quantitatively attached to the nuclear 
matrix (4). It has been suggested that the nuclear matrix may function In 
localizing and structurally organizing hnRNA during its processing, since 
both mftNA-precursors and spliced products can be detected in the matrix 
associated RNA (5). After completion of its processing the matured messenger 
RNA is transported to the cytoplasm where It is translated. 
mRNA-sequences In the nucleus as well as In the cytoplasm are compiexed with 
several proteins. However, a different set of proteins seems to be associated 
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with mRNA-sequences in the nucleus as compared to cytoplasmic mRNA, indicating 
that during nucleo-cytoplasmic transport one set of proteins is exchanged for 
another (6). Finally,in the cytoplasm mRNA can exist either as free mRNP or 
be bound to the cytoskeleton, a cytoplasmic framework composed of structural 
proteins, which can be isolated by treatment of cells with a non-ionic 
detergent (7, 8). 
In this study we pursued specific adenoviral mRNA-sequences from 
transcription to their destination in the cytoplasm. Although all adenoviral 
mRNA-sequences roughly seem to follow the same pathway through the Infected 
HeLa cell, significant differences between specific mRNAs occur In the rate 
of their nucleo-cytoplasmic transport and their localization in the cytoplasm. 
MATERIALS AND METHODS 
Infection and labeling of cells 
HeLa S3 cells were infected with adenovirus type 2 (2000 particles per 
cell) at a density of 5x10 cells/ml In Eagles minimal essential medium 
containing 1 mM arginine (MEM). After adsorption of the virus to the cells 
during 1 h at 37 0C, the cells were diluted to О.ЗхЮ 6 cells/ml with MEM 
containing 5% newborn calf serum. Cells were harvested at IB h after 
Infection. To obtain a time course of labeled mRNA 18 h after Infection, cells 
were concentrated to 20x10 cells/ml and incubated for the indicated periods 
3 
of time with 50 vCi/ml (5,6- H) uridine (45 Ci/mnol, Radiochemical Centre 
Amersham, England), 25 tiCi/ml (5'- H) guanos ine (20 Ci/mnol, Amersham) and 
3 
25 PCi/ml (5- H) cytidlne (31 Ci/mmol, Amersham). To obtain steady state 
labeled mRNA the cells were labeled from 16 to 18 h after Infection with 5 
VCi/ ml (5,6-3H) uridine at a density of 4xl06 cells/ml. 
Purification and oligotdTj-cellulose chromatography of cytoplasmic and nuclear 
RNA 
The incorporation of labeled precursors in the RNA was terminated by 
rapidly mixing the cells with an equal volume of crushed, frozen NKM solution 
(0.13 M NaCl, 0.05 M KCl, 1.5 mM MgCl 2). After centri fugatlon for 5 min at 
800g the cells were washed once with NKM, pelleted and resuspended in RSB 
(10 mM NaCl, 10 mM Tris, pH 7.4, 1.5 mM MgCl 2). After the addition of 0.1 vol 
of a sodium deoxycholate-Nonidet P40 mixture (5% each) the cells were 
disrupted by intensive vortexing. The nuclei were pelleted and from the 
supernatant cytoplasmic RNA was isolated by phenol/chloroform extraction (9). 
The nuclei were washed once In RSB and resuspended in the same buffer. Nuclear 
RNA was isolated by phenol extraction at 550C as described by Long et al. 
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(10). To select the poly(A)-containing RNA oligo(dT)-cellulose chromatography 
was performed as described by Aviv and Leder (11) using the T2 grade of 
Collaborative Research Inc. 
Fractionation of cytoplasmic RNA into free and cytoskeleton-bound mRNA 
Cytoskeletons from HeLa cells were prepared essentially as described by 
van Venrooij et al. (12). Cells were harvested by centri fugati on and washed 
once with Isotonic NKM solution and once with hypertonic buffer (0.3 H sucrose 
10 mM KCl, l.S mM Mg-acetate, 10 mH Tr1s-acetate, pH 7.4). The cells were 
resuspended In hypertonic buffer (40x10 cells/ml) and 1 vol. of lï Triton 
X-100 (BOH Chera. Ltd., Poole, Dorset) In hypertonic buffer was added. The 
suspension was gently swirled 1n Ice for 30 sec and centrifugad (S min, 800g) 
to sediment the cytoskeletons. The supernatant containing the free mRNA was 
pipetted off and the pellet was washed with hypertonic buffer containing 
0.5Z Triton X-10O. After centri fugation the pellet was resuspended In RSB. To 
solublllze the cytoskeletal fraction 0.1 vol. of a sodium deoxycholate-
Nonldet P40 mixture (SX each) was added to the suspended cytoskeletons and the 
suspension was Intensively vortexed. The nuclei were removed from the 
cytoskeletal fraction by centri fugation at SOOg for б min. Immediately after 
cell fractionation the various fractions were made U in SDS and deproteinlzed 
by phenol/chloroform extraction (9). The RNA was then passed over ollgo(dT)-
cellulose (T2-grade, Collaborative Research Inc.) to select the poly(A)-
contalnlng mRNA (11). 
Preparation of nuclear matrix RNA 
Nuclear matrices of HeLa cells IB h after Infection were Isolated as 
previously described (4). Nuclei were Isolated from infected HeLa cells as 
described above. The nuclei were resuspended in RSB containing 0.1 H NaCl and 
treated with DMAse I for 30 min at 10oC (500 yg/ml). After ONAse I digestion 
the nuclei were pelleted through a 302 sucrose layer by centri fugation at low 
speed. The pelleted material was extracted once with 0.4 M (NH^.SO.. After 
repelleting the nuclear matrices were washed with RSB, suspended In RSB 
buffer containing IX SDS and Incubated at 100oC for 3 min. The boiled mixture 
was adjusted to 0.2 H NaCl and extracted with phenol/chloroform (1:1). After 
two additional extractions with chloroform the RNA was precipitated with two 
volumes of ethanol. 
Adenoviral DNA Isolation and restriction fendonuclease digestions 
Viral DNA was isolated from the purified virions as described by Petterson 
and Sambrook (13). EcoRI and HindiII (Boehrlnger, Mannheim) restriction 
digestions were performed at 370C for 4 h using 1 unit of enzyme per ug DNA. 
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Standard conditions were 50 nti Tris, pH 7.4, 7 nfl MgCl2. SO mM NaCl, 3 M OTT. 
SstI (Bethesda Research Laboratories Inc.) digestions were performed at 370C 
for 12 h (1 un1t/pg DNA) 1n Tris buffer containing 10 mM Tris, pH 7.4, 7 mM 
MgC12. 10 mM KCl, 20 mM NaCl, 3 mM OTT. In case of Smal (Boehrlnger, 
Mannheim) the DNA was digested at 2&°C for 12 h (1 unlt/vg DNA) In a buffer 
containing 15 mM Tris, pH β.Б, 6 mM MgClj, 15 mM KCl, 3 mM DTT. Restriction 
fragments were separated by agarose gel electrophoresis; 0.8Ϊ agarose gels 
were run for 20 h at 80 V In buffer TNE (40 mM Tris, pH 8.0, β mM NaAc, 2 M 
EDTA). The DNA was recovered from agarose gel slices by the method of 
electrophoretlc elutIon. 
RNA-DNA hybridization 
The DNA restriction fragments were limoblllzed to nitrocellulose filters 
as described by Gillespie and Gillespie (14). RNA was dissolved In 200 ul 
3x SSC (SSC, 0.15 M sodium chlor1de-0.0l5 M sodium citrate), 1 nM EDTA, 0.1Ï 
SOS, SOS fonumlde. To this solution a filter containing 2 мд equivalent of 
DNA of a particular restriction fragment was added. The RNA was denatured by 
Incubating the mixture at 650C for 6 min. Hybridization was then carried out 
at 380C for an appropriate period of time. After hybridization the filters 
were washed several times in 2x SSC and subsequently with 0.1 N NaOH at 450C 
for 10 min. The solution containing the eluted RNA was then neutralized with 
HCl and diluted with one volume of water. The radioactivity in the hybridized 
RNA was determined by means of liquid scintillation counting using pico· 
fluor™15 (Packard Inst.) as a scintillant. 
RESULTS 
Association of mRNA-sequences with the nuclear matrix 
It has been shown that the nucleus of HeLa cells, as well as of other cell 
types, contains a higher ordered proteinaceous structure, usually referred to 
as the nuclear matrix, to which the hnRNA is quantitatively attached (1-4). 
Recently it was shown that the process of RNA splicing is performed while the 
RNA Is attached to the matrix structure (5). With this finding the possibility 
arose that only mRNA-sequences which have to be spliced are bound, for example 
via Intron sequences, to the matrix structure. Release of processed mRNA 
would then occur simultaneous with the final splicing step. UnspiIced mRNAs, 
in that case, would not be found associated with the matrix. The messenger 
which codes for polypeptide IX (15), a structural component of the virion, is 
transcribed from the viral r-strand between coordinates 9.8 and 11.2 (16; 
the viral genome is divided Into 100 map units). Recently it was shown that 
the nucleotide sequences of this mRNA is collnear with the DNA (17) and until 
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now this messenger is the only known adenoviral mRNA which is unspliced. 
To test our hypothesis HeLa cells 18 h after infection with AdZ were 
labeled with Η-nucleosides for 30 min. After labeling the nuclei were 
isolated as indicated in Materials and Methods and divided in two. From one 
part nuclear RNA was isolated by means of the hot phenol extraction procedure 
(see Materials and Methods). From the other part of the nuclei nuclear 
matrices were prepared, The nuclear matrix RNA was then isolated as 
described in the Materials and Methods section. Both nuclear and nuclear 
matrix RNA were fractionated In polvadenylated (6% of the labeled RNA) 
and non-polvadenylated RNA (941 of the labeled RNA) via oligoidTb 
cellulose chromatography. This demonstrates that not only polyA(+) 
but also polyA(-) hnRNA is bound to the nuclear matrix. The amount of RNA 
containing nucleotide sequences specific for L3, E1B or pIX in each fraction 
was then quantitated by the method of filter hybridization as described In 
the Materials and Methods section. The nucleotide sequences of the pIX-
specific RNA reside In the region E1B (18; 4.6-11.2 m.u.), which is active 
In transcription at the early stage of Infection. However, transcription of 
this region seems to continue in the late phase of Infection. Two early 
messengers are transcribed from the region E1B which both contain the 
nucleotide sequences that make up the mRNA for pIX (18; F1g. 1A). Nuclear 
and nuclear matrix RNA were hybridized to a Hindlll/Smal restriction fragment 
of the Ad2 DNA (7.9-10.8 m.u.; Fig. 1A), which binds the ElB-speclfic RNA as 
well as the pIX-speclfic RNA-sequences. The RNA was also hybridized to a 
SstI/H1ndIII fragment (5.0-7.9 m.u.; Fig. 1A), which only detects the E1B-
speciflc RNA. The percentage of hybridization due to the pIX RNA was 
calculated by substractlng the percentage found with the Sst/Hind fragment 
from the percentage that was found when the Hind/Sma fragment was used. To 
detect the L3-spec1f1c RNA a Hind/EcoRI restriction fragment (19; 50.1-58.5 
m.u.; Fig. IB) was used. The results, listed In table I, show that 701 or 
more of the nuclear RNA, which contains L3-, E1B- or plX-specific sequences 
1s attached to the nuclear matrix. There Is no significant difference In the 
binding to the nuclear matrix between RNA which contains sequences for the 
unspliced pIX mRNA and the RNA sequences which form the L3 or E1B messengers 
via splicing. Therefore, binding to the nuclear matrix seems to be a common 
property of mRNA sequences, that have to be transported to the cytoplasm and 
Is not limited to the messengers which are generated via splicing. 
Sucrose gradient analysis of newly accumulated mRNA in the cytoplasm 
At the late stage of Infection of HeLa cells with Ad2 most of the newly 
synthesized mRNAs, which appear in the cytoplasm are viral specific (20). 
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Fig. 1. A. Map coordinates of the early region IB. The mRNAs which are 
transcribed from the region EIB are represented by arrows, arrowheads point 
at the 3' end of the mRNAs. Caret symbols indicate the intervening sequences 
which are absent from the spliced messengers. The cleavage sites of the 
endonuclease restriction enzymes which have been used to obtain Ad2 DNA 
fragments, are as indicated. B. Hap coordinates of the late region 3. The 
mRNAs which are transcribed from the region L3 are represented by arrows, 
arrowheads point at the 3' end of the mRNAs. Jointed stalks represent the 
spliced t r i p a r t i t e leader sequences. The cleavage sites of the endonuclease 
restriction enzymes which have been used to obtain Ad2 DNA fragments, are as 
indicated. 
Figure 2 shows the sedimentation profile of steady state mRNA late after 
infection as determined by sucrose gradient centri fugation. Three size classes 
can be distinguished: 18-24 S (class I ) , 14-17 S (class I I ) and 7-12 S 
(class I I I ) . The f i r s t type of experiment we undertook was to see i f there 
were appreciable differences in the time of appearance in the cytoplasm 
between mRNAs of different size classes. Therefore, HeLa cells 18 h after 
infection were labeled with Η-nucleosides (see Materials and Methods) for 5, 
15, 30 or 45 min, respectively. The poly(A)-containing cytoplasmic RNA was 
Isolated, denatured and layered on top of a 16-43.5« (w/v) Isokinetic sucrose 
gradient. After centri fugation the gradients were fractionated and the 
radioactivity in each fraction was determined. As can be seen from the 
gradient profiles In Figure 3 class I I I mRNA appears quite rapidly In the 
cytoplasm (Flg. ЗА). After labeling for 30 min or longer the gradient profi le 
(Fig· 3C and 30) already closely resembles that for steady state mRNA (Fig. 2) 
500 
r 
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Table I . Determination of the percentages of L3-, E1B- and pIX-speclfic 
nuclear RNA sequences which are bound to the nuclear matrix. 
PA+ 
L3-specif1c 
PA 
PA+ 
E l B - s p e c i f i c 
PA­
PA* 
pIX-specific 
PA" 
Hybridization 
of nuclear RNA 
(*) 
7.1 
9.8 
7.4 
6.7 
1.0 
3.8 
Hybridization 
of matrix RNA 
(%) 
6 . 1 
7.6 
5.3 
5.7 
0.7 
з.г 
Nuclear RNA 
bound t o the 
matrix {%) 
86 
78 
72 
85 
70 
84 
Poly A ( + ) / 
poly A ( - ) 
0.8 
0.9 
0.2 
Ad2 Infected HeLa cells 18 h after Infection were labeled with 3H-nuc1eosIdes 
for 30 min.After labeling nuclear and nuclear matrix RNA were prepared and 
fractionated in polyA(+) and polyA(-) RNA by ol1go(dT)-cellulose chromatography 
(Materialsand Methods). In each fraction of RNA the amounts of L3-, E1B- and pIX 
specific sequences were determined by f i l t e r hybridization as described in 
the Materials and Methods section. The restriction fragments of Ad2 DNA 
which were used, are as indicated in the text. The percentages of 
hybridization were corrected for non-specific adsorption by incubation of RNA 
with a blank f i l t e r under the same conditions. The third column shows the 
percentages of specific RNA sequences which are bound to the nuclear matrix. 
These data were calculated from the amounts of certain specific RNA sequences 
in nuclear and nuclear matrix RNA as shown In the f i r s t and second column. 
The fourth column shows the ratio between the amounts of certain specific RNA 
sequences in polyA(+) and polyA(-) nuclear matrix RNA. Each percentage is the 
mean value of the results obtained in 5 separate hybridizations. The 
deviation of the values in the f i r s t and second column is within 1/10 of the 
indicated values. 
while at the intermediate labeling time of 15 min the size distribution also 
was found to be intermediate (Flg. 3B). The ratios between the amounts of 
newly synthesized class I and class I I I mRNAs and between class I I and class 
I I I mRNAs rise between 5 and 45 min labeling I l lustrating the fact that there 
1s a significant difference between the time of appearance In the cytoplasm 
of 7-12 S poly(A)-conta1n1ng messengers on one hand and messengers larger 
than 13 S on the other. 
Nuclear exit times of different adenoviral messengers 
The gradient profiles of Figure 3 showed that 7-12 S messengers appear more 
rapidly In the cytoplasm than larger mRNAs. We were interested to see I f this 
result could be verified for specific mRNAs by determining the nuclear exit 
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Fig. 2. Sucrose gradient profile of steady 
state labeled poly(A)-contain1ng cytoplas­
mic RNA. HeLa cells were infected with Ad2 
and from 16 to 18 h after infection thg 
cells were labeled with 5 yCi/ml (5,6- H) 
uridine. The cytoplasmic RNA was isolated 
as described in the Materials and Methods 
section. To Isolate the poly(A)-
containlng fraction of the cytoplasmic 
RNA, ol1go(dT)-cellulose chromatography 
was performed as described by Aviv and 
Leder (11). The RNA was dissolved in a 
buffer of low ionic strength containing 
10 mH Tris, pH 7.4, 2 ілИ EDTA, 0.2% SOS, 
heated to 100oC for a few minutes, and 
after rapid cooling the solution was 
layered on top of a 16-43.5Ï (w/v) 
isokinetic sucrose gradient containing 
the same buffer. Centri fugation was for 
about 16 h at 20°С In a SW41 rotor at 
150,000g. The gradient was fractionated 
and the radioactivity counted with 
p1co-fluor™l5 (Packard I n s t . ) . The 
horizontal bars Indicate the different 
size classes of RNA which can be 
distinguished in the gradient profi le. 
time of the messenger for pIX, which is the major 9 S adenoviral messenger at 
the late stage of Infection ( 1 5 ) , and that of the messengers which are 
transcribed from the late region 3 (F1g. IB) and which sediment at a higher 
density than 18 S (15). HeLa cells IB h after Infection were labeled for 4, 
8, 12, 16 min and 5, 15, 30, 45 min, respectively. Poly(A)-conta1n1ng 
cytoplasmic RNA was isolated and hybridized to appropriate restriction 
fragments of the Ad2 DNA, inmoblllzed to nitrocellulose f i l t e r s , as described 
In the f i r s t section of this paragraph (Fig. 1; Materials and Methods). The 
same quantities of RNA were, under the same conditions, also hybridized to 
f i l t e r s containing 2 pg of total Ad2 DNA. The percentages of RNA hybridized 
to restriction fragments were then divided by the percentages of RNA 
hybridized to total Ad2 DNA. 
The results are depicted In Figure 4 and In agreement with our expectation 
they show that the f i r s t plX-specific sequences appear in the cytoplasm 
already after 4 min labeling, while labeled L3 messengers begin to accumulate 
after 16 min (Fig. 4 ) . 
Partition of messengers over free and cytoskeleton-bound mRNA fractions 
Morphological studies including Inmunofluorescence and electron 
microscopy have revealed the existence of a cytoskeletal framework composed 
6138 
Nucleic Acids Research 
Ή Icpm χ lift 
5 Ю 15 20 2 5 5 10 15 20 25 
FVactlon ixmber 
Fig. 3. Sucrose gradient analysis of newly accumulated poly(A)-contain1ng 
mRNA in the3cytoplasm. HeLa cells were Infected with Ad2. After labeling the 
cells with Η-nucleosides (see Materials and Methods) for a period of time as 
indicated in the text, 18 h after infection, the poly(A)-containing cytoplas­
mic RNA was isolated and analysed on an isokinetic sucrose gradient as 
described in the legend of Figure 2. Labeling time: S min (ЗА); 15 min (ЗВ); 
30 min (ЗС); 45 min (3D). 
of structural proteins In the cytoplasm of eukaryotic cells, which can be 
isolated by gently extracting the cells with a non-ionic detergent such as 
TX-100 (7, 8). Seme workers have found that cytoplasmic mRNA is in part bound 
to the cytoskeleton but that It can exist also as free mRNP. Further results 
have Indicated some specificity in the distribution of mRNA-sequences over the 
free and cytoskeleton-bound mRNA fractions (12, 21, 22). 
To determine if adenoviral mRNA preferably exists as free mRNP or as 
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Fig.4. Determination ot nuclear exit times by filter hybridization. Ad2 
infected HeLa cells 18 h after infection were labeled with JH-nucleosides 
for 4, 8, 12, 16 min and 5, 15, 30, 45 min respectively (Materials and 
Methods). Poly(A)-containing cytoplasmic RNA was prepared, dissolved in ZOO 
Wl 3x SSC, 1 n#1 EDTA. 0.1Ï SDS, 50« formamide and hybridized to DNA fragments 
immobilized to nitrocellulose filters. After hybridization the percentage of 
RNA which was hybridized to the DNA was determined as described in the 
Materials and Methods section. To detect L3-specific sequences the KNA was 
hybridized for 70 h to filters containing Ζ jig equivalent of the Hindlll/ 
EcoRI fragment indicated in Figure IB. The percentages were corrected for non­
specific adsorption by incubation of a blank filter with RNA under the same 
conditions. To detect plX-specific sequences the RNA was hybridized for 150 h 
to 2 vg equivalent of an Sstl/Hindlll as well as a Hindlll/Smal fragment 
(Fig.1A). The percentages of hybridization due to plX-specific sequences were 
calculated by substracting the percentages found with the first fragment from 
those which were found with the second fragment. Using identical conditions 
the same quantity of RNA was hybridized to filters containing 2 yg Ad2 DNA. 
The percentage of the RNA hybridized to a DNA frgment was divided by the 
percentage of the RNA which hybridized to total Ad2 DNA under these condi­
tions. Each point in the curves is the mean value of 5 separate hybridizations. 
cytoskeleton-bound mRNA, HeLa cells were labeled from 16 to 18 h after 
infection to obtain steady state labeled mRNA (Materials and Methods). After 
labeling poly(A)-contain1ng mRNA was prepared from both the free and cyto-
skeletal RNA fraction as described in the Materials and Methods section. In 
accordance with earlier results (12) it was found that only 30% of the steady 
state labeled mRNA exists as free mRNP while as much as 70% is bound to the 
cytoskeleton. The sucrose gradient profiles as depicted in Figure 5 show 
that there is only a slight difference In the size distribution and 
composition between free and cytoskeletal mRNA. By the method of filter 
hybridization as described in the first section of this paragraph we 
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Fig. 5. Sucrose gradient analysis of steady 
state labeled polyA(+) mRNA isolated from 
the free and cytoskeletal RNA f r a c t i o n s . 
HeLa c e l l s were infected with Ad2. Af ter 
labeling the c e l l s with (5,6-3H) ur idine 
(5 uCi/ml) from 16 to 18 h a f t e r i n f e c t i o n , 
the free and cytoskeleton RNA fract ions were 
isolated as described in the Materials and 
Methods section. 01igo(dT)-cellulose 
chromatography was performed (11) to iso late 
the poly(A)-containing RNA. The RNA was then 
dissolved in a buffer of low ionic strength 
containing 10 mM T r i s . DH 7.4, 2 mM EDTA, 
0.2% SDS, heated to ІОСГС f o r a few minutes, 
and a f t e r rapid cooling the solut ion was 
layered on top of a 16-43.5% (w/v) isok inet ic 
sucrose gradient containing the same b u f f e r . 
Centri fugati on was for about 16 h at 20 С 
in a SW41 rotor at 150,000g. A. Free 
polyA(+) mRNA. B.Cytoskeleton^bound polyA(+) 
mRNA. 
FrectfOn numMr 
quantitated the amounts of L3-, E1B- or pIX-specific mRNA-sequences in both 
the free and the cytoskeletal mRNA fraction. The results (Table II) 
demonstrate that each of the individual mRNAs preferably is bound to the 
cytoskeletal framework. However, significant differences can be detected in 
the partition of specific messengers over both cytoplasmic fractions. This 
possibly reflects the affinity of individual messengers for the cytoskeletal 
framework but, as was suggested earlier (12), can also point to a regulation 
mechanism of the translation of specific (adenoviral) mRNAs. 
DISCUSSION 
The mRNAs of eukaryotic cells are usually derived from larger precursor 
molecules. These primary products of transcription are modified by a number 
of processing steps, i.e. capping, polyadenylation, methylation and splicing. 
After processing, which is performed in the cell nucleus, the newly formed 
mRNA is transported out to the cytoplasm. At some time during mRNA transport, 
the proteins which are associated with the mRNA in the nucleus are replaced 
by a cytoplasm-specif1c set of mRNA-associated proteins (6). In the cytoplasm 
messengers can occur either as free mRNP or be bound to the cytoskeleton, a 
cytoplasmic framework (12, 21, 22). In the present study we pursued some 
adenoviral mRNA-sequences from transcription to their destination In the 
cytoplasm. Our main results can be suimarlzed as follows: 
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Table I I . Partition of L3-, E1B- and pIX-specific poly(A)-containing mRNA 
over free and cytoskeletal RNA fractions. 
L3-specific mRNA 
ElB-specific mRNA 
}IX-specific mRNA 
free RNA fraction 
11.55! 
г.г% 
28.5% 
cytoskeletal 
RNA fraction 
88.5% 
97.8% 
71.5% 
Ad2 infected HeLa cells were labeled from 16 to 18 h after infection with 
Зн-nucleosides. After labeling the polyA(+) mRNA was Isolated from both the 
free and cytoskeleton-bound RNA fractions (Materials and Methods). In each 
fraction of cytoplasmic mRNA the amounts of L3-, E1B- and pIX-specific mRNA 
were determined by f i l t e r hybridization as described In the Materials and 
Methods section. The restriction fragments of the Ad2 DNA, which were used, 
are indicated In the f i r s t section of this paragraph. The percentages of 
hybridization were corrected for non-specific adsorption by Incubation of RNA 
with a blank f i l t e r under the same conditions. From these data the partition 
of specific mRNA sequences over the free and cytoskeletal RNA fractions were 
calculated. Each percentage Is the mean value of the results of 5 separate 
hybridizations. The absolute deviation in the indicated percentaqes is less 
than 2.5%. Recently we have found the same results using 1 h labeled RNA and 
cloned DNA fragments. 
1. In the nucleus pre-mRNA sequences, polyadenylated or non-polyadenylated, 
are associated with the nuclear matrix regardless of the fact that their 
processing pathway Includes the process of RNA splicing or not. 
2. Generally, small-sized messengers (+ 9 S) appear more rapidly in the 
cytoplasm than larger mRNAs. When specific mRNAs are compared, the nuclear 
exit time differs significantly. 
3. In the cytoplasm messengers are preferably bound to the cytoskeletal 
framework although significant differences occur in the steady state 
distribution of specific mRNAs over free and cytoskeleton-bound RNA 
fractions. 
HnRNA Is quantitatively attached to a nuclear matrix ( 1 - 4 ) . Adenovirus 
region L4 RNAs are attached to the nuclear matrix both as precursors and as 
products of splicing. Indicating that splicing 1s performed while the RNA Is 
associated with the matrix structure ( 5 ) . Accordingly, using the method of 
f i l t e r hybridization for a more quantitative approach, we have found that at 
least 70X of the L3- and ElB-specific nuclear RNAs, which both are processed 
via RNA splicing, are attached to the nuclear matrix. Similarly I t was shown 
that the polyA(-) nuclear matrix RNA contains at least 70% of the non-
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polyadenylated pIX-specific sequences present in the nucleus. From this we 
concluded that pre-mRNA fop the pIX messenger is attached to the nuclear 
matrix, although the mRNA is not formed via splicing. At least 70X of the 
nuclear poly(A)-containing pIX RNA is also attached to the nuclear matrix, 
Indicating that not only splicing but also polyadenylation is performed while 
the RNA is bound to the matrix structure, Fror.i Table I i t can be seen that 
polyA(+) and polyA(-) nuclear matrix RNA roughly contain the same amount of 
L3- or ElB-specific sequences. However, the polyA(+) fraction contains about 
4 times less pIX-specific sequences than the polyA(-) fraction. This suggests 
that polyadenylation is the last step in the processing of pIX RNA and 
indicates that the mature mRNA, after polyadenylation, is immediately 
transported out to the cytoplasm. The measurement of the nuclear exit time of 
these specific sequences confirms this suggestion. As seems to be the case 
for most adenoviral mRNAs (23) processing and transport of mRNA-sequences of 
the late region 3 last more than 16 min. However, the processing and 
transport of pIX mRNA is performed in only about 4 min (Fig. 4 ) . The 
relatively rapid appearance of pIX mRNA in the cytoplasm could be explained 
by the fact that the processing pathway does not include RNA splicing, which 
could be a time-consuming processing step. An alternative explanation would 
be that the rapid appearance of pIX mRNA could be the result of an enhanced 
rate of nucleo-cytoplasmic transportation. Our findings do not support the 
existence of different transport mechanisms for pIX and L3 messengers. 
However, rapid transport could simply be the result of the smaller size of 
the pIX messenger. The gradient profiles of Figure 3 show that small-sized 
messengers (+ 9 S) are the f i r s t to appear in the cytoplasm. This seems to be 
a more general feature since other workers have obtained similar results 
using uninfected HeLa cells and cultured L-cells (24, 25). They reported that 
9 S mRNA accumulated within 10 min in the small polyribosomes of these cel ls. 
In addition i t was reported that the ß-globin mRNA, a 10 S mRNA which is 
formed via RNA splicing, reached the cytoplasm within 5 min after termination 
of transcription (26, 27). Studies on the accumulation of EIA and E1B 
mRNAs have been performed by Wilson and Пате 11 (28). 
In the cytoplasm about 70% of the adenoviral poly(A)-contain1ng mRNA is 
bound to the cytoskeletal framework. Binding to the cytoskeleton might be 
obligatory for the mRNA to be translated (12, 22). Sucrose gradient analysis 
of free and cytoskeletal polyA(+) mRNA late after Infection reveals that both 
fractions of RNA sediment with roughly the same velocity (Fig. 5 ) . However, 
translation experiments have indicated that among adenovirus-specific 
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messengers there may be soecies which exist preferably as free or as cyto-
skeletal mRNA (12). Using filter hybridization we found that L3-, E1B- and 
pIX-mRNA species are preferably bound to the cytoskeletal framework (Table II). 
However, while the ElU mRNA was almost quantitatively bound to the 
cytoskeletal framework, about 3UÏ of the pIX mRNA was present as free mRNP. 
This demonstrates that among specific mRNA species there are differences in 
the binding to the cytoskeletal framework supporting the hypothesis that 
cytoskeleton-binding may be a regulatory step in the synthesis of (viral) 
proteins (12, 21, 22). 
Supmarizing, our results show that various adenoviral mRNA-sequences seem 
to follow a similar pathway through the infected HeLa cell, notwithstanding 
large differences in their nuclear processing, their exit time and their 
partition over free and cytoskeleton-bound mRNA fractions. 
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SUMMARY 
In nuolei of eukaryotic о іі гап сгір е are produced by 
RNA polymerase II which» in order to he able to function as 
messenger RNA in the cytoplasm, have to undergo modification 
processes such as capping, methylation, polyadenylation and 
splicing. We have focussed our attention on RNA splicing· In 
particular the excision of іп гоц sequences from the adenoviral 
major late pre-mRNAs was studied. The major late mRNAs are com­
posed of four exonsi leader 1, which contains the cap, leader 
2, leader 3 and a protein coding sequence, to which the poly(A)-
tail is added. When the leaders have been spliced they are re­
ferred to as the tripartite leader sequence. Three introns, 
numbered 1, 2 and 3, separate the exons in the pre-mRNAs; intron 
1 is located between leaders 1 and 2, intron 2 between leaders 
2 and 3, and intron 3 between leader 3 and the protein coding 
sequence. 
Some aspects of the splicing mechanism. 
Under steady state conditions putative processing interme­
diates, missing part of an intron, can be found in the nucleus 
indicating that removal of introns 1 and 2 is a stepwise pro­
cess and occurs in the 5' to 3' direction (Chapter III), Within 
an intron preferred and non-preferred cleavage sites can be 
distinguiahed. Rapid cleavage at preferred sites can occur al­
ready in the nascent transcript(Chapter II) showing that splicing 
can precede polyadenylation. Because an intron can have more 
than one preferred cleavage site, the first cleavage event may 
occur at different locations in the intron. Alternative splicing 
pathways seem to be operative in the removal of introns 1 and 2 
(Chapter II), The last cleavage is performed at the intron-exon 
boundary (acceptor site) and is rapidly followed by the ligation 
of the exons (Chapters II and III), A model for splicing based 
on our findings is presented in Chapter III. 
Splicing occurs in the 5' to 31 direction. 
When splicing of the tripartite leader sequence is studied, 
early and late cleavage events can be distinguished. The last 
cleavage occurs at the acceptor site of intron 2 and is intro-
U5 
duced in a splicing intermediate from which intron 1 is already 
excised (Chapter II). Since ligation directly follows acceptor 
site cleavage, this indicates that ligation of leader 1 to 
leader 2 precedes ligation of leaders 2 and 3. These results 
are in agreement with the findings of Keohavong et al, (Nucleic 
Acids Res. 10, 1215-1229 (1982)), Although the ligation of the 
tripartite leader sequences thus follows the 5' to 3' direction, 
cleavages can be introduced in intron 2 before intron 1 is 
attacked (Chapter II). Around leader 3 the cleavage events occur 
in an ordered fashion as well. Cleavage at the 3' end of this 
leader (donor site of intron 3) can only be performed when the 
5' end is already cleaved (acceptor site of intron 2) (Chapter 
IV). Because cleavage at the acceptor site of intron 2 is ra-
pidly followed by ligation of leaders 2 and 3 (Chapter II), 
ligation of the leader sequences thus precedes ligation of leader 
3 to the protein coding sequence. This indicates that ligation 
of the four exons, which constitue major late mRNAs, follows 
the 5' to 3' direction. Although cleavage at the donor site 
of intron 3 may be fast, it is a late event in the splicing 
pathway because it has to wait for the late cleavage at the 
acceptor site of intron 2 (Chapter IV), 
Possible involvement of the nuclear matrix in the splicing and 
transport of mRNA. 
Introns 1 and 2 can be cleaved internally without concomitant 
ligation of the bordering exons. This creates the necessity to 
keep or bring the cleaved-off RNA pieces together in the right 
orientation in order to make correct ligation of the exons 
possible after complete removal of the intervening sequencep. 
The requirement for such a factor is emphasized by the finding 
that rapid cleavage in intron 3 can occur before completion of 
the tripartite leader (Chapter IV). This indicates that simul-
taneous cleavages can occur in a pre-mRNA at locations which 
are separated from each other by more than 18000 nucleotides. 
The nuclear matrix, a predominantly proteinaceous intranuclear 
substructure, may provide such a framework, because both cellular 
and adenoviral hnRNA are quantitatively associated with the 
matrix (van Eekôlen and van Venroojj, J.Cell Biol. 88, 554.-563 
(1981); van Eekelen et al., Eur.J.Biochem. Ц^, Дбі-Дб? (1981); 
Chapters V and VI).Analysis of nuclear matrix associated 
adenoviral RNA revealed the presence of precursors, intermediates 
and producta of RNA splicing demonstrating that splicing occurs 
while the RNA is attached to the matrix structure (Chapter V). 
All the nuclear mRNA sequences which have some relation to the 
splicing process, including the products of rapid cleavage in 
either of the three introns, can be found in association with 
the matrix (Chapter III and V) showing that indeed the nuclear 
matrix may be involved in fixing the position of the RNA during 
splicing. Furthermore, all these RNAs can be cross-linked, by 
in vivo UV-irradiation of intact cells, to the host C-proteine, 
which are probably identical to the C-type core proteins (Chap­
ter V). The C-proteins are thought to be involved in the binding 
of the RNA to the nuclear matrix (van Eekelen and van Venrooy, 
J.Cell Biol. 88, 554-563 (1981)), 
Studying the nuclear localization of specific viral mRNA 
sequences it appears that polyadenylated as well as non-poly-
adenylated RNAs are almost quantitatively associated with the 
nuclear matrix (Chapter VI). This demonstrates that not only 
splicing but also polyadenylation takes place while the RNA is 
associated with the matrix structure. The same was found for 
pIX-specific RNA, of which the processing pathway does not in­
clude splicing. This indicates that "to be spliced" is obviously 
not a requirement for association of the RNA with the nuclear 
matrix. As soon as processing is completed the RNA is rapidly 
released from the nuclear matrix into the cytoplasm, where it 
to a certain extent becomes associated with the cytoskeletal 
framework (Chapter VI). The pIX-specific mRNA sequences have a 
nuclear dwell time of 4 min, while the major late mRNAв appear 
in the cytoplasm only about 20 min after transcription (Chapter 
VI). It is not unlikely that the late cleavage event at the ac­
ceptor site of intron 2 is responsible for the long stay of most 
late mRNA sequences in the nucleus. However, the size of the 
mRNA may also have its influence on the speed of nucleocyto-
plasmic transportation (Chapter VI) . 
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SAMENVATTING 
In de kern van eukaryotische cellen worden door het RNA poly­
merase II гапасгір еп gevormd die, om als boodschapper RNA 
(mRNA) in het cytoplasma te kunnen functioneren, moeten worden 
gemodificeerd (geprocessed) door o.a "capping", methylering, 
polyadenylering en "splicing". Wij hebben onze aandacht gericht 
op RNA splicing. In het bijzonder werd gekeken naar het losknip-
pen van introns uit pre-mRNAs, die overgeschreven zijn van het 
"major late" transcriptie gebied van het adenovirus genoom. De 
mRNAs die in dit gebied worden gecodeerd zflri samengesteld uit 
vier exons: leader 1, waar de 5' cap aan vast zit, leader 2, 
leader 3 en het gedeelte dat voor een eiwit codeert en dat ook 
de poly(A)-staart draagt. Eenmaal met elkaar verbonden worden 
de drie leaders samen de "tripartite leader" genoemd. Drie in­
trons, genummerd 1, 2 en 3, scheiden de exons van elkaar in de 
pre-mRNAs: intron 1 ligt tussen leader 1 en 2 in, intron 2 
tussen leader 2 en 3, en intron 3 ligt tussen leader 3 en het 
exon dat voor een eiwit codeert. 
Enkele aspecten van het splicing mechanisme. 
In het kern RNA z^ n intermediairen van de processing aanwezig, 
die een deel van een intron missen, wat er op wijst dat het uit­
knippen van zowel intron 1 als intron 2 in stappen verloopt in 
de 5' - 3' richting (hoofdstuk III), De plaatsen waar in het 
intron geknipt kan worden, kunnen onderscheiden worden in voor-
keursplaatsen en niet-voorkeursplaatsen. Het knippen op voor-
keursplaatsen kan al optreden in een RNA molecuul dat nog bezig 
is gesynthetiseerd te worden (hoofdstuk II). Kennelijk kan 
splicing aan polyadenylering vooraf gaan. Omdat een intron 
meerdere voorkeurs-knipplaatsen kan bevatten, kan de eerste knip 
op verschillende plaatsen in het intron worden aangebracht. 
Dergelijke alternatieve wegen voor splicing treden op bu het 
verwijderen van introns 1 en 2 (hoofdstuk II). Op de grens van 
intron en exon (acceptor site) vindt de laatste knip plaats, die 
snel gevolgd wordt door het ligeren van de exons (hoofdstukken 
II en III). Op grond van onze bevindingen wordt in hoofdstuk III 
een model voor splicing gepresenteerd. 
Splicing geechiedt in de З'-З' richting. 
Bü de vorming van de tripartite leader via eplicing kan г 
onderscheid worden gemaakt tussen vroege en late knippen. De 
laatste knip wordt aangebracht op de acceptor site van intron 
2. Dit gebeurt in een RNA-molecuul waar intron 1 al uit verwij­
derd is (hoofdstuk II). Aangezien het knippen van een acceptor 
site direct gevolgd wordt door ligering van de exonst gaat het 
llgeren van leader 1 met leader 2 kennelijk vooraf aan het li-
geren van leaders 2 en 3. Dit resultaat is ook verkregen door 
Keohavong en medewerkers (Nucl. Acids Res. 10, 1215-1229 (1982)). 
Hoewel het ligeren van de leaders dus in З'-З' richting verloopt, 
kan er toch in intron 2 geknipt worden voordat intron 1 wordt 
aangetast (hoofdstuk II). Ook rondom leader 3 wordt in een be­
paalde volgorde geknipt. Op het 3' eind van deze leader (donor 
site van intron 3) kan slechts worden geknipt, indien het knip­
pen op het 5' eind (acceptor site van intron 2) al heeft plaats­
gehad (hoofdstuk IV). Omdat knippen op de acceptor site van 
intron 2 snel gevolgd wordt door ligering van leader 2 met 
leader 3 (hoofdstuk II), gaat het ligeren van de leaders onder­
ling dus vooraf aan het ligeren van leader 3 met het eiwit-
coderende exon. Ligeren van de vier exons, waaruit de mRNAs van 
het major late gebied zijn opgebouwd, gebeurt geheel in de З'-З' 
richting. Hoewel het knippen op de donor site van intron 3 dus 
snel gebeurt, is het toch een late stap in het splicing proces 
omdat er gewacht moet worden op de late knip op de acceptor 
site van intron 2 (hoofdstuk IV), 
De mogelijke betrokkenheid van de kernmatrix bjj splicing en 
transport van mRNA. 
In introns 1 en 2 kan worden geknipt zonder dat dit gepaard 
gaat met ligering van de exons. Daardoor ontstaat de behoefte 
om de losgeknipte stukken RNA op de een of andere wijze bij el­
kaar te houden of bij elkaar te brengen, en wel in een zodanige 
oriëntatie dat de exons, nadat het intron in zijn geheel ver-
wijderd is, op de juiste manier worden geligeerd. Daarbij komt 
dat ook in intron 3 al kan worden geknipt voordat de tripartite 
leader klaar is (hoofdstuk IV). De knippen in het pre-mRNA 
kunnen in feite gelijktijdig worden aangebracht op plaatsen die 
meer dan 18000 nucleotiden van elkaar verwijderd zün. De kern-
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matrix, п structuur die voornamelijk is opgebouwd uit eiwit, 
zou in een dergelijke behoefte kunnen voorzien, omdat zowel 
cellulair ala adenovirus heterogeen nucleair RNA, waar het рг -
mRNA een onderdeel van is, kwantitatief met de matrix geassocieerd 
zijn (van Eekelen en van Venrooü, J.Cell Biol. 88^ 55í-5b3i van 
Е к і п et al., Eur.J.Biochem. 119, 461-467 (1981); hoofd­
stukken V en VI). Щ analyse van adenovirus-specifiek matrix 
RNA werden precursors, intermediairen en producten van splicing 
aangetroffen, waaruit kan worden geconcludeerd dat splicing 
optreedt terwijl het RNA aan de matrix gebonden is (hoofdstuk V). 
Alle mRNA-sequenties in de kern, die enige relatie hebben met 
het splicing proces, daarbij inbegrepen de producten die ontstaan 
door snel knippen in elk van de drie introns, zijn geassocieerd 
met de matrix (hoofstukken III en V). Hieruit volgt dat de 
kernmatrix inderdaad betrokken kan zijn bij de oriëntatie van het 
RNA gedurende het splicing-gebeuren. Bovendien kunnen al deze 
RNAs, door middel van UV-bestraling van intacte cellen, covalent 
worden gebonden aan gastheer eiwitten, die waarschijnlijk identiek 
zijn met de C-type hnRNP core eiwitten (hoofdstuk V). Deze 
eiwitten spelen vermoedelijk een rol bij de binding van het RNA 
aan de kernmatrix (van Eekelen en van Venrooü, J.Cell Biol. 88, 
554-563 (1981)). 
B5 het bestuderen van de lokalisatie van specifieke virale 
mRNA-sequenties in de kern bleek dat zowel gepolyadenyleerde 
als niet-gepolyadenyleerde RNAs nagenoeg kwantitatief geassoci-
eerd zijn met de kernmatrix (hoofdstuk VI). Hieruit volgt dat 
niet alleen splicing, maar ook polyadenylering optreedt ter-
wijl het RNA geassocieerd is met de matrix-structuur. Eenzelfde 
resultaat werd gevonden voor pIX-specifiek RNA, waarvan het 
mRNA niet gevormd wordt via splicing. "Splicing ondergaan" is 
klaarblijkelijk niet vereist voor het binden van RNA aan de matrix. 
Meteen na het voltooien van de processing wordt het RNA van de 
kernmatrix losgemaakt en gaat het naar het cytoplasma, waar 
het voor een bepaald percentage geassocieerd wordt met het 
cytoskelet (hoofdstuk VI). Het pIX-specifieke RNA heeft een 
verblijftijd van slechts 4 minuten in de kern, terwijl mRNAs af-
komstig van het major late gebied pas zo'n 20 minuten na 
transcriptie in het cytoplasma verschijnen. Het is niet onwaar-
schijnlijk dat het vertraagde knippen op de acceptor site van 
intron 2 de oorzaak і van het lange verbljjf in de kern van 
de meeste late mRNA-eequenties. Ook de grootte van het mRNA zou 
echter van invloed kunnen zijn op de transportsnelheid (hoofd­
stuk VI). 
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